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Abstract 
Human surfactant protein D (hSP-D) is a C-type lectin and member of the collectin family 
that is involved in pathogen recognition as part of the innate immune response.  
Recognition occurs through the carbohydrate arrays on the surfaces of the pathogens.  This 
work focuses on characterising, at the atomic level, the recognition of oligosaccharide 
analogues of the carbohydrate arrays using a recombinant fragment of human surfactant 
protein D (rfhSP-D). 
The crystal structures of three rfhSP-D complexes with the α(1→6)-linked isomaltotriose, 
β(1→4)-linked cellotriose and β(1→3)-linked laminaritriose have been successfully solved in 
P21 using rigid body refinement.  Isomaltotriose was refined to 1.96Å with refinement 
statistics: Rwork 0.1664 and Rfree 0.2084.  Cellotriose was refined to 1.59Å with refinement 
statistics: Rwork 0.0.1879 and Rfree 0.2106.  Laminaritriose was refined to 1.75Å with 
refinement statistics: Rwork 0.1808 and Rfree 0.2193.  In combination with two previously 
solved malto-N-ose complexes, the structures reveal a new binding mechanism for β-D-
glucoses in SP-D and identify a new extended binding surface. 
The crystal structure of rfhSP-D in complex with the disaccharide unit of peptidoglycan, 
muramyl disaccharide, extracted from the gram-positive bacteria, Micrococcus luteus has 
been solved in P21 and refined to 1.95Å with final refinement statistics of Rwork 0.1708 and 
Rfree 0.2169.  This crystal structure provides the first insight into recognition of 
peptidoglycan, an important part of the bacterial cell wall. 
The rfhSP-D complex with the R7 rough mutant oligosaccharide from S. enterica minnesota 
has been redetermined from previous work in the group.  The structure has been solved in 
P21 and refined to 1.75Å with final refinement statistics of Rwork 0.1730 and Rfree 0.1960.  The 
crystal structure, along with the known R5 oligosaccharide complex, builds on the 
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understanding of the flexibility and versatility of lipopolysaccharide recognition by hSP-D 
and the important role of the two flanking residues, Asp325 and Arg343. 
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Chapter 1:  Introduction to the collectins, surfactant protein D and 
its ligands 
1.1 Introduction to the immune system 
The immune system is a complex and essential part of every multicellular organism that is 
responsible for protecting the organism from potentially pathogenic infections from a 
range of bacteria, viruses, fungi and protozoa.  In the phylogenetically ancient horseshoe 
crab, Limulus polyphemus, the immune system is reliant on a small number of systemic 
immune molecules that are able to specifically bind a wide range of different targets and 
effectively removing them from the system [Marchalonis and Edelman, 1968; Roche and 
Monsigny, 1974; Kawabata and Iwanaga, 1999].  In humans, the immune system has 
evolved into a large, interconnected web of immune proteins and highly specialised 
immune cells, concerting a response to invading pathogens and minimising the damage 
the pathogen can cause [Janeway, 1989; Chaplin, 2006].  This has led to the human immune 
system being divided into two sections: (1) the innate, protein driven, immune system; and 
(2) the acquired immune system. 
1.1.1 The innate immune system 
The innate immune system serves as the ‘first line of defence’ when the immune system is 
challenged because of its ability to recognise a huge range of pathogens by common 
recognition markers on the pathogens surface, referred to as pathogen-associated 
molecular patterns (PAMPs).  Many of these markers are often integral to the pathogen 
which makes them good targets for pattern recognition receptors (PRRs) of the immune 
system as they will be expressed throughout whole genera of pathogens, leading to the 
innate immune system being described as non-pathogen specific [Kawai and Akira, 2010].  
However, PRRs recognise specific patterns (PAMPS) allowing the immune response to 
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selectively target pathogens rather than structures regularly found on host cells, preventing 
an autoimmune activation.   
1.1.2 The acquired immune system 
The acquired or “adaptive” immune system responds less rapidly to an infection of a new 
microbe as it must be primed to elicit a response against a particular pathogen because not 
only is the response considerably more pathogen-specific, but also a molecular 
“knowledge” of the pathogen is required before an effective immune response can be 
mounted.  Many of the molecules in the acquired immune response, such as antibodies 
secreted by differentiated plasma cells, are highly specific to a single epitope on the surface 
of a pathogen and, therefore, do not bind more than one type of pathogen [Medzhitov, 
2007].  A second presentation of the microbe results in clearance of an infection more 
efficiently than the innate system as the previously generated antibodies are preserved on 
the surface of memory T cells and memory B cells in the circulation [MacLeod, Kappler and 
Marrack, 2010; Pape et al., 2011]. 
1.1.3 The C-type lectin superfamily and their role in the immune system 
An essential part of the innate immune system are the C-type lectins, a large family of 
calcium-dependent carbohydrate recognition proteins that share homology in a 
characteristic lectin domain.  The lectin domain is formed primarily from an antiparallel 
beta sheet comprising five or six beta strands and two flanking alpha helices, forming a 
globular domain with a hydrophobic core, with the additional beta strand (β1 in Figure 1.1) 
forming a beta hairpin at the N-terminal of the domain [Zelensky and Gready, 2005].  
Beyond the highly structured part of the domain, there are two loop regions between β3 
and β4 that form the main calcium coordinating regions and form the main ligand 
recognition surface.  The first, or short, loop region (L1, Figure 1.1) is widely conserved 
within C-type lectin domains (CTLDs) and has been shown to have a wide range of 
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topology between proteins, depending on the presence of the third calcium ion (Ca3).  The 
second loop region (L2) is less widely conserved and has led to two distinct groups of 
CTLDs being identified: canonical CTLDs that have a long L2 region extending from the C-
terminal of the L1 region; and compact CTLDs that do not have the long L2 region and, in 
some cases, lacks the L1 loop [Weis, Taylor and Drickamer, 1998; Zelensky and Gready, 
2005].   
As previously alluded to, the number of calcium ions varies across the C-type superfamily 
with some containing as few as one calcium ion, such as in the CTLD of E- and P-selectin, 
whilst others, including surfactant protein D, can contain up to three calcium ions [Somers 
et al., 2000; Shrive et al., 2003].  The most conserved calcium binding site is the first binding 
site (Ca1, Figure 1.1), formed between the C-terminal end of the L2 region (where present) 
and the fifth beta sheet (β5, Figure 1.1).  The remaining two calcium ions bound via the 
loop regions, Ca2 and Ca3, are more variable than the Ca1 site, especially the Ca3 site 
which varies even among subfamilies of C-type lectins; such as the collectins [Weis and 
Drickamer, 1994; Shrive et al., 2003; Feinberg, Taylor and Weis, 2007; Girija et al., 2015].  
Interestingly, beyond these three main calcium ion sites, a fourth alternative calcium 
binding site has been identified at the base of the domain, between α2 and the beta sheet, 
of C-type lectins that may have downstream functions in the activation of immune cell 
receptors [Zelensky and Gready, 2005]. 
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Figure 1.1:  The C-type Lectin Domain.  Left: 2-Dimensional, expanded representation of the C-type lectin domain (blue) and the calcium coordinating 
elements (orange).  Right: 3-Dimensional ribbon diagram of the C-type lectin domain of human surfactant protein D, coloured to match left.  The three 
calcium ions (represented by orange circles/spheres) are coordinated by the loop region 1 (L1), the C-terminal of loop region 2 (L2) forming an alpha-
helical turn (α3), and the fifth beta strand (β5).  The sixth beta strand (β6) inserts between the two alpha helices to complete the beta sheet.  Residues 235 – 
355 of a recombinant fragment of hSP-D (1PW9) was used to generate the ribbon diagram [Shrive et al., 2003].  
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The conservation of the C-type lectin fold results in members of the superfamily having 
numerous roles in the immune system that relate to their location in relation to the cell.  
This allows the family to be broadly divided into two groups that have different 
immunological roles.  The soluble lectins, which include the collectins, have been identified 
as PRRs in most tissues and systemically in circulation; contributing to a significant part of 
the innate immune systems ability to recognise pathogenic carbohydrate arrays through 
interactions with the lectin carbohydrate recognition domain (CRD) [Drickamer, Dordal and 
Reynolds, 1986; Crouch, Smith, et al., 2006; Veldhuizen, Van Eijk and Haagsman, 2011].  
Following recognition of the invading microorganism, the soluble lectins then activate and 
regulate the cellular response to the pathogen by stimulating phagocytosis and modulating 
the release of inflammatory cytokines [Sano et al., 1999; Jack et al., 2001; Nadesalingam, 
Reid and Palaniyar, 2005; Wright, 2005; Ip et al., 2008].  This eventually leads to the 
activation of the acquired immune system.  The role of the soluble lectins also extends to 
regulating other immune systems including complement through interactions between 
mannose binding protein (MBP), surfactant protein A (SP-A) and, reported more recently, 
CL-K1 and CL-L1 and key components of the complement cascade, such as the C1 complex 
and serine proteases that cleave C3 [Watford et al., 2001; Gingras et al., 2011; Henriksen, 
Brandt, Andrieu, et al., 2013; Ma, Skjoedt and Garred, 2013]. 
The second, much larger group of C-type lectins that have a role in the immune response 
are the membrane-bound receptors that recognise a range of ligands from a wide variety 
of sources.  Many of the membrane-bound receptors, including mincle, dectin-1 and -2 and 
dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN), recognise the carbohydrate 
arrays of pathogens and elicit activation of the intracellular signalling pathways through 
cytoplasmic domains [reviewed by Drickamer and Taylor, 2015].  These signalling pathways 
are often shared with other immune receptors, such as toll-like receptors in the case of DC-
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SIGN activation, and lead to the release of proinflammatory cytokines and trigger 
phagocytosis of the bound organism [Gringhuis et al., 2009, 2014; Werninghaus et al., 2009; 
Lobato-Pascual et al., 2013].   
The other group of membrane-bound C-type lectins function in cell adhesion and 
glycoprotein clearance that enable leukocyte migration and minimise the inflammatory 
glycoprotein components of damaged cells and microorganisms.  The selectin family (E-
selectin, P-selectin and L-selectin), for example, play a critical role in capturing circulating 
leukocytes through glycoproteins on their surface and initiate the migration of the 
leukocyte across the endothelium and into the infected tissue [Somers et al., 2000].  Other 
membrane-bound C-type lectins such as CL-P1 (or scavenger receptor C-type lectin, SRCL) 
langerin and macrophage mannose receptor (MR) have been shown to have more versatile 
roles within the immune response [Weis, Taylor and Drickamer, 1998] with all three 
involved in clearing glycoproteins by endocytosis.  Both MR and langerin can also directly 
recognise fungal pathogens and stimulate phagocytosis whereas CL-P1 has been shown to 
have a role cell adhesion comparable to the selectins [Stahl et al., 1978; Taylor, Gordon and 
Martinez-Pomares, 2005; Feinberg, Taylor and Weis, 2007; de Jong et al., 2010]. 
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1.2 Introduction to the collectins 
The collectins are a subfamily of the C-type lectin superfamily that have a characteristic 
collagen-like domain linked to the N-terminal of the C-type lectin domain by a short alpha-
helical neck region.  This section introduces the collectin family and the general structural 
features associated with the mammalian collectins. 
1.2.1 Known mammalian collectins 
Collectins have been putatively identified in both vertebrate and invertebrate species, 
including phylogenetically distant members of the chordata phylum; all of which share 
structural and functional homology [Nair et al., 2000; Green, Nair and Raftos, 2003; Green et 
al., 2006].  The most well understood of the mammalian collectins.  A total of nine 
mammalian collectins have been identified with many being present across more than one 
genus.  A subset of these are only found in Bovidae species and are known as the bovine 
collectins. 
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Table 1.1:  Summary of the mammalian collectins.  The table summarises the number of 
isoforms, important phylogenetic families they have been identified in, the length of the 
characteristic collagen-like domain (in amino acid residues) and the total number of cysteine 
residues in the N-terminal that are important for oligomerisation.  The data for the number of 
isoforms, where available, relates to the number of isoforms present in humans. 
Collectin Isoforms1 Species  Collagen 
Domain 
Length2 
Total 
Cysteine 
Residues3 
References 
Surfactant 
Protein D 
1 H. sapiens, 
Suidae, 
Muridae, 
Bovidae 
26→202 
(176) 
2 [Håkansson 
et al., 1999; 
Shrive et al., 
2003] 
Surfactant 
Protein A 
2 H. sapiens, 
Muridae 
27→100 
(73) 
35 [Head et al., 
2003; 
Kishore et 
al., 2006] 
Kid Binding 
Protein 
2* H. sapiens, 
Muridae 
41→101 
(60) 
3 [Weis et al., 
1992; 
Gingras et 
al., 2011] 
CL-L1, 
Collectin 104, 
CL-Liver 14 
2# H. sapiens 
Muridae 
53→112 
(59) 
1 [Ohtani et 
al., 1999; 
Axelgaard et 
al., 2013] 
CL-K1, 
Collectin 114, 
CL-Kidney 14 
2# H. sapiens, 
Muridae, 
Bovidae 
62→101 
(39) 
1 [Keshi et al., 
2006; 
Hansen et 
al., 2010] 
CL-P1, 
Collectin 124, 
CL-Placenta 14 
1 H. sapiens, 
Muridae, 
Bovidae 
423→589 
(166) 
N/A [Ohtani et 
al., 2001; 
Coombs et 
al., 2005] 
Conglutinin N/A Bovidae 44→98 
(54) 
35 [Lee et al., 
1991] 
CL-43 N/A Bovidae 48→162 
(114) 
2 [Hansen et 
al., 2003] 
CL-46 N/A Bovidae 46→216 
(170) 
2 [Hansen et 
al., 2002] 
1Isoforms in H. sapiens 
2Number of amino acids residues in the collagen-like domain 
3Number of cysteine residues in the N-terminal domain 
4Alternative name for collectin 
5One of the cysteine residues are in the collagen-like domain 
*In mice 
#Including the CL-LK hybrid trimer identified by [Henriksen et al., 2013a] 
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1.2.2 General structure and oligomerisation of collectins 
Most collectins identified to date are secreted as homotrimers containing three identical 
subunits, with the exception of CL-P1 which is a membrane-bound scavenger receptor and 
hSP-A which may be secreted as a heterotrimer of two, very similar isoforms of hSP-A, SP-
A1 and SP-A2 [table 1.1; DiAngelo et al., 1999].  All of the collectins, however, share four 
major structural domains: (1) the cysteine-rich N-terminal domain; (2) the long collagen-
like domain; (3) the α-coiled coil neck domain and; (4) the carbohydrate recognition 
domain (CRD), or lectin domain, in a distal position to the N-terminal at the C-terminus 
[Figure 1.2].   
The N-terminal domain (1) contains a high proportion of cysteine residues (table 1.1) in all 
of the soluble collectins, which are involved in forming extensive sulphide bridges between 
monomers and trimeric units to form larger oligomeric structures [McCormack, 
Damodarasamy and Elhalwagi, 1999].  Disruption of the sulphide bridges at positions 15 
and 20 of rat SP-D had a dramatic effect on its ability to form larger oligomers and 
attenuated any agglutination of viral particles or stimulation of the immune response, 
suggesting that the multimerisation through the N-terminal is critical for the collectins to 
function [Brown-Augsburger et al., 1996]. 
The collagen-like domain (2) is characterised by a right-handed triple helical bundle formed 
from three, left-handed helical monomers which contain the Gly-Xaa-Yaa motif associated 
with collagen [Kishore et al., 2006; Gingras et al., 2011].  As with other collagen helices, 
proline at position X is commonplace in the collectins, with other amino acids substituted 
at position Y, resulting in torsional flexibility around the glycine residue that creates a loose 
coiled conformation, promoting the formation of the triple helix when two other 
monomers are present.  Once the collagen-like domain has formed it is a highly stable 
structure, forming a rod-like fragment when proteolytically cleaved in SP-D, due to an 
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extensive network of hydrogen bonds between the backbone amide bonds and carbonyl 
oxygens [Crouch et al., 1994].  Interestingly, a conserved cysteine residue (Cys20 in MBP) is 
present at the beginning of the collagen domain that forms a single interchain interaction 
that appears to aid the assembly of the collagen domain, showing some interplay between 
the cysteine-rich N-terminal and the collagen-like domain [Hartshorn et al., 1994]. 
The role of the collagen-like domain extends beyond simple structural strength and 
separation of the two terminal domains, playing a more active role in the function of all of 
the collectins due to a number of structural differences.  In SP-A and MBP, for example, 
there is an interruption in the Gly-X-Y motif, where X and Y are substituted with a highly 
conserved Gln-Gly motif in the X-Y positions, that causes the collagen domain of the trimer 
to kink, forcing the CRD cluster to be offset compared to the main collagen axis in a similar 
way to the overall architecture of the C1q hexamer [Drickamer, Dordal and Reynolds, 1986; 
Voss et al., 1988; King, Simon and Horowitz, 1989; Tenner et al., 1989; Kishore and Reid, 
2000].  This is compounded by an additional cysteine present in the SP-A sequence, 
conserved between the two isotopes and mammalian species, that coincides with the 
collagen interruption and potentially forms additional disulphide bonds between the 
monomers of the trimer and may stabilise the larger hexatrimer [Figure 1.3; Head et al., 
2003]. 
In MBP, the kink in the collagen-like domain enables MBP-associated serine proteases 
(MASPs) to bind to the collagen-like helix in the space created by the kinks in a similar way 
to C1r and C1s proteases associated with C1q in the C1 complex, allowing the MBP-MASP 
complex to activate the lectin pathway in the complement system [Schwaeble et al., 2002; 
Wallis, 2002].  However, SP-A does not activate the complement system because it does 
not contain the MASP-recognition motif necessary for MASPs to bind MBP, preventing the 
formation of a SP-A-MASP complex [Watford, Ghio and Wright, 2000; Gingras et al., 2011].  
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Interestingly, MASPs have recently been identified in complex with CL-L1, CL-K1 and a 
naturally occurring heteromeric CL-LK, which contains two CL-K1 monomers and a CL-L1 in 
the trimeric unit [Henriksen et al., 2013a; Henriksen et al., 2013b].  The quaternary structure 
of these three trimers is not clear but there is increasing evidence that these oligomer-
MASP complex have a role in activating the lectin pathway of complement [Henriksen et al., 
2013a; Ma, Skjoedt and Garred, 2013]. 
The α-coiled coil neck region is a flexible region that precedes the C-terminal CRD and is 
formed from three parallel α-helices in the assembled trimer, forming a left-handed coil 
[Hoppe, Barlow and Reid, 1994; Shrive et al., 2003].  Remarkably, it appears that the neck 
region may be fundamental in forming the collagen-like domain as the α-coiled coil neck 
domain of SP-D has been shown to self-assemble and, in turn, assemble the collagen-like 
fragment.  This property is reflected in the crystal structure of a recombinant fragment of 
hSP-D (containing a short collagen fragment, the neck domain and C-terminal CRD, 
residues 179-355), which is in its native trimeric assembly despite lacking the N-terminal 
and most of the collagen-like domain [Shrive et al., 2003]. 
The final domain is the CRD (4) that shares homology with the C-type lectins, forming a 
large globular domain with a hydrophobic core and, in the case of collectins, containing 
between two and four calcium ions [Sheriff, Chang and Ezekowitz, 1994; Head et al., 2003; 
Shrive et al., 2003; Girija et al., 2015].  The CRD forms the basis of pathogen recognition in a 
calcium dependent mechanism, through interactions with the elaborate and often 
conserved carbohydrate arrays on the surface of microbes and allergens.  The mechanism 
for the recognition of carbohydrates by hSP-D, discussed later in this chapter, has been 
widely studied and is the focus of the work presented in this thesis.  There has also been 
some success in deciphering the molecular mechanisms of carbohydrate recognition in 
MBP, SP-A and CL-K1 from a variety of species.  
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Collectin-P1 is the exception to the general homology.  While it does have the 
characteristic C-type lectin domain at the C-terminus, the α-coiled coil domain and 
collagen-like domain are switched placing the coiled coil domain proximal to the 
membrane-anchor domain and the collagen-like domain connecting directly to the CRD, 
showing closer homology to type-A scavenger receptors (SRAs) in overall domain 
arrangement [Peiser, Mukhopadhyay and Gordon, 2002].  As a result, it has been suggested 
that CL-P1 is not a true collectin and, instead, is much more closely related to SRAs with 
genetic convergence producing a collectin-like CRD with a galactose specificity [Coombs et 
al., 2005; Feinberg, Taylor and Weis, 2007].   
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Figure 1.2:  Trimerisation of Collectin Monomers.  Summary of collectin trimerization, providing detail about each domain (N-terminal domain (green); 
collagen-like domain (cyan/purple); α-coiled coil neck domain (orange) and; carbohydrate recognition domain (red)) and the characterised structures 
(where available).  Structure for the mannose binding protein collagen-like domain, two lower inserts, solved at 1.49Å, was generated from [3POD, Gingras 
et al., 2011] and the native structure of the C-terminal fragment of hSP-D, two top inserts, solved at 1.6Å, was generated from [1PW9, Shrive et al., 2003].  
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Figure 1.3:  Oligomerisation of Collectin Trimers.  Summary of the known oligomerisation states of collectin trimers using the same colour scheme as 
Figure 1.2 for reference domains.  Three major oligomers have been identified; Dodecameric (tetramer of trimers) cruciform, Hexatrimeric bundles and; 
higher order oligomers of hSP-D cruciform.  Observed in electron microscopy of bronchoalveolar lavage and blood samples.  
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A major characteristic of the collectins is their quaternary oligomerisation that is integral to 
the function of all members of the family [Palaniyar et al., 2002].  Surfactant protein D and 
conglutinin, a bovine collectin that shares its evolutionary origins with SP-D, have both 
been observed as dodecameric cruciforms formed around a central ‘hub’ of covalently 
linked N-terminal domains of all four trimers [Figure 1.3; Lu et al., 1993; Crouch et al., 1994; 
Hansen and Holmskov, 2002].  Interestingly, despite the overall homology, the SP-D 
dodecamer appears to have further associations between the trimers, which form two 
trimeric pairs that restrict the overall freedom of the trimers around the N-terminal hub 
compared to conglutinin, which appears to have a greater degree of freedom around the 
hub [Lu et al., 1993].  Around 10% of SP-D has also been identified in much larger, higher 
order oligomers containing up to 32 trimeric units arranged radially around the N-terminal 
hub, forming a ‘cart wheel’ or ‘fuzzy ball’ of CRDs around an N-terminal/collagen core 
[Crouch et al., 1994].  As with the dodecamer, the higher order oligomer appears to contain 
pairs of trimers which may suggest the large assembly, that brings 96 individual CRDs 
together, may be a complex of the dodecameric cruciforms linking together through free 
cysteine residue in the terminal of multiple dodecamers.  The high number of CRDs in both 
the dodecameric and oligomeric complexes is suggested to be important in agglutinating 
pathogens, promoting recognition by multiple CRDs and crosslinking pathogens and 
receptors in vivo [Crouch et al., 1994]. 
SP-A and MBP also assemble into larger oligomers of the basic trimer coordinated by 
disulphide bridges in the N-terminal domain.  However, the collagen-like domains in SP-A 
and MBP assemble into a parallel bundle at the N-terminal and the interruption in the 
collagen motif allows the recognition domains to project away from each other, in a similar 
way to the assembled C1q complex [Figure 1.3; Kishore and Reid, 2000].  A recent study has 
suggested that there may be also be additional trimeric and tetrameric oligomers of MBP 
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and that these may, in fact, maintain the activation of the lectin pathway in the absence of 
the hexatrimer, suggesting that the hexatrimeric bundle may not only improve the affinity 
of pathogen recognition but may improve the MASP activity of the MBP-MASP complex by 
bringing two MASP proteins together [Kjaer et al., 2016].  This may suggest the hexameric 
bundle is, in fact, formed from two trimers of trimers.  
Unlike the other collectins, CL-L1, CL-K1 and CL-P1 in humans and CL-46 and CL-43 in 
Bovidae have not been observed in large immunological complexes, beyond dimers and 
trimers, by electron microscopy however mass analysis of CL-L1 and CL-K1 has suggested 
that there are larger tetramers and hexamers in serum [Keshi et al., 2006; Ohtani, Suzuki 
and Wakamiya, 2012].  The CL-LK hybrid trimer has also been shown to form trimers in 
serum, with some speculation that it may be able to form larger hexamers however further 
work is required to completely characterise CL-LK multimerisation [Henriksen et al., 2013a].  
CL-P1 is an exception to the other human collectins because it is membrane-bound 
scavenger receptor and does not undergo any further oligomerisation in the membrane, 
although there is evidence that trimers may cluster together at the cell-cell interface where 
they are active [Ohtani et al., 2001; Coombs et al., 2005].  Surprisingly, considering that 
oligomerisation of the human collectins seems important for function, the bovine collectin 
CL-43 has only been observed as single trimeric units and does not form any oligomeric 
complexes but has been shown to have a high affinity for viral particles [Holmskov et al., 
1995; Rothmann et al., 1997; Hartshorn et al., 2002].  The multimerisation of CL-46, the final 
bovine collectin descended from SP-D, is widely reported to form a dodecameric cruciform, 
similar to SP-D and conglutinin, however there is no direct evidence of this in the literature. 
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1.2.3 Localisation of human collectins 
The human surfactant proteins, SP-D and SP-A, are both primarily expressed in the lining of 
the alveolar sacs in the bronchoalveolar lavage, secreted by the alveolar type II cells, clara 
cells and alveolar macrophages [Voorhout et al., 1992].  SP-D has been largely associated 
with the aqueous sublayer of the lavage, closer to the cell surface, whereas SP-A more 
readily associates with the lipid in the surfactant, actively regulating how the surfactant is 
behaving and preventing the air sacs from closing by reducing surface tension during 
exhalation [Madsen et al., 2000].   
Beyond the epithelia of the lung, expression of hSP-D has been identified in a range of 
other tissues, including the majority of the mucosal tissues and many other important 
tissues such as the brain, kidneys and heart [Madsen et al., 2000; Leth-Larsen et al., 2004; 
Ujma et al., 2017].  More recently, it has also been identified in the secretion from the 
gallbladder, where it is believed to play a role in regulating the gut flora to maintain 
healthy digestion, and the eye of mouse models infected with S. aureus [Zhang et al., 2015; 
Sarashina-Kida et al., 2017].  Similarly, expression of SP-A has been identified in the 
gastrointestinal tract, genital and reproductive tracts and beyond, playing an important role 
in host defence against a range of opportunistic pathogens, including human 
immunodeficiency virus and Chlamydia trachomatis [Oberley, Goss, et al., 2004; Meschi et 
al., 2005].  The localisation of the surfactant proteins at the interfaces between the host and 
the outside world, where cells are under a constant bombardment of potentially toxic and 
pathogenic substances and organisms has led to hSP-D and hSP-A being identified as a 
key part of the ‘first line of defence’ in the innate immune response. 
By comparison, the other collectins are found more systemically and not at the epithelial 
interfaces where the surfactant proteins localise.  Mannose binding protein and CL-L1 are 
primarily synthesised in hepatocytes where they are then secreted into the bloodstream 
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and enter general circulation, operating as an underlying surveillance mechanism once a 
pathogen successfully enters the bloodstream [Drickamer, Dordal and Reynolds, 1986; 
Ohtani et al., 1999; Axelgaard et al., 2013].  Similarly, CL-K1 is synthesised in renal cells and 
secreted back into the blood following renal processing, allowing the CL-K1 to immediately 
enter the circulation.  Interestingly, the natural occurrence of the CL-LK hybrid trimer 
suggests that there is also colocalisation of CL-K1 and CL-L1 monomers as the trimers are 
secreted in their assembled form [Henriksen, Brandt, Andrieu, et al., 2013].  This has 
putatively been identified as hepatocytes, however further studies are required to complete 
the characterisation of the synthesis.  The exception to this, is CL-P1, or scavenger receptor 
C-type lectin, which is membrane-bound.  CL-P1 was first identified in the placenta from its 
gene sequence homology with the other collectins but has since been identified in human 
umbilical vein endothelial cells (HUVECs) and the systemic endothelial cells. Wider 
expression in most tissues has however been observed [Ohtani et al., 2001].  
1.2.4 Carbohydrate recognition by the collectins 
The main function of the collectins is to recognise carbohydrates via the carbohydrate 
recognition domains that they all share with the wider C-type lectin superfamily.  The CRD 
in the collectins is particularly well conserved between family members with the calcium 
coordinating residues being 88.9% conserved or having similar functional properties, with 
the only exception being in the two SP-A isoforms that share a conserved proline at 
position 175 which would otherwise coordinate Ca2 and Ca3 in the other collectins [Figure 
1.4].  Despite this, specificity for different carbohydrates has been observed for each 
collectin which suggests the residues surrounding the calcium-binding pocket play a 
significant role in selecting ligands [table 1.2].   
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Table 1.2:  Ligand Specificity of the Collectins.  Specificity based on IC50 values in the literature.  
Abbreviations:  Mal, maltose; Glc, glucose; GlcN, Glucosamine; GlcNAc, N-acetylglucosamine; 
Man, mannose; ManNAc, N-acetyl-mannosamine; Fuc, fucose; Gal, galactose; GalNAc, N-acetyl-
galactose; Lac, lactose 
Collectin Ligand Specificity References 
hSP-D Mal, ManNAc > L-Fuc > Glc > Man >> 
GlcN > Gal, GlcNAc 
[Ogasawara et al., 
1992; Lim et al., 
1994; Hansen et 
al., 2002] 
hSP-A ManNAc > L-Fuc, Mal > Glc > Man/Gal [Haurum et al., 1993] 
hMBP GlcNAc > Man, L-Fuc > ManNAc >> Mal > Glc 
[Haurum et al., 
1993] 
hCL-K1 L-Fuc >> Man [Keshi et al., 2006] 
hCL-L1 Man/L-Fuc > ManNAc >> Glc, GlcNAc 
[Ohtani et al., 
2012; Axelgaard 
et al., 2013] 
hCL-P1 GalNAc >L-Fuc, D-Fuc, Gal >> Glc > GlcNAc, Man 
[Yoshida et al., 
2003] 
bCong GlcNAc >> ManN > L-Fuc, Man > Glc > ManNAc, GlcN, Mal > Gal > D-Fuc 
[Haurum et al., 
1993; Hansen et 
al., 2002] 
bCL-46 GlcNAc >> ManNAc, ManN > Malt > Glc, Man, L-Fuc >> Gal 
[Hansen et al., 
2002] 
bCL-43 Man, ManNAc > L-Fuc > GlcNAc > Glc, 
Malt > Gal > Lac >> GalNAc 
[Hansen et al., 
2002; Hartshorn 
et al., 2002] 
 
In all of the collectins, there is a preference for glucose-type or mannose-type 
carbohydrates with some, such as hSP-D, showing higher affinities for disaccharide units 
compared to the monosaccharides (table 1.2).  This is with the exception of CL-K1 which 
has high affinity for L-fucose which is common in mammalian glycosylation structures 
despite its irregular L-form [Keshi et al., 2006; Girija et al., 2015].  The ligand specificity 
results from small changes in the amino acid residues that form the main Ca1 binding 
pocket and directly influence the accessibility of Ca1, interacting with the ligands to 
increase binding affinity [Figure 1.4; Shrive et al., 2003, 2009].  Studies using mutants of 
hSP-D and MBP have investigated the effects of changing or removing the influential side 
chains that flank the Ca1 pocket.  In SP-D, mutations of Asp325 (D325A) and Arg343 
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(R343V) opens up the binding site, allowing for recognition of much longer mannose 
ligands [Goh et al., 2013].  Similarly, point mutants of ligand coordinating side chains in rat 
MBP have identified His202, Asp212, Arg216, Pro217 and Tyr218 as important residues for 
ligand selection and recognition, going as far as mutating all of the side chains and 
changing the preference of the CRD [Feinberg et al., 2000].  A similar mutation study using 
rat SP-A has also shown that substitutions of residues 171, 175, 197 and 203 (which form 
the loop that flanks the Ca1 binding site) with SP-D-like side chains produces an affinity 
profile similar to SP-D, confirming that the selectivity is conferred by the residues that flank 
the binding site [Rynkiewicz et al., 2017].  
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Figure 1.4:  Primary Sequence Alignment of Nine Collectins.  Key calcium coordinating residues 
are highlighted and coloured according to similarity to human SP-D (hSP-D).  Both isoforms of 
human SP-A (SP-A1; SP-A2) are represented for completeness.  Yellow, identical; green, similar 
property; cyan, different property (i.e. non-polar); magenta, large side chain with different 
property.  CRD numbering (236-355) based on the native rfhSP-D structure [Håkansson et al., 
1999].  Sequences from the National Center for Biotechnology Information (NCBI) protein 
database were manually aligned using the calcium binding amino acids to anchor the 
alignment.   
Chapter 1  Roles of the Collectins 
22 | P a g e  
 
1.3 Roles of the collectins in the immune system 
The primary role of all collectins is recognising the carbohydrates on the surfaces of 
potentially pathogenic cells and particles, including medically important bacteria and 
viruses, providing an essential contribution to the innate immune response.  However, the 
role of each collectin in the immune response is different, contributing various modes of 
action to disable the pathogen or stimulate further responses [Figure 1.5].   
 
Figure 1.5:  Cell Clearance by the Collectins.  Summary of pathogen clearance by the collectins 
through a number of pathways.  The four major pathways are opsonisation (highlighted by pale 
purple); agglutination and deactivation of virulence factors; direct cell lysis; and activation of the 
lectin pathway in complement, leading to cell clearance.  (*) no published evidence that CL-46 
forms tetratrimeric cruciforms.  (?) unclear how CL-43 upregulates phagocytosis 
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1.3.1 Opsonisation and phagocytosis 
Opsonisation, the process by which a pathogen or immunogenic material is ‘tagged’ for 
destruction, is a common function for all of the soluble collectins [Malhotra and Sim, 1995; 
Pikaar et al., 1995].  MBP, SP-A and SP-D have all been shown to opsonise strains of 
bacteria, virus particles and fungi, with SP-D being identified as an opsonin (molecular ‘tag’) 
for further species including the protozoa Schistosoma mansoni, allergens and carbon 
nanotubes [Van De Wetering et al., 2004; Pondman et al., 2017].  The bovine collectins also 
opsonise a range of pathogens associated with disease in cattle, including M. bovis and 
Nebraska Calf Diarrhoea Virus [Reading, Holmskov and Anders, 1998].  The function of CL-
43, in particular, is primarily as an opsonin as it does not multimerise but has been shown 
to effectively upregulate phagocytosis of influenza A virus (IAV) [? in Figure 1.5]. 
The surfactant collectins opsonise gram-positive and -negative bacteria, such as E. coli and 
S. aureus, viral particles from human immunodeficiency virus (HIV) and IAV and fungal 
pathogens including Aspergillus fumigatus [McNeely and Coonrod, 1993; Hartshorn et al., 
1996, 1998; Madan et al., 1997; Madsen et al., 2013].  A number of receptors can then be 
activated through interactions between SP-A and SP-D and the extracellular domains, 
eliciting cell activation and phagocytosis [reviewed by Jakel et al., 2013].  The interaction 
between the surfactant proteins and the calreticulin/CD91 complex stimulates phagocytosis 
and release of tumour necrosis factor α (TNF-α) from macrophages and alveolar type II cells 
following activation of nuclear factor-κB (NF-κB) and p38 signalling pathways [Gardai et al., 
2003].  Recognition of hSP-D and hSP-A by calreticulin/CD91 is reported to occur through 
the collagen-like domains [Gardai et al., 2003], enabling them to bind a surface 
carbohydrate by the CRD whilst being bound by the receptor, potentially anchoring the 
pathogen to the surface of the macrophage during phagocytosis.   
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A similar binding mechanism has also been observed more recently during the recognition 
of hSP-D by the CCR2+ monocyte receptor, osteoclast-associated receptor (OSCAR) 
[Barrow et al., 2015; Zhou et al., 2016].  As with the calreticulin/CD91 interaction in 
macrophages, binding of SP-D to OSCAR elicited a release of TNF-α from the monocytes 
leading to propagation of the inflammatory response [Barrow et al., 2015].  Interestingly, 
the recognition of the SP-D collagen domain was further characterised, identifying a nine-
amino acid motif (GPOGPAGFO) as the main recognition domain which was ligated by two 
separate binding sites in the Fc region of OSCAR [Zhou et al., 2016]. 
Other receptors involved in phagocytosis have also been implicated in SP-A and SP-D 
stimulated cellular uptake, including toll-like receptors (TLRs), CD14 and, tentatively, the 
soluble receptor gp340.  TLR2 and TLR4 both recognise SP-A and SP-D following bacterial 
recognition, regulating phagocytosis following activation of either receptor [Murakami et 
al., 2002; Sato et al., 2003; Ohya et al., 2006].  In SP-D, the interactions with TLR2 and TLR4 
appear to be via the CRD but by a secondary binding site as the rough lipopolysaccharide 
from E. coli and inositol phosphate were still able to bind SP-D in a calcium dependent 
manner.  Interactions with the neck domain were ruled out using neck-domain specific 
monoclonal antibodies which were able to bind both native SP-D and rfhSP-D following 
incubation with the extracellular domains of TLR2 and TL4 [Ohya et al., 2006].  It has been 
reported that the interaction with soluble CD14 and gp340 are both CRD mediated, 
however, in the case of gp340 where the interaction is calcium-dependent, maltose was still 
able to bind in the main binding pocket, suggesting gp340 recognition occurs through an 
alternative site and is a protein-protein interaction [Holmskov et al., 1997].  Activation of 
both soluble receptors leads to activation of alveolar macrophages and amplifies 
opsonisation and phagocytosis.  Further CRD-dependent interactions between SP-A, SP-D, 
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macrophages and dendritic cells have been identified, some of which were calcium-
dependent, however the receptors still require characterisation [Jakel and Sim, 2012]. 
1.3.2 Agglutination and deactivation 
In addition to opsonising pathogens, the soluble collectins also agglutinate bacteria, fungi 
and viruses, increasing the chemokine signal and inactivating the pathogen to limit 
virulence.  Agglutination occurs through crosslinking of distant binding sites on different 
cells by the oligomeric collectins, causing the cells to aggregate into larger, collectin-
mediated clumps that are easier to phagocytose [Kishore et al., 2006].  SP-A, SP-D, MBL 
and conglutinin have been observed agglutinating E. coli, Aspergillus fumigatus and 
Influenza A Virus, among others, where SP-D and conglutinin agglutinated the susceptible 
cells more effectively than SP-A and MBL [Madan et al., 1997; Hartshorn et al., 1998; LeVine 
et al., 2001].  It is thought that this is primarily due to the oligomeric forms of SP-D and 
conglutinin which allow crosslinking of targets more than 100nm from each other, 
stabilised by the N-terminal cysteine-rich core formed in the centre of the dodecameric 
cruciform.  This may suggest that the same pattern of agglutination is also possible for CL-
46 which may also form the same dodecameric quarternary structure as SP-D and 
conglutinin.   
How agglutination inactivates the pathogens at the molecular level remains unclear, but 
two main models have been suggested: (1) agglutination sequesters the virulence factors 
or; (2) inactivation is a result of the virulence factors being directly blocked by the 
collectins.  The latter, model 2, appears to be the case in virus particles as in both IAV and 
HIV, the virulent haemagglutinin and gp120, respectively, are the primary targets for SP-D 
and SP-A and effectively block viral entry by interrupting the binding mechanism between 
the virus particles and the target cells [Hartshorn et al., 1994; Meschi et al., 2005].  However, 
the virulence of bacteria and fungi is less well defined and likely involves a more complex 
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interaction with the host.  Sequestration of virulence factors is an obvious side effect of 
agglutination as the cells embedded in the aggregated cell mass are unable to interact with 
the host, leaving only the external layer and free pathogens to invade and affect the host.  
The likelihood is that inactivation of the agglutinated pathogens is a result of both models, 
whereby the virulence factors are bound by the collectin and the agglutination sequesters 
any remaining available factors. 
1.3.3 Complement activation and regulation 
Activation of the complement system by the collectins is the preserve of MBP and, 
putatively, CL-K1 and CL-LK heterocomplex, due to their ability to associate with serine 
proteases (MASPs) and form an activating complex [Schwaeble et al., 2002; Hansen et al., 
2010; Gingras et al., 2011; Henriksen, Brandt, Andrieu, et al., 2013].  Activation of the 
complement cascade culminates in the attachment of the complement membrane attack 
complex to the cell causing an increase in permeability resulting in the eventual death of 
the cell [Esser, 1994].  Mannose binding protein was the first collectin to be identified as a 
complement activation molecule, through what then became known as the lectin pathway 
because of the lectin activity of MBP. Activation proceeds through assembly with MASPs 
(MBP associated serine proteases) which bind in two sites in the collagen region and share 
overall homology with the C1 complex which activates the classical pathway [Kishore et al., 
2004; Gingras et al., 2011].  More recently, MASPs have also been identified associated with 
trimers of trimeric CL-K1 and the putative heterotrimer CL-LK, and have been shown to 
activate the lectin pathway in synergy with MBP [Henriksen, Brandt, Andrieu, et al., 2013; 
Ma, Skjoedt and Garred, 2013]. 
Other collectins have also been implicated in the complement system but in a regulatory 
role.  SP-A recognises and binds the C1 complex in a calcium-dependent manner through 
interactions with C1q that prevent the activation of the C1r and C1s serine protease 
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components [Watford et al., 2001].  The function of inhibiting the complement pathway 
remains unclear, however it may play a role in minimising the immune response to low 
titres of pathogens that the lungs are regularly exposed to as a result of inhalation, 
preventing complete activation of the immune system and avoiding unnecessary damage 
to the linings of important tissues.  This may suggest that SP-A and SP-D behave as a 
threshold mechanism, beyond which the infection is too great for surfactant mediated 
immunity to combat and other immune system mechanisms are required to fight the 
infection. 
1.3.4 Direct cell killing 
Surfactant protein A and surfactant protein D have both been shown to clear bacterial and 
fungal cells by direct cell killing, however the mechanism for this is poorly understood.  A 
study by Wu and co-workers suggested that adherence of the surfactant collectins to the 
cell wall of rough strains of E. coli and strains of Klebsiella, Enterobacter and E. coli isolated 
from patients, increased the permeability of the cell wall thus limiting cell growth and 
eventually causing cell death [Wu et al., 2003].  The study identified intracellular 
components in the external environment of the strains following localisation of SP-A and 
SP-D on their surface, suggesting that pores were induced in the bacterial surface. 
In a similar study, Histoplasma capsulatum, an intracellular fungal pathogen, was shown to 
be directly killed by the pulmonary collectins by increasing fungal cell wall permeability 
[McCormack et al., 2003].  Again, the results suggested that binding of SP-A or SP-D to cell 
wall created pores that not only caused the release of proteins from the cells, but also 
allowed for otherwise impermeant substrates to enter the cell, suggesting that the pore did 
not have any selectivity.  This may suggest that an influx of water into the cells may, in part, 
lyse the cells as a means of cell clearance, leaving the collectins and other innate receptors 
to clear the debris.  Interestingly, however, this study also showed that once H. capsulatum 
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is internalised by a macrophage, neither SP-A or SP-D is able to inhibit the growth of the 
fungus, suggesting that the SP-A and SP-D do not have an intracellular immune role 
[McCormack et al., 2003]. 
In both cases, the mechanism for pore formation requires further investigation as there is 
little understanding as to how SP-A and SP-D are able to directly kill pathogens.  However, 
these two studies show that direct killing may be a key role for the collectins when 
immunocytes are not localised to the infection in the early stages, providing some insight 
into the role of the collectins in defending against intracellular pathogens before they enter 
the cell. 
1.3.5 Other roles in the immune response 
The roles of the collectins beyond cell clearance by the four main pathways (sections 1.3.1 – 
1.3.4) are extensive and wide ranging.  The best understood of these is the regulation of 
the inflammatory response to infection by the surfactant proteins.  SP-A and SP-D both 
have roles in regulating the expression and release of pro-inflammatory cytokines and 
downregulating the release of TNF-α [Murakami et al., 2002; Gardai et al., 2003; Kawai and 
Akira, 2010; Fournier et al., 2012].  SP-D is able to recognise and activate the signal 
inhibitory regulatory protein α (SIRP-α) and SIRP-β through calcium-dependent interactions 
between the CRD and the membrane proximal domain, causing a downstream blockade of 
the p38 cascade when SIRP-α is activated [Fournier et al., 2012].  Interestingly, the p38 
cascade is activated by SP-D and SP-A when the collagen-like domain interacts with the 
calreticulin/CD91 complex to stimulate TNF-α expression, suggesting that recognition of a 
pathogen acts as a switch mechanism by competing with the CRD for SIRP-α recognition 
[Gardai et al., 2003; Fournier et al., 2012].  This interaction is further complicated by an 
interaction between the SIRP-α-SP-D complex and CD47 which has been shown to further 
regulate the downstream cascades [Takizawa and Manz, 2007; Fournier et al., 2012]. 
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1.4 Human surfactant protein D 
Human surfactant protein D, along with MBP and SP-A, is one of the best understood 
collectins in terms of both structure and function.  This section intends to provide a brief 
summary of some of that research, focussing on the structure and interactions that SP-D is 
capable of making with both microorganisms and cell surface receptors. 
1.4.1 Native structure of a rfhSP-D 
The unbound, native structure of rfhSP-D, a recombinant fragment of hSP-D containing 
amino acid residues 179 through to the C-terminal Phe335, includes a small portion of 
collagen domain, the α-helical coiled coil neck domain and the CRD [Håkansson et al., 
1999; Shrive et al., 2003].   Overall, the structure is similar to MBP and rat SP-A forming a 
trimeric fragment containing three CRDs arranged around a central trimeric axis formed by 
the α-coiled coil neck domain [Sheriff, Chang and Ezekowitz, 1994; Weis and Drickamer, 
1994; Håkansson et al., 1999; Head et al., 2003; Shrive et al., 2003].  However, in contrast to 
rat SP-A which forms a “T”-shaped fragment, the CRDs in rfhSP-D form a “Y”-shaped 
fragment more similar to MBP. This is, in part, due to the CRDs in rfhSP-D making 
comparatively few interactions either between subunits or with the neck domain, allowing 
the CRDs to be more flexible around a short semi-rigid hinge-like region that centres 
around Pro235 [Weis and Drickamer, 1994; Head et al., 2003; Shrive et al., 2003].  The 
interactions present include a small set of hydrophobic interactions between the neck 
region side chains of Val231 and Phe234 and the CRD of the adjacent subunits (A to C, B to 
A and C to B) [Håkansson et al., 1999].  These hydrophobic interactions are supplemented 
by interactions between the neck domain and the CRD of the other adjacent subunit (A to 
B, B to C and C to A) comprising hydrogen bonds (Phe234-Lys246; Gln227-Glu242; Gln227-
Phe355) and intra-subunit long salt bridges between Glu232 and Lys246.  
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The CRD is characteristic of other C-type lectins containing a twisted β-sheet flanked by 
two α-helices that form one of two large insertions into the β-sheet; the second insertion 
creates the primary calcium binding pocket, where Ca1 is bound, between the α-helical turn 
(α3) and β-strand (β5).  The primary calcium binding pocket (Ca1) of the CRD is in a distal 
position to the alpha-helical neck domain in all three CRDs of the trimeric structure and the 
three sites form a plane across the molecule which, in vivo, would facilitate recognition of 
carbohydrate arrays [Weis and Drickamer, 1994; Shrive et al., 2003].  There are a further two 
calcium ions in each CRD, spatially separated from Ca1 by the helical turn [Figure 1.6]. 
It has been suggested that the second calcium ion, Ca2, is involved in stabilising the helical 
turn though direct interactions with the carbonyl of Glu329, reducing the flexibility in the 
side chain and maintaining the contact between Glu329 and Ca1 [Shrive et al., 2003].  The 
third calcium is closer to the surface of the CRD and makes fewer interactions with the 
protein, potentially providing a site for cell surface receptors to recognise the CRD or, 
alternatively, acting as a secondary binding site for longer polysaccharide ligands that 
occur naturally.  The proximity of the Ca2-Ca3 binding sites to the main binding pocket 
may also allow for cell receptors to recognise both the bound ligand and the CRD. 
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Figure 1.6:  Native carbohydrate recognition domain of rfhSP-D with the calcium coordination 
(right).  Calcium coordination is completed by Glu321 OE1, Asn323 OD1, Glu329 OE1, Asn341 
OD1 and Asp342 OD1 and main-chain O.  Figures generated from PDB accession code 1PW9 
[Shrive et al., 2003]. 
 
Coordination of the calcium ion in the main binding pocket, Ca1, is completed through six 
coordinate covalent bonds between the calcium ion (Ca2+) from five acidic side chains and 
a main chain carbonyl group from Asp342.  Glu321, Asn323 and Glu329 from the α3 region 
and Asn341 from the β5-strand form four of the main interactions through carboxyl and 
carbonyl groups which donate electron pairs to the calcium [Håkansson et al., 1999; Shrive 
et al., 2003].  The final two coordinate bonds with Ca1 are completed by Asp342 which, 
along with the carbonyl group, coordinates through the carboxyl group, forming the base 
of the calcium binding pocket.  The protein thus coordinates six of the eight calcium 
interactions and the final two are fulfilled by water molecules in the native structure. 
1.4.2 Ca4 and the asymmetric tyrosine 
The high resolution structure of rfhSP-D revealed a fourth calcium ion (Ca4) at the 
pseudosymmetric three-fold axis of the trimer, at the base of an elongated funnel created 
by the three CRDs, coordinated by the side chains of Glu323 from all three subunits [Figure 
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1.7a; Shrive et al., 2003].  However, in the maltose-bound structure, the Ca4 binding site is 
depleted causing the side chain of Glu323 in subunit B to rearrange and interact with the 
asymmetric tyrosine in subunit C.  The asymmetric tyrosine 228 in subunit C is present in all 
the published structures and fundamentally changes the interface between the neck and 
CRD domains of adjacent subunits, allowing LysA229 to move into the space vacated by 
TyrC228 [Shrive et al., 2003]. 
The role of Ca4 is unclear as the binding site is unoccupied in the maltose-bound structure 
suggesting that the calcium described in the native structure may be a remnant of 
crystallisation or demonstrate a calcium concentration dependent occupancy of the fourth 
binding site [Figure 1.7b].  However, a subsequent study using a range of different ligand 
bound complexes revealed that Ca4 is present in the structure at physiological calcium 
concentrations [Shrive et al., 2009].  The conformational changes associated with the 
occupancy of the Ca4 binding site [Figure 1.7b] may suggest that Ca4 occupancy could act 
as a switch mechanism in response to environmental calcium, potentially allowing for 
receptor binding in the downstream immune response.  
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Figure 1.7:  Comparison of Ca4 binding site in the native rfhSP-D (above) and maltose-bound 
complex (below).  Calcium (yellow) depletion causes GluB232 to move away from the calcium 
site and interact with asymmetric TyrC228. 
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1.4.3 hSP-D recognition of pathogenic species 
The carbohydrate recognition domain of SP-D enables it to recognise a wide range of 
organisms from almost all phylogenetic groups [table 1.3].  Recognition occurs through the 
glycosylation structures on the surface of the pathogen, including lipopolysaccharides on 
gram-negative bacteria, lipoteichoic acids on gram-positive bacteria and 
glycosaminoglycan, lipoarabinomannans and glycoproteins from other groups of 
pathogens [Kuan, Rust and Crouch, 1992; van de Wetering et al., 2001; Crouch et al., 2009; 
Ferguson et al., 2010].  It has also been shown that peptidoglycan, a core component of the 
cell wall of all bacteria, is recognised by hSP-D [van de Wetering et al., 2001]. 
Rough LPS mutants of gram-negative bacteria have been shown to be bound with higher 
affinity than smooth LPS mutants, such as S. enterica minnesota R7 and E. coli J5 [Kuan, 
Rust and Crouch, 1992].  Smooth mutants differ from rough mutants by the presence of the 
repeating O-antigen at the terminal of the core polysaccharide of the LPS [Holst and Brade, 
1991, 1992; Haishima, Holst and Brade, 1992].  The difference in affinity was particularly 
evident in three strains of S. enterica minnesota LPS where the smooth mutant was not 
bound by radiolabelled SP-D but two rough mutants, R7 and R5, were both strongly bound 
by the same radiolabelled SP-D [Kuan, Rust and Crouch, 1992]. 
A recent study has shown that a rfhSP-D has a protective role in mice challenged with the 
main component of the fungal cell wall, a β(1→3)-linked polymer of glucose, β-glucan, 
attenuating the allergic response and suggesting that β-glucan is recognised by rfhSP-D 
[Fakih et al., 2015].  This provides some indication of how hSP-D binds to fungal pathogens 
such as A. fumiugatus and C. albincans.  Similarly, the lipoarabinomannan component of 
the mycobacterial cell wall of M. tuberculosis was bound by hSP-D from recombinant and 
BAL sources via the terminal mannose in a calcium-dependent, lectin domain interaction 
[Ferguson et al., 2010].  Mycoplasma pneumoniae was also shown to be recognised in this 
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way [Chiba et al., 2002].  Peptidoglycan and lipoteichoic acids from gram-positive bacteria 
have been successfully identified as ligands for hSP-D, providing a mechanism for 
recognition of gram-positive bacteria [van de Wetering et al., 2001]. 
There have been extensive studies of hSP-D recognition and interaction with the medically 
important viruses, influenza A virus (IAV), responsible for annual flu outbreaks, and human 
immunodeficiency virus (HIV), responsible for causing systemic breakdown of the immune 
system leading to acquired immune deficiency syndrome [LeVine et al., 2001; Meschi et al., 
2005; Crouch et al., 2009; Madsen et al., 2013].  IAV is recognised by the highly 
mannosylated viral glycoprotein heamagglutinin (HA) through calcium dependent CRD 
interactions with the mannosylation on the surface of HA [Crouch et al., 2009; Goh et al., 
2013].  gp120 of HIV, a 120kDa glycoprotein in the lipid bilayer, is also highly mannosylated 
in a comparable way to HA and is also recognised by the CRD of hSP-D through a calcium-
dependent recognition of the terminal mannose, preventing cellular entry [Meschi et al., 
2005; Madsen et al., 2013].  SP-D recognition was conclusively shown to be dependent on 
the mannosylation of gp120 by deglycosylation of the protein and exposure to 
recombinant SP-D.  The deglycosylation resulted in complete abrogation of SP-D binding 
and agglutination of HIV, confirming that SP-D does not complete any protein-protein 
interactions [Meschi et al., 2005]. 
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Table 1.3:  Comparison of SP-A and SP-D Recognition of Pathogenic Species.  Table shows 
which pathogenic species surfactant protein A (SP-A) and surfactant protein D (SP-D) recognise, 
using + to indicate evidence of surfactant protein binding.  (rf) recombinant fragment SP-D 
binds pathogen when (+). 
Pathogen    SP-A    SP-D (rf) References 
Gram-Negative Bacteria  
     Chlamydia pneumoniae + + [Oberley et al., 2004b] 
     Chlamydia trachomatis + + [Oberley et al., 2004a] 
     Escherichia coli + + (+) [Kuan et al., 1992; Van Iwaarden et al., 1994] 
     Haemophilus influenzae + + (+) [LeVine et al., 2000] 
     Helicobacter pylori  + [Murray et al., 2002] 
     Klebsiella pneumoniae + + [Ofek et al., 2001; Sahly et al., 2002] 
     Pseudomonas aeruginosa + + [Restrepo et al., 1999] 
     Salmonella enterica  + (+) [Kuan et al., 1992] 
Gram-Positive Bacteria  
          Staphlococcus aureus + + [McNeely et al., 1993; Zhang et al., 2015] 
     Streptococcus pneumoniae + + (+) [McNeely et al., 1993; Jounblat et al., 2004] 
Mycobacteria  
     Mycobacterium avium + + [Kudo et al., 2004] 
     Myocbacterium tuberculosis + + [Ferguson et al., 2010] 
Mycoplasma  
     Mycoplasma pneumoniae + + (+) [Chiba et al., 2002] 
Viruses  
     Herpes Simplex Virus +  [Van Iwaarden et al., 
1992] 
     Human Immunodeficiency Virus + + [Meschi et al., 2005; 
Gaiha et al., 2008] 
     Influenza A Virus + + [Benne et al., 1995; 
LeVine et al., 2001] 
     Respiratory Syncytial Virus + + [Hickling et al., 1999; LeVine et al., 2004] 
Fungi  
     Alternaria alternata (tenuis)  + [Ooi et al., 2007] 
     Aspergillus fumigatus + + [Madan et al., 1997] 
     Candida albicans + + 
[Rosseau et al., 1997; 
van Rozendaal et al., 
2000] 
     Histoplasma capsulatum + + [McCormack et al., 2003] 
     Pneumocystis jiroveci (carinii) + + [O’Riordan et al., 1995] 
     Saccharomyces cerevisiae  + [Allen et al., 2001] 
Protozoa  
      Nippostrongylus brasiliensis  + [Thawer et al., 2016] 
     Schistosoma mansoni  + [Van De Wetering et al., 2004] 
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1.5 Small ligands and surfactant protein D 
There have been several studies using rfhSP-D, a recombinant fragment of hSP-D 
containing the neck and carbohydrate domains in complex with mono-, di- and 
trisaccharides.  This has revealed some key aspects about the binding mechanism that SP-D 
uses to recognise its ligands and provided insights into what elements of the CRD are 
responsible for selecting and recognising those ligands.  
1.5.1 Importance of small ligand studies 
Understanding the molecular mechanisms which proteins employ to recognise their targets 
is an essential part of understanding the function of the protein.  To do this often requires 
using crystallography to determine, at high resolution, the atomic structure of the protein 
and identify in the finest detail how a ligand interacts with the surface or binding site of the 
protein.  Small ligands that are representative of putative binding epitopes of large 
physiological ligands not only provide a convenient route to crystallographically 
characterise ligand binding, but where the environment around the binding sites in the 
crystal is spatially restricted due to the proximity of other molecules, they may provide the 
only opportunity for understanding some of the fundamental recognition mechanisms that 
provide insight into how the protein may recognise its natural ligands in vivo. 
Many physiological hSP-D ligands are long, complex oligosaccharides on the surface of 
pathogens that are often membrane bound or form part of insoluble structures on the 
surface of cells.  Smaller oligosaccharide subunits that are often more soluble than the 
larger polysaccharides that they assemble into provide a way of accessing the binding sites 
in the crystal systems, enabling the binding mechanisms to be elucidated.  The native 
recombinant hSP-D fragment rfhSP-D first characterised by Håkansson and colleagues has 
provided invaluable insight into how SP-D is able to recognise a myriad of ligands using 
this technique, allowing for the primary binding mechanism to be characterised. 
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1.5.2 Mono and disaccharides: establishing the recognition mechanism 
The mechanism of carbohydrate recognition by human surfactant protein D was first 
elucidated by Shrive and colleagues (2003) using both native rfhSP-D and a maltose-bound 
complex of the biologically and therapeutically active recombinant fragment [Shrive et al., 
2003].  Recognition of maltose, a small disaccharide of α(1→4)-linked glucose, occurred by 
the non-reducing terminal glucose primarily through interactions with Ca1, allowing the 
second glucose to project out of the binding pocket.  In subunits B and C, the second 
glucose is not defined in the structure suggesting that there is free rotation around the 
α(1→4) glycosidic bond.  However, in subunit A the crystal system restricts the rotation, 
allowing for the second glucose to be defined [Figure 1.8]. 
The calcium in the main binding pocket primarily coordinates the two equatorial hydroxyl 
groups on the third (C3, O3’) and fourth (C4, O4’) carbons of the non-reducing terminal 
glucose which displace the two water molecules from their coordinating positions in the 
native structure [Shrive et al., 2003].  The coordinate bonds between the two hydroxyls and 
Ca1 form the basis of the recognition mechanism, supplemented by protein-ligand 
hydrogen bonds from the side chains of Glu321, Asn323, Glu329 and Asn341.  Glu321 and 
Asn323 hydrogen bond to O3’ through the carboxylic acid and amine, respectively.  
Similarly, O4’ interacts with Glu329 and Asn341.  The second glucose in the disaccharide 
does not interact directly with the CRD in the crystal structure which is at first sight 
surprising as maltose has a higher affinity for SP-D than glucose.  Interestingly, the two 
flanking residues, Asp325 and Arg343, do appear to influence ligand binding, forming long 
range interactions with the calcium coordinating glucose and, in the case of Arg343, 
undergo conformational changes in response to maltose binding [Shrive et al., 2003].  This 
is particularly evident in subunit A where Arg343 has two conformations, presumably due 
to the proximity of the second glucose residue, caused by a 10° rotation in ligand position. 
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A subsequent study also revealed that two alternative isomers of mannobiose are 
recognised by surfactant protein D in a comparable mechanism to maltose [Shrive et al., 
2009].  Both the α(1→2)-linked and α(1→4)-linked mannobiose disaccharides were 
recognised by the non-reducing terminal mannose residue, coordinating the calcium ion in 
the main binding pocket by the two equatorial hydroxyls synonymous with the maltose 
complex (O3’ and O4’).  In both structures, the O3’ and O4’ coordinate Ca1 and complete 
the protein interactions with Glu321, Asn323, Glu329 and Asn341 however the orientation 
of the mannose residue visible in the binding site differs between the two isoforms.   
In the α(1→2)-linked disaccharide, the ring is orientated in the same plane as maltose in all 
three subunits allowing O3’ to hydrogen bond with Glu321 and Asn323 and O4’ to interact 
with Glu329 and Asn341, placing the undefined second mannose residue in space distal to 
the flanking residues Asp325 and Arg343 in subunits A and B [Shrive et al., 2003].  In 
subunit C, it is less clear which of the mannose residues are being coordinated by the 
calcium and the density for the second mannose residue is very poor.  The α(1→4)-linked 
mannobiose, on the other hand, binds in two distinct mechanisms as a result of a 180° 
rotation about the axis of the binding mannose residue.  In subunit A, it is reported that the 
orientation is comparable to the maltose-bound and α(1→2)-mannobiose-bound 
complexes however, in subunit C where there is less restriction of the binding site due to a 
weaker interaction with the symmetry related molecule, the coordinating mannose residue 
is rotated such that O3’ interacts with Glu329 and Asn341 and O4’ interacts with Glu321 
and Asn323 [Figure 1.8; Shrive et al., 2003, 2009].  Interestingly, the density for the α(1→4) 
mannobiose in subunit B shows evidence for both binding mechanisms with higher 
occupancy in the rotated conformation, most similar to subunit C [Shrive et al., 2009]. 
The rotations in the binding mannose also revealed a key role for Arg343 and Asp325 in 
the recognition of ligands by surfactant protein D.  In the subunits where the ring was in an 
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equivalent position to maltose, the O6’ formed contacts with NH1 or NH2 of Arg343 with 
varying strength due to rearrangements of the side chain allowing Arg343 to move closer 
to the binding site, in part aided by the stabilising interactions between Arg343 and Glu333 
[Shrive et al., 2009].  The contact with Arg343 is also important in the recognition 
mechanism for the subunits where the mannobiose is rotated, interacting weakly with the 
hydroxyl on carbon 2 (O2’).  In this position, the O1’ hydroxyl also interacts with Asp325 on 
the opposing flank [Figure 1.8] suggesting that Asp325 and Arg343 play important roles in 
ligand recognition and orientation in the calcium binding site.  
The influence of the undefined mannose residue on the orientation of the ligand is unclear 
as it is not defined in either mannobiose isoform.  However, a study using a recombinant 
fragment of porcine SP-D in complex with mannose revealed a mechanism more similar to 
the α(1→2)-linked mannobiose suggesting that the α(1→4)-linkage is affecting the 
recognition mechanism, at least in the crystal structure [Van Eijk et al., 2012].  How this 
affects longer mannosyl ligands that SP-D is known to recognise, such as mannan and the 
N-linked mannosylation of viral proteins, is unclear although it may provide some insight 
into why the affinities for mannosyl ligands differ. 
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Figure 1.8:  Calcium coordination in the mono- and disaccharide bound complexes.  (a) maltose 
complex; (b) α(1→2)-linked mannobiose complex; (c) galactose complex; (d) α(1→4)-linked 
mannobiose complex (subunit A); (e) α(1→4)-linked mannobiose complex (subunit B); (f) N-
acetylmannosamine (ManNAc) complex; (g) 90° rotation of ManNAc complex to illustrate 
Asp325 interaction.  Figure generate from PDB accession codes 1PWB, 3IKQ, 3IKN, 3IKR and 
2ORJ [Shrive et al., 2003, 2009; Crouch et al., 2007]  
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N-acetyl-mannosamine (ManNAc) has also been complexed with rfhSP-D and successfully 
crystallised, showing that recognition of the ManNAc occurs in a similar way to α(1→2)-
linked mannobiose, the A subunit of α(1→4)-linked mannobiose and maltose with O3’ and 
O4’ being the primary points of recognition [Shrive et al., 2003, 2009; Crouch et al., 2007].  
However, in the ManNAc-bound complex, the orientation of the ligand is thought to be 
limited by the position of Arg343, forcing the N-linked acetyl group to extend away from 
the two flanking residues and above Glu321 and Asn323 [Figure 1.8; Crouch et al., 2007].  
As with the other ligand-bound structures discussed so far, coordination of the calcium also 
allows for Glu321, Asn323, Glu329 and Asn341 to interact with the calcium coordinating 
O3’ and O4’ hydroxyls, further characterising the overall binding mechanism.  As seen in 
the mannobiose structures, ManNAc O6’ interacts with Arg343 to complete the protein-
ligand interactions in the ManNAc complex and may also limit the orientation of the 
ManNAc in the binding site, elaborating on the important role of Arg343 in ligand selection 
and recognition [Allen et al., 2004]. 
Interestingly, the low affinity ligand galactose, relative to maltose and ManNAc, has been 
shown to have a novel binding mechanism not seen in the other oligosaccharide ligands 
studied.  In the galactose/rfhSP-D complex, the two water molecules that complete the 
calcium coordination are displaced by the O1’ and O2’ hydroxyls of the galactosyl ring 
instead of the O3’ and O4’ of the glucosyl and mannosyl type rings [Shrive et al., 2009].  
Importantly the two coordinating hydroxyls are in the same equatorial positions in 
galactose as the O3’ and O4’, sharing the same geometry in relation to the main ring, 
allowing the hydroxyls to coordinate Ca1 in approximately the same positions.  O1’ forms 
additional protein-ligand interactions with Glu329 and Asn341, in a similar way to O4’ in 
the other structures, whilst O2’ interacts with Glu321 and Asn323.  This orientation presents 
the ring-bound oxygen (O5’) to Arg343, allowing it to directly interact with the oxygen 
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atom, forming an Arg343 mediated bridge between O5’ and the O6’ on the galactose 
[Figure 1.8]. 
The physiological relevance of the galactose-bound complex is unclear.  While galactose is 
a common component of glycosylated structures in Gram-negative bacteria and viruses, 
O1’ and O2’ are regularly unavailable for recognition by surfactant protein D [Holst, 2011].  
In many of the complex oligosaccharides, O1’ is involved in glycosidic linkages between 
monosaccharide residues where galactose is in a terminal or non-terminal position, such as 
in haemagglutinin subtype 5 where O1’ and O3’ form the basis of glycosidic bonds 
[Gamblin and Skehel, 2010]. 
The small oligosaccharide studies reveal a conserved binding mechanism in hSP-D that is 
dependent on calcium coordination by the two equatorial hydroxyl groups, equivalent to 
the O3’ and O4’ positions in glucose or mannose.  The small ligand studies have also 
identified Asp325 and Arg343 as essential determinants in ligand binding, directly involved 
in recognition of some of the monosaccharides and playing a selective role in the small 
ligands where they do no directly interact with the ligand. 
1.5.3 Carbohydrate analogue recognition: elaborating the binding mechanism 
Carbohydrate analogues form an important part of cell signalling and the structural 
component of many lipid moieties.  Two of these analogues are myo-inositol and inositol 
phosphate.  Structures for myo-inositol and inositol-1-phosphate in complex with 
recombinant fragment human surfactant protein D have been solved at high resolution 
[Crouch et al., 2007; Shrive et al., 2009].  In both structures, the inositol ring was primarily 
recognised in a calcium dependent mechanism coordinating two equatorial hydroxyls on 
adjacent carbon atoms in a similar way to the other carbohydrate ligands.  Myo-inositol 
was coordinated by the hydroxyls at positions O1’ and O6’ of the ring which assume the 
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positions of the O3’ and O4’ hdyroxyls of mannose-type ligands in relation to the calcium 
ion [Crouch et al., 2007].  Recognition of myo-inositol was completed by the familiar amino 
acid residues: Glu321 and Asn323 interact with O1’ and; Glu329 and Asn341 interact with 
O6’.  The orientation of the myo-inositol in the binding site was similar to the other 
monosaccharides including the mannose in porcine SP-D but the density reported for myo-
inositol did suggest that the ring could rotate 180° in the binding site in the same way as 
α(1→4)-mannobiose showed binding heterogeneity [Crouch et al., 2007; Shrive et al., 2009; 
Van Eijk et al., 2012]. 
There are two structures for inositol-1-phosphate (IP1) in complex with rfhSP-D which show 
agreement in the binding mechanism [Crouch et al., 2007; Shrive et al., 2009].  The calcium 
ion recognises the O4’ and O5’ hydroxyl groups of the inositol ring where O4’ interacts with 
Glu321 and Asn323 and O5’ makes contacts with Glu329 and Asn341 by the same 
mechanism as previously identified with an additional hydrogen bond between O6’ of IP1 
and Arg343 [Figure 1.9].  The phosphate, substituted at position C1, extends in the 
direction of Asp325 and Arg343, causing small shifts in the conformations of the two side 
chains, with a more pronounced change in Arg343 in subunit C compared to subunit B.  
Shrive and colleagues also noted a small change in the orientation of IP1 in the binding site 
consistent with the differences of side chain positions, further suggesting an important role 
of these two side chains in ligand orientation [Shrive et al., 2009].   
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Figure 1.9:  Calcium coordination of myo-inositol (left) and inositol-1-phosphate (right).  
Coordination of the calcium ion in the myo-inositol complex is completed by O1’ and O6’, and 
O4’ and O5’ in the inositol-1-phosphate complex.  Arg343 is fundamental in recognition of both 
ligands, forming hydrogen bonds to the main ring in both complexes. 
 
In the crystal structures of the myo-inositol complex and IP1 complex the ligand is absent in 
subunit A as a result of crystal packing, which is surprising as maltose is comfortably 
accommodated by subunit A in the same crystal form.  Simple fitting of IP1 in subunit A 
suggested that this may be because of a clash between the phosphate moiety and the 
symmetry related molecule as a result of IP1 favouring the geometry in the other subunits 
[Shrive et al., 2009].  The favoured geometry may be a result of the proximity of the 
negatively charged phosphate limiting ligand orientation as a point mutation of Arg343 
(R343K) revealed a greatly improved affinity for IP1 as a result additional flexibility [Crouch 
et al., 2007]. 
These two structures demonstrate that the calcium-dependent mechanism identified in 
mono- and disaccharide complexes with rfhSP-D is capable of recognising a diverse 
number of ligands with little alteration to the CRD or the immediate binding site.  They also 
elaborate on the importance of Asp325 and Arg343, the two flanking residues, and their 
role in selecting and orientating ligands in the binding site through their interactions with 
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the inositol ring through small conformational changes in their side chain positions, even 
when the only interactions are water mediated [Shrive et al., 2009]. 
1.5.4 Maltotriose: extending the binding surface 
While the mono- and disaccharide-bound complexes reveal important details of the 
binding mechanism in rfhSP-D, many of the ligands that SP-D and the other collectins 
recognise are long polysaccharides at the cell surface and contain many more saccharide 
residues [Haishima, Holst and Brade, 1992; Vollmer, Blanot and De Pedro, 2008; Fakih et al., 
2015].  Trisaccharides are the next step towards identifying how longer oligosaccharides 
may be recognised by an extended binding surface in the CRD of SP-D, as in the scavenger 
receptor CL-P1 CRD where a lewisx acid containing a Gal-GlcNAc-Fuc triose was recognised 
by both terminal residues in a bidentate fashion [Feinberg, Taylor and Weis, 2007].   To 
explore this, maltotriose (three α(1→4)-linked glucoses) was complexed with rfhSP-D 
revealing an extending binding surface was also present in hSP-D for this ligand [Crouch, 
McDonald, et al., 2006]. 
Primary recognition of the non-reducing terminal glucose was comparable to the maltose-
bound complex published by Shrive and colleagues [Shrive et al., 2003; Crouch et al., 2007].  
Binding of the ligand in the Ca1 pocket was between the calcium ion and the two 
equatorial hydroxyl groups, O3’ and O4’ with further hydrogen bonds to the calcium 
coordinating side chains Glu321, Asn323, Glu329 and Asn341.  As with maltose, O3’ 
hydrogen bonds to the carboxylic acid and amine groups of Glu321 and Asn323, 
respectively, and O4’ to Glu329 and Asn341 in the same way.  However, due to the 
increased binding angle, in relation to the protein, in the maltotriose-bound complex, the 
distances from the binding glucose residue to the flanking residues are larger than the 
maltose structure as a result of a π-stacking interaction between the reducing terminal 
glucose and Phe335 [Figure 1.10; Crouch et al., 2006].   
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The π-stacking interaction was present in all three subunits of the rfhSP-D complex and 
appears to stabilise the ligand across the binding surface, providing an explanation for the 
increased affinity for maltotriose over other glucosyl ligands [Crouch, McDonald, et al., 
2006].  However, the physiological relevance of this mechanism is unclear as longer malt-
N-oses, such as those naturally occurring on pathogens, may prevent the formation of the 
π-stacking system because of steric clashes with the surrounding main chain of the CRD.  In 
addition, the third glucose in the maltotriose structure appears to be in a β-enantiomeric 
form which results in an overall “flatter” ring that is essential for the two rings to stack 
together.  This was demonstrated in the same study which revealed a p-nitrophenyl-
maltoside, with the reducing terminal glucose of maltotriose substituted by a nitrophenyl 
ring, in the same orientation as maltotriose and showed a higher affinity for rfhSP-D due to 
the more complete π-π stacking system [Crouch, McDonald, et al., 2006]. 
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Figure 1.10:  Calcium coordination of maltotriose and additional interactions with Phe335, 
Thr336 and Asn337.  Calcium coordination is completed by O3’ and O4’ hydroxyls by the first 
glucose in the trisaccharide with additional interactions between Glu321, Asn323, Glu329 and 
Asn341.  Recognition of maltotriose is completed by interactions between Arg343 and the 
nonterminal glucose; π-stacking interactions with Phe335 and further hydrogen bonds with 
Thr336 and Asn337.  Figure generated from PDB accession code 2GGU [Crouch, McDonald, et 
al., 2006] 
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1.6 Natural targets for SP-D and early mechanisms for recognition 
Small oligosaccharide ligands provide important information about the binding mechanism 
of hSP-D, however many of the ligands recognised by SP-D are longer oligosaccharides 
embedded in the cell envelope, either forming structurally important parts of the cell well 
or integral components of the outer cell membrane.  A number of studies have explored 
how hSP-D recognises natural targets and structural insight into these binding mechanisms 
are beginning to emerge.  This section introduces the components of the pathogen cell 
wall that hSP-D is able to recognise and the structural data that provides insight into the 
binding mechanisms employed by hSP-D. 
1.6.1 Carbohydrate arrays of pathogens 
The surfaces of all pathogens are decorated with a complex array of long carbohydrate 
moieties that are integral to the structure and function of the cell wall with many of them 
exposed to the environment.  They play an important role as virulence factors in viruses 
and, in the case of lipopolysaccharides (LPS) from gram-negative bacteria, are able to act as 
endotoxins and directly attack the host cells.  However, the integral nature of many of the 
carbohydrates and their exposure to the surroundings make them ideal targets for the 
innate immune system with many of them forming the basis of the pathogen-associated 
molecular patterns that hSP-D and other immune lectins are able to recognise and thus 
lead to cell clearance.  Extensive work has been done to characterise the cell wall of many 
pathogenic species with much still to do but the nature of the carbohydrate arrays is 
introduced here. 
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Figure 1.11:  Overview of the Carbohydrate Arrays on Various Classes of Pathogen.  Brief 
schematics of the carbohydrate arrays of (a) Gram-negative bacteria; (b) mycobacteria; (c,d) 
Gram-positive bacteria, both models differentiated by peptidoglycan direction; (e) fungi ; (f) 
enveloped virus particles.  Based on data from references and others [Brennan and Nikaido, 
1995; Caroff and Karibian, 2003; Vollmer, Blanot and De Pedro, 2008]. 
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The cell wall of gram-negative bacteria is characterised by: an inner cytoplasmic membrane, 
composed mainly of phospholipids, transport proteins and membrane-associated synthetic 
enzymes; a thin peptidoglycan layer surrounded by a fluid filled periplasmic space that 
provides structural stability; and an outer cytoplasmic membrane containing complex array 
of porins and LPS [Figure 1.11a].  The LPS molecules are localised to the outer leaflet of the 
outer membrane and contain four distinct domains that allow them to engage with the 
host: the membrane-anchor lipid A, the inner core oligosaccharide, the outer core 
oligosaccharide and the long repeating O-antigen [Figure 1.12; Holst, 2016]. 
Lipid A is composed of a glucosamine-1-phosphate α(1→6)-linked to glucosamine-4-
phosphate with four primary acyl chains linked by two amide bonds (N-linked) at carbon 2 
(C2) and two ester bonds (O-linked) at carbon 3 (C3) of each glucosamine [Luderitz et al., 
1973].  There are additional O-linked secondary acyl chains bound to the primary acyl 
chains in some lipid A moieties.  The inner core oligosaccharide is a short, conserved chain 
of bacteria-specific monosaccharides – L-glycero-D-manno-heptose and 3-deoxy-D-
manno-oct-2-ulosonic acid – forming the backbone of the chain with further glucose and 
N-acetylglucosamine residues [Haishima, Holst and Brade, 1992; Holst and Brade, 1992; 
Rund et al., 1999; Holst, 2007].  The outer core is less well conserved, containing a larger 
variety of monosaccharides and linking the inner core oligosaccharide to the O-antigen.  
The O-antigen is a long, repeating oligosaccharide that adds complexity to the LPS that 
varies between strains of the same species and a level of resistance to the immune system 
[Lüderitz, Staub and Westphal, 1966; Forsberg, Bhat and Carlson, 2000; Li et al., 2017].   
Chapter 1  Natural Targets for SP-D 
52 | P a g e  
 
 
Figure 1.12:  General structure of a lipopolysaccharide.  Lipid A (red); inner polysaccharide core 
(green); outer polysaccharide core (blue); O-antigen (orange).  Rough mutant LPS lack the O-
antigen. 
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The presence of the O-antigen in the LPS varies between species and mutants.  When the 
O-antigen is present, the LPS is described as a smooth mutant and where the O-antigen is 
not present, the LPS are described as rough mutants [Haishima, Holst and Brade, 1992; 
Olsthoorn et al., 1998].  The extent of the rough mutant is dependent on the mutations 
associated with the LPS synthesis and results in varying degrees of the core polysaccharide, 
culminating in deep rough mutants which lack all but the core heptose residues in the inner 
core.  Surfactant protein D has been shown to have a higher affinity for rough mutants than 
smooth mutants. 
The cell wall of gram-positive bacteria is structurally less complex than gram-negative 
bacteria but retains many of the physical properties [Figure 1.11c and 1.11d].  This is 
principally due to a considerably thicker layer of peptidoglycan surrounding the cell 
membrane, forming a semi-impermeable barrier to the environment and maintaining the 
cell shape and stability.  Peptidoglycan is a large polymer of muramyl disaccharide, an α
(1→4)-linked disaccharide of N-acetylglucosamine and N-acetylmuramic acid, that is 
crosslinked by a network of short oligopeptides and penta-alanine bridges to form a multi-
layered structure of polysaccharide cores [de Pedro and Cava, 2015; Kim, Chang and Singh, 
2015].  The peptidoglycan layer is crossed by transport proteins and lipoteichoic acids that 
anchor into the cell membrane and additional teichoic acids anchor into the peptidoglycan 
layer. 
The orientation of the peptidoglycan in the cell wall of gram-positive still remains unclear 
despite extensive work in the area [reviewed by Vollmer, Blanot and De Pedro, 2008; 
Vollmer and Seligman, 2010].  This has led to two distinct models of peptidoglycan 
architecture.  The first model, summarised in Figure 1.11c, describes the polysaccharide 
cores of peptidoglycan extending along the surface of the cell membrane, either following 
the axis of cell fission or wrapping around the poles of the cell, encapsulating the cell in 
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long, crosslinked carbohydrate chains.  The second model suggests the peptidoglycan 
extends away from the cell membrane in a perpendicular direction, shown in Figure 1.11d, 
forming shorter chains that stack together with more extensive peptide crosslinking, 
forming a hexagonal matrix.  Interestingly, there is evidence for both models in different 
species, with the sacculi of Bascillus subtilis being shown to have rings of peptidoglycan, 
like in the first model, whereas sacculi from S. aureus revealed a pitted, or net-like surface 
more similar to the second model [Hayhurst et al., 2008; Saar Dover et al., 2015].  This 
suggests that there may not be a single answer for the peptidoglycan arrangement in the 
cell wall and may differ between species; changing the way the immune system detects 
different species. 
Mycobacteria have a much more complex cell wall, containing a number of additional 
layers compared to other types of bacteria that includes a lipid-based capsule containing 
mycolic acids [Figure 1.11b; Brennan and Nikaido, 1995].  Many of the additional layers are 
composed primarily of polysaccharides such as arabinan and arabinogalactan which 
encapsulates a thin layer of modified peptidoglycan and covalently links to the mycolic 
acids on the outer surface of the cell envelope [Hunter, Gaylor and Brennan, 1986].  The 
mycolic acid layer also contains a variety of glycolipids and lipooligosaccharides, which 
resemble LPS, and contribute to reducing the permeability of the cell wall.  The only 
interruptions to the lipid layer are large transport proteins which extend to the 
peptidoglycan layer and the large, branched, membrane-anchored lipoarabinomannan that 
decorate the surface of the cells and play an active role in the virulence of the mycobacteria 
[Chan et al., 1991; Briken et al., 2004; Kang et al., 2005].  Interestingly, it is these structures 
that have been identified as targets for the C-type lectins and hSP-D [Maeda et al., 2003; 
Kudo et al., 2004; Ferguson et al., 2010]. 
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Fungal cell walls [Figure 1.11e] differ from bacterial cell walls significantly, with a higher 
proportion of protein and no peptidoglycan layer to withstand changes to the turgor 
pressure within the cell.  Instead, there is a thick layer of the immunogenic β(1→3)-glucan 
(a β(1→3)-linked glucose oligosaccharide) and chitin close to the cell membrane that 
provide strength and shape to the fungal cell [Bowman and Free, 2006; Lenardon, Munro 
and Gow, 2010; Fakih et al., 2015].  The cell wall is completed by highly mannosylated 
proteins and β(1→6)-glucan (β(1→6)-linked glucose oligosaccharide) that interweaves with 
the β(1→3)-glucan matrix [Gander, 1974; Bowman and Free, 2006; Fesel and Zuccaro, 2016]. 
Unlike the surface of other pathogens, the external surface of an encapsulated virus is 
derived from the host cell membrane and forms a viral envelope surrounding the central 
viral particle [Figure 1.11f].  The membranous layer contains a mixture of host-derived 
proteins and numerous copies of a small set of viral glycoproteins that decorate the 
envelope, allowing for cell invasion and, in some cases, immune escape [Sodeik and 
Krijnse-Locker, 2002; Van Kooyk and Geijtenbeek, 2003; Shirato et al., 2004; Welsch et al., 
2007].  In most encapsulated viruses, the exposed glycoproteins are heavily glycosylated 
with complex arrays of N-linked oligosaccharides derived from their mammalian host [Mir-
shekari et al., 1997; Vigerust and Shepherd, 2007].  The extensive glycosylation forms the 
basis for host cell targeting through interactions with extracellular lectin-like domains, 
anchoring the virus to the host and enabling cell invasion.   
In human immunodeficiency virus (HIV), for example, the variable glycosylation of gp120 
facilitates binding to dendritic cells through interactions with the C-type lectin DC-SIGN 
(dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin) and its 
homolog DC-SIGNR which results in transfer to CD4+ T-cells in the lymph nodes 
[Geijtenbeek et al., 2000; Mitchell, Fadden and Drickamer, 2001; Snyder et al., 2005; Raska 
et al., 2010].  Similarly, the high mannose post translational modification of haemagglutinin 
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and neuraminidase in influenza A virus has also been recognised as major virulence factors 
during cell invasion; demonstrated by the inhibition of cell entry in the presence of red 
alga-derived lectins [Blok et al., 1982; Varghese, Laver and Colman, 1983; Jayaraman et al., 
2012; Sato et al., 2015]. 
Presence of the viral envelope leads to two classifications of virus: encapsulated viruses 
where the viral envelope is present and non-encapsulated viruses that lack the 
membranous envelope.  In both cases, the viral capsid, at the centre of the virus particle, is 
assembled from a series of interlocking, symmetry related proteins that form a protein-rich 
‘case’ around the genomic nucleic acids that code for all of the viral proteins.  This gives 
rise to viral capsids being described by their symmetry properties. However, as the capsid is 
enclosed by the viral envelope in encapsulated viruses, the proteins that make up the 
capsid are not exposed to the host defences.  Instead, the glycosylation of envelope 
glycoproteins form the major recognition sites for the innate immune system and 
surfactant protein D [Benne et al., 1995; Meschi et al., 2005; Van Eijk et al., 2012].  
1.6.2 Recognition of mannosylated structures by a mutant rfhSP-D 
These studies used a mutant recombinant fragment of human surfactant protein D that has 
a single point mutation in the flanking residue Arg343 [Crouch et al., 2009; Goh et al., 
2013].  By mutating the Arg343 to valine (R343V), it was shown that the affinity increased 
for branched mannosyl ligands, haemagglutinin from influenza A virus (IAV) and intact IAV 
particles compared to native hSP-D which was shown to bind all of the ligands but with 
significantly lower affinity [Crouch et al., 2009].  The largest increase in binding affinity (in 
the R343V mutant) was observed for a highly branched nonamannose which had the 
highest affinity of all the oligosaccharides used in the study.  The authors concluded that 
this may be a result of improved access to the binding site when Arg343 is not present and 
confirms the important role of Arg343 in ligand selection in the natural SP-D molecule, first 
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suggested by the earlier small oligosaccharide-bound complexes [Shrive et al., 2003, 2009; 
Allen et al., 2004; Crouch et al., 2007].   This was confirmed by crystallography using an 
α(1→2)-linked dimannose in complex with the R343V rfhSP-D mutant which successfully 
illustrated the effects of reducing the size of the 343 side chain as the second mannose 
residue in the chain accommodated the space left by the side chain, allowing it to interact 
with Asp325 and the more distant Arg349 side chain [Figure 1.13a, Crouch et al., 2009].   
It was also suggested that the R343V mutant may be recognising a non-terminal epitope in 
the longer hexa- and nonamannose ligands, enabled the by more accessible binding site 
[Crouch et al., 2009].  The mechanism for this was later elucidated by the same group who 
successfully complexed the mannosylation from HA (nonasaccharide made up of α(1→2), 
α(1→3) and α(1→6)-linked mannose residues, man9) with a mutant rfhSP-D containing two 
point mutations that reduced the size of both flanking residues [Goh et al., 2013].  In this 
mutant the R343V mutation, as previously mentioned, had an additional D325A mutation, 
reducing Asp325 to a minimum size without introducing additional flexibility to the α3 
region.  This resulted in a further increase in affinity for the HA and the intact virus 
compared to both the native structure and the R343V single point mutant.  The 
D325A+R343V mutant rfhSP-D crystallised in a different space group, P212121, to previous 
structures as a result of Asp325 not being available to make the key crystal contact.  In the 
binding site, the structure revealed three α(1→2) mannose residues through calcium 
recognition via the non-terminal mannose O3’ and O4’ hydroxyls.  The reducing terminal 
mannose was bound in a similar orientation to that seen in the dimannose/R343V complex 
and the third mannose was positioned in approximately the position of Asp325 in the 
native structure [Figure 1.13; Shrive et al., 2003; Goh et al., 2013]. 
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Figure 1.13:  Calcium coordination of α(1→2)-linked mannobiose (a) and nonamannose (b) in 
two mutants of rfhSP-D.  (a) mannobiose coordinates the calcium in the R343V mutant through 
O3’ and O4’ hydroxyls.  (b) nonamannose coordinates the calcium in the same way in a 
D325A/R343V double mutant of rfhSP-D.  Figures generated from PDB accession codes 3G84 
and 4M18 [Crouch et al., 2009; Goh et al., 2013]. 
 
The study confirms the importance of Asp325 in ligand selection and orientation in the 
calcium binding pocket, first proposed by Shrive and colleagues in 2009, as the presence of 
Asp325 occludes the binding site and prevent man9 from being recognised by Ca1, which 
is supported by the binding studies comparing the double mutant to native in recognising 
the H2N3 strain of IAV [Shrive et al., 2009; Goh et al., 2013].  This selection mechanism has 
been seen in other collectins, including MBP where the two amino acids in equivalent 
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positions to D325 and R343, His189 and Ile207 respectively, dramatically affect the binding 
specificity to monosaccharides, identifying His189 (325 in human SP-D) conferring the 
major ligand selection activity [Iobst and Drickamer, 1994; Iobst et al., 1994]. 
1.6.3 Recognition of lipopolysaccharides by rfhSP-D 
Recognition of Gram-negative bacteria by surfactant protein D is a well-established 
phenomenon, first recognised when laboratory and clinical bacterial samples of E. coli, S. 
paratyphi, and K. pneumonia were successfully bound and agglutinated by full length SP-D 
collected from BAL [Kuan, Rust and Crouch, 1992]. Since then, a range of Gram-negative 
bacteria including S. enterica and H. influenzae have been shown to be bound by hSP-D by 
the polysaccharide portion of the lipopolysaccharide through different regions in the 
polysaccharide [Kuan, Rust and Crouch, 1992; LeVine et al., 2000].  In Klebsiella pneumonia, 
the highly mannosylated O-antigens appears to be selectively targeted by SP-D, mediated 
through CRD interactions with the mannose residues, whereas in most cases, the inner core 
polysaccharide provides the recognition motif for SP-D, shown by the propensity of hSP-D 
to recognise rough LPS mutants [Kuan, Rust and Crouch, 1992; Sahly et al., 2002].  More 
recently, it has been suggested that the increased affinity for rough LPS mutants may be a 
result of heptose recognition in the widely conserved inner core polysaccharide with a 
recent study confirming that a rfhSP-D has a higher affinity for heptose-rich synthetic 
oligosaccharide cores compared to cores with no heptose residues [Wang et al., 2008; 
Reinhardt et al., 2016]. 
The nature of the interaction between heptose and a rfhSP-D was previously investigated 
using a representative L-glycero-α-D-manno-heptose-bound complex, revealing a novel 
binding mechanism between the O6’ and O7’ hydroxyls of the glyceryl side chain and Ca1 
in the main binding pocket [Wang et al., 2008].  The interactions between the O6’ and O7’, 
which assumed a comparable position to the O3’ and O4’ hydroxyls of maltose and 
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mannobiose, and rfhSP-D were completed by the surrounding side chains associated with 
the recognition of carbohydrate ligands; namely Glu321 and Asn323 which interact with 
O6’ and Glu329 and Asn341 which interact with O7’ [Shrive et al., 2003, 2009; Crouch et al., 
2009].  The mannose-type ring makes no direct interactions with the protein in subunits A 
and C but makes a single interaction with the amine group of Asn323 in subunit B [Figure 
1.14; Wang et al., 2008].  The interaction in subunit B appears to be a consequence of the 
crystal system and the direct interactions made between the mannosyl ring and the 
symmetry related molecule which differ between the three subunits. 
In the same study, a synthetic analogue of the heptose disaccharide found in the core of 
most LPS structures of E. coli, S. enterica and H. influenzae was also successfully crystallised 
with a rfhSP-D [Holst and Brade, 1991; Haishima, Holst and Brade, 1992; Phillips et al., 1992; 
Wang et al., 2008].  Calcium coordination of the binding heptose occurred in the same way 
as the L-D-heptose-bound complex, primarily through coordinate bonds with the O6’ and 
O7’ hydroxyls of the glyceryl side chain and completed by the same protein-ligand 
interactions with the calcium coordinating site chains [Figure 1.14].  The second heptose, 
linked by an α(1→3) glycosidic bond, was defined in the structure as a result of crystal 
contacts and makes no direct interaction with the protein. 
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Figure 1.14:  Calcium coordination of L-glycero-D-manno-heptose (left) and α(1→3)-linked 
diheptose (right).  Calcium coordination is completed through O6’ and O7’ hydroxyls in both 
complexes, with recognition completed by hydrogen bonds between Glu321, Asn323, Glu329 
and Asn341.  Figure generated from the PDB accession codes 2RIB (left) and 2RIC (right) [Wang 
et al., 2008]  
 
A significant step in the understanding of how SP-D recognises rough LPS mutants was 
made following the elucidation of the binding mechanism for a natural rough mutant of H. 
influenzae Eagan 4A [Clark et al., 2016].  Clark and colleagues used a delipidated 
oligosaccharide from Eagan 4A, containing the lipid A proximal Kdo-Heptose-β-D-Glucose, 
to successfully crystallise the first LPS polysaccharide-bound complex.  The structure 
revealed ligand bound in subunits B and C where the primary recognition occurred through 
the calcium coordination from O6’ and O7’ of the heptose.  These two hydroxyl groups also 
complete the core protein-ligand interactions with Glu321, Asn323, Glu329 and Asn341.  
The overall position of the heptose is very similar to the heptose-bound complexes, 
however there are additional interactions with the Kdo residue that was successfully 
defined in both subunits where ligand was bound [Figure 1.15].  Interestingly, the Kdo was 
in a furanose derivatised form following a β-elimination during ligand preparation, forming 
a five-membered ring with a long 2-oxobutanoic acid side chain [Auzanneau, Charon and 
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Szabó, 1991; Clark et al., 2016].  The flanking residue Asp325 was found to be essential in 
the Kdo recognition, making a direct hydrogen bond to the O6’ of the furanosyl ring 
however the 2-oxobutanoic acid was not defined and assumed to be free to move in the 
crystal structure.  It was suggested by the authors that there may be a role for both of the 
flanking residues, Asp325 and Arg343 in recognising a complete six-membered Kdo ring as 
a simple overlay appears to suggest this is possible, however direct evidence for this is still 
required [Clark et al., 2016].  Despite the second heptose being defined in the heptose 
disaccharide-bound complex, there was no evidence for the β-D-glucose which was 
substituted at O3’ position of the heptose ring [Wang et al., 2008].  This is not surprising, 
however, when you consider the major interactions between the crystal contact and the 
second heptose are mainly mediated through the O6’ and O7’ hydroxyls in the heptose 
disaccharide-bound complex, suggesting there are no stabilising interactions between the 
β-D-glucose and the protein binding pocket. 
Taking these studies together, it is clear from the high affinity for heptose and the ability of 
hSP-D to recognise the Hep-Kdo motif common to most lipopolysaccharides that 
recognition of rough mutants is primarily via the proximal heptose [Wang et al., 2008; Clark 
et al., 2016].  This may explain the propensity for hSP-D to recognise rough rather than 
smooth LPS mutants of Gram-negative bacteria as the long O-antigens of smooth LPS 
mutants may shield the inner core from protein recognition, as was suggested by Clark and 
colleagues [Clark et al., 2016].  However, what these studies fail to do is to describe 
alternative epitopes that hSP-D may also be able to utilise in recognition of rough strains 
especially considering the flexibility of SP-Ds binding mechanism to recognise a plethora of 
different carbohydrates, demonstrated by the small ligand studies [Shrive et al., 2003, 2009; 
Crouch, McDonald, et al., 2006; Crouch et al., 2009].  Further work is required to clarify this. 
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Figure 1.15:  Calcium coordination of the hydrolysed inner core polysaccharide from H. 
influenzae Eagan 4A.  Coordination of the calcium is completed through the O6’ and O7’ 
hydroxyls of the proximal heptose.  Recognition is completed by Glu321, Asn323, Glu329 and 
Asn341 with addition hydrogen bonding between O6’ of the anhydro-Kdo and Asp325.  Figures 
generated from the PDB accession code 4E52 [Clark et al., 2016] 
 
1.6.4 Recognition of gram-positive cell wall components 
Gram-positive bacteria, including the clinically important species Streptococcus 
pneumoniae and Staphlococcus aureus, have been shown to be targets for surfactant 
protein D, leading to agglutination and activation of phagocytes [McNeely and Coonrod, 
1993; Hartshorn et al., 1998; Jounblat et al., 2004; Leth-Larsen et al., 2005; Zhang et al., 
2015].  How the recognition occurs has been investigated using a number of different 
components of the bacterial cell wall, identifying peptidoglycan and lipoteichoic acid as 
recognition site for gram-positive bacteria, however no structural investigations have been 
completed to date [van de Wetering et al., 2001].   
The study by de Wetering successfully demonstrated that unmodified peptidoglycan, which 
is representative of in situ peptidoglycan, could be bound by hSP-D in a semi-quantitative 
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assay that showed 7.4% of the total protein added successfully bound to the 
peptidoglycan.  Inhibition assays of both peptidoglycan and lipoteichoic acid, using a range 
of monosaccharides, revealed that lipoteichoic acid has a higher affinity for hSP-D than 
peptidoglycan [van de Wetering et al., 2001].  The lipoteichoic acid, from B. subtilis, was 
shown to be bound by hSP-D in a saturable manner suggesting that there are a limited 
number of binding sites.  The recognition of peptidoglycan and lipoteichoic acid was 
calcium dependent and is thought to occur through the CRD as inhibition assays using 
inositol, maltose, glucose and mannose all successfully inhibited binding and are known to 
bind in the calcium binding pocket in the CRD.  The mechanism for this remains to be 
elucidated. 
1.7 Conclusions from work so far 
The work so far has revealed a binding mechanism in SP-D that is dominated by the 
calcium coordination of two hydroxyls that adopt a conserved position in relation to the 
calcium ion and the surrounding side chains.  Studies have revealed that this mechanism 
allows hSP-D to be versatile and recognise a range of mono- and oligosaccharides in the 
calcium binding pocket, completing protein-ligand interactions with Glu321, Asn323, 
Glu329 and Asn341 in all cases.  The propensity to recognise a range of carbohydrates 
allows hSP-D to recognise a wide range of pathogens through their carbohydrate arrays on 
the surface, making it an essential part of the innate immune response and important 
regulator of the acquired immune response.   
The crystal structures have also revealed important roles for the two binding site flanking 
residues, Asp325 and Arg343, in selecting and recognising natural ligands.  These two side 
chains are in key positions to interact directly with bound oligosaccharides and orchestrate 
calcium coordination by orientating the hydroxyls in the binding site.  Longer 
oligosaccharides have also highlighted the possibility of an extended binding surface 
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surrounding the main calcium coordinating pocket which may also play a vital role in 
recognising ligands and contribute to pathogen recognition by hSP-D. 
1.8 Aims and objectives of this work 
Studies presented here are a continuation and extension of work carried out by Trevor 
Greenhough, Annette Shrive and Ian Burns, and previous members of the research group 
Amy Shaw, Carrie Smallcombe and Ruben da Silva with some insight from William Neale, a 
current member of the group. 
The characterisation of pathogen recognition by surfactant protein D is an important 
aspect of understanding the role of hSP-D in innate immune defence, particularly in 
establishing how SP-D is capable of recognising such a wide range of targets from all 
pathogenic phyla.  Previous work in this group has established the native structure of a 
biologically and therapeutically active recombinant fragment of human SP-D and a number 
of ligand-bound complexes have also been solved, identifying the calcium-dependent 
mechanism of ligand recognition [Shrive et al., 2003, 2009; Clark et al., 2016].  The aims of 
this project are to extend this work to further characterise the binding determinants of hSP-
D. 
To do this, my project sets out to first determine how the recombinant fragment of SP-D 
recognises longer oligosaccharide ligands (trioses and above) that utilise the alternative 
anomer of D-glucose, β-D-glucose, common in pathogenic carbohydrate arrays and 
isomers of malt-N-oses.  Ligand-protein complexes, using commercially available 
cellotriose (β(1→4)-linked), laminaritriose (β(1→3)-linked) and isomaltotriose (α(1→6)-
linked), were investigated using crystallographic techniques to determine the structural 
determinants of ligand binding, compare them to maltotetraose (α(1→4)-linked 
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tetrasaccharide) and maltoheptaose (α(1→4)-linked heptasaccharide) and characterise 
recognition of non-terminal monosaccharide residues if any were present. 
The second objective was to determine how SP-D recognises components of 
peptidoglycan, a structural component of the bacterial cell wall, using a muramyl 
disaccharide unit extracted from the Gram-positive Species M. luteus.  Full length SP-D has 
been shown to recognise and bind to soluble and insoluble peptidoglycan however how 
the recognition occurred has not been elucidated at the molecular level.  The study 
presented here describes for the first-time recognition of muramyl disaccharide and 
provides some insight into how longer peptidoglycan ligands may be accommodated by a 
recombinant fragment of hSP-D. 
The final objective is to build on previous work in the group which identified a novel 
binding mechanism for the proximal Hep-Kdo motif of a lipopolysaccharide from the rough 
lipopolysaccharide mutant H. influenzae Eagan 4A [Clark et al., 2016].  A structure of a 
delipidated oligosaccharide from S. enterica sv. Minnesota R7 mutant in complex with 
rfhSP-D has been investigated by a previous PhD student [Smallcombe, 2014].  However, 
my objective was to revisit the structure to resolve unanswered questions and provide a 
definitive description of the ligand-protein interactions, using the now fully characterised 
R5-bound complex structure as a comparison [Littlejohn et al., 2018]. 
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Chapter 2:  Introduction to protein crystallography 
In crystallography, there are a set of concepts that are essential to understanding how 
structural data can be derived from a crystal.  This chapter is not an exhaustive review of 
protein crystallography.  Instead, it intends to briefly explore the important concepts, to 
provide context to how the data was collected, analysed and how that data enabled the 
completion of the work throughout the remaining chapters. 
2.1  A brief history of crystallography 2.1.1 The advent of the crystallographic method 
X-ray diffraction was first described by Laue in 1912, following experiments with crystals of 
zinc sulphate [Friedrich, Knipping and Laue, 1913; Laue, 1913].  The diffraction pattern, 
thought to be evidence of a polychromatic source, was the first time that any structural 
insight into atomic positions was derived from a crystal.  Laue proposed that the crystal was 
a three-dimensional array, with zinc and sulphur atoms at the corners of each of the cubes 
that made up the array.   
In the same year, following Laue’s discovery, the Braggs used the diffraction pattern from 
ZnS to elucidate Bragg’s Law and, in doing so, provided the tool for solving all future 
structures from either chemical or protein sources (discussed in section 2.4.1, [discussed in 
section 2.4.1; Bragg, 1912].  Lawrence and William Bragg went on to use the structure of 
ZnS to prove Bragg’s Law, determining that there are additional atoms in each face of the 
ZnS cube.  Since then, Bragg’s Law has been used to reveal a huge wealth of information 
about the atomic positions in not only some of the most basic materials, like sodium 
chloride, but also large protein complexes, viral capsids and, most famously, the structure 
of DNA [Bragg and Bragg, 1915; Watson and Crick, 1953]. 
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2.1.2 Development of macromolecular crystallography 
More complex structures of small biomolecules were soon solved using crystallographic 
techniques pioneered by Dorothy Hodgkin.  In 1939, the first of the important biological 
molecule structures to be solved was cholesterol, an important component of the cell 
membrane, followed by penicillin in 1949 and vitamin B12 in 1956 [Carlisle and Crowfoot, 
1945; Hodgkin, 1949; Hodgkin et al., 1955].  This developed the crystallographic technique 
so far that the first structure of insulin was solved in 1969 – a project that was started 30 
years before when the first diffraction patterns from a crystal of insulin were captured 
[Adams et al., 1969]. 
In the intervening years, the first protein structures of myoglobin (1958) and haemoglobin 
(1960) were solved, followed by the first high-resolution structure of myoglobin in 1960, 
demonstrating that protein structures could be resolved to near-atomic resolution 
[Kendrew et al., 1958, 1960; Perutz et al., 1960].  Since then, the number of crystal structures 
of large macromolecules, including large protein complexes like the ribosome, which is 
over four million kDa, has increased year on year to beyond 135 000 at the time of writing 
[Berman et al., 2000].  In no small part, this is thanks to the early pioneers in the field and 
the continued work to push and improve the techniques into the future. 
2.1.3 The advent of modern computational techniques 
The increasing complexity of the protein structures being investigated and the realisation 
that Fourier transforms can be used to help determine those structures led to the 
realisation that the emerging power of computation could be utilised.  From the early days 
of crystallography, the first computers were used to accurately calculate the complex 
Fourier transforms required to reproduce electron density maps from the diffraction images 
(discussed in section 2.4.3).  However, most of the process was still manually completed by 
painstakingly measuring each reflections position and intensity and then interpreting the 
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data output from the computational machines to elucidate the electron density and the 
molecular structure. 
As the capacity of computers continued to increase through the 80s and 90s, so did the 
ability of the crystallographic tools to successfully process digital diffraction images and 
downstream processing, many of which form the basis of the programs still used today 
(discussed in chapter 3).  A major improvement came with the ability to display electron 
density computationally and visualise it in three dimensions using programs like O written 
by Alwyn Jones [Jones et al., 1991].  Since then, many of the earlier algorithms have been 
refined and optimised to produce programs that are able to deal with even difficult data, 
allowing for more and more protein structures to be successfully solved and deposited 
[PDB].  This has culminated in a concerted effort to continue progressing modern 
computational techniques as part of the collaborative computational number 4 (CCP4) and 
a similar suite of programs, Python-based Hierarchical Environment for Integrated 
Xtallography (PHENIX) [Adams et al., 2010; Winn et al., 2011].  These two program suites 
have revolutionised macromolecular crystallography. 
2.2  Protein crystallisation 2.2.1 Crystallisation background 
For X-ray crystallography to be possible, a crystal of the protein must be grown because a 
regular and repeating three dimensional array is needed to provide an interpretable 
diffraction pattern that allows for the nature and location of the atoms to be discerned.  
The 3D array is a result of all the atoms adopting equivalent positions in a regular lattice, 
related by symmetry operations, discussed in section 2.3.  However, the array must be 
ordered and regular throughout the crystal for the diffraction pattern to useful and, 
therefore, the formation of the crystal must be carefully controlled.  
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The main obstacle to protein crystal formation is the free energy required for the critical 
nucleation of an ordered crystal that can then go on to grow into a crystal; using the initial 
nucleation as a template for the remaining protein molecules to bind with the surface of 
the crystal, in a lower energy process.  To overcome the limiting energy, and for an ordered 
nucleus to propagate, the protein must enter a meta-stable, supersaturated condition that 
is beyond the solubility of the protein but, importantly, is not sufficient for the protein to 
precipitate out of the solution.  Once the nucleation event occurs, the concentration of the 
protein in solution begins to fall as the crystal grows, with the concentration gradient 
driving crystal growth.  However, when the concentration of the protein reaches 
equilibrium between the solution and the crystal, the concentration gradient stops, and the 
crystal growth stops as a result. 
Control of the crystallisation must also extend to the production of crystals and not protein 
precipitate.  This is achieved through careful increases in the concentration of a 
precipitating solution which drives the protein molecules into a super saturated state by 
gradually evaporating the water from the protein-precipitant mixture.  This is usually 
achieved by a process of vapour diffusion.  Two methods of vapour diffusion have been 
developed: Hanging drop method; and sitting drop method.  Both methods are 
fundamentally the same, with a small volume (or drop) of protein solution and precipitant 
buffer spatially separated from a larger well of precipitant buffer in an air-tight 
environment.  This allows for water to slowly diffuse out of the smaller volume and 
equilibrate with the reservoir which has the effect of gradually increasing the concentration 
of the protein and the precipitant in the drop, until the energy required for nucleation is 
overcome and crystal growth is initiated.  The crystals are then able to grow until the 
concentration of free protein in the solution is equal to the protein concentration in the 
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crystal.  The method used during the set of experiments described here was the sitting 
drop method [Figure 2.1]. 
 
 
Figure 2.1:  Sitting drop method. The figure shows the sitting drop method for vapour diffusion 
which allows for the gradual increase of protein concentration in the crystallisation drop until 
nucleation occurs and the protein crystal forms.  In all of the experiments, 24-well linbro plates 
were used with approximately 1ml of reservoir solution and a 1:1 ratio of protein solution to 
precipitant buffer to a final volume of 4μl in the drop 
 
2.2.2 Improving crystallisation 
In each crystallisation experiment, there is some degree of improvement required to 
optimise the crystal quality, size and singularity because the specific conditions within the 
crystallisation well will differ between wells, even if the intended conditions are the same as 
a previously successful condition.  The concentration of precipitant is commonly varied to 
optimise the crystallisation, but pH and type of salt are also regularly varied to improve 
both singularity of the crystals, reducing the size of crystal showers, and increasing the size 
of the crystals.  These changes improve the crystal quality by changing either the stability of 
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the protein at supersaturation, encouraging better nucleation, or affecting the critical 
nucleation energy by either increasing it, to reduce the number of crystals nucleating, or 
reducing it to allow for better nucleation.  Nucleation can also be aided by seeding 
microcrystals, which overcomes the critical nucleation energy and allows for crystals to 
grow in a more energetically favourable condition. 
2.3  Symmetry and the crystal lattice 
A crystal is, when broken down to its component parts, an array of a single repeating unit 
of 3D space, these units being related to each other by a number of translational and 
rotational symmetry elements that allow for the given 3D space to be completely filled.  
This single repeating unit is the unit cell.  By characterising the relationships between the 
unit cells, the spacegroup can be derived using the symmetry elements.  This short section 
will introduce the main concepts required to determine the spacegroup of protein crystals 
which are required for successful interpretation of the diffraction pattern and subsequent 
solution of the crystal structure. 
2.3.1 Basic lattice principles 
For diffraction to be useful in solving a molecular structure, an ordered three dimensional 
crystal comprising a repeated single unit, the unit cell, is required.  The unit cell dimensions 
are described by three edges, a, b, and c, and the three angles between those edges, α, β, 
and γ [Figure 2.2].  Geometrical parameters of planes within the crystal, in terms of the unit 
cell parameters, can then be calculated, completing the three-dimensional description of 
the unit cell.  The fixed size of the unit cell also allows the coordinates in the x, y, and z 
directions to be expressed as fractions of the unit cell and, by extension, in terms of the 
crystal planes which intersect these coordinates.  These planes are described by the Miller 
indices h, k, l and intersect with the unit cell axes at a/h, b/k, and c/l.  This property of Miller 
indices can then be used to determine the unit cell experimentally because the dissecting 
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planes are also the Bragg planes which, when aligned throughout the crystal according to 
the lattice of repeated unit cells, generate strong reflections in accordance with Bragg’s law.  
For the crystal to form correctly, the unit cell must also be able to tessellate (by translation) 
consistently throughout three-dimensional space so that there is no space between the 
unit cells.  Within the unit cell itself the molecules are related by a number of symmetrical 
rotations, translations and mirror planes (the latter not being appropriate for proteins due 
to the enantiomeric nature of the amino acid). The repeated translational tessellation of 
unit cells throughout the crystal means that the symmetry elements within the unit cell also 
extend throughout the crystal.   
There is also usually an asymmetric unit within the unit cell that does not have any crystal 
symmetry but may have local, or non-crystallographic, symmetry; such as the approximate 
3-fold axis which relates the individual protein subunits in the recombinant fragment of 
human surfactant protein D (rfhSP-D) trimer [Håkansson et al., 1999; Shrive et al., 2003]  
Importantly, the symmetry elements mean that each unit cell shares exactly the same 
environmental conditions as every other unit cell in the crystal, making it possible to 
successfully diffract an incident beam of X-rays in a reproducible and constructive way 
resulting in a diffraction pattern that is interpretable in terms of the nature and position of 
each and every atom in the crystal and hence in the unit cell and the constituent molecules 
themselves.  
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Figure 2.2:  Unit cell parameters superimposed on a unit cell.  The length of each axis (a, b, c) is 
determined by the distance between the lattice points (blue spheres) and describe the smallest 
basic repeating unit of a larger crystal lattice.  The angles (α, β, γ) are measured between the 
three unit cell axes; α between b and c; β between a and c; and γ between a and b.   
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2.3.2 Bravais lattices and crystal systems 
The geometry of the unit cell, and therefore the overall crystal, is described by the Bravais 
lattice which can then, more broadly, be described by the crystal system.  There is a total of 
seven crystal systems describing the overall shape of the unit cell with the unit cell 
parameters (a, b, c, α, β, γ) measured from the diffraction pattern during indexing [table 
2.1].  Within these seven systems, there are 14 Bravais lattices.  If the lattice points are only 
found at the corners of the unit cell, they are identified as a Primitive lattice (P) but in the 
cases where there are equivalent lattice points not at the vertices, they are identified as 
body-centred (I), face-centred (all faces, F) and face-centred (one face, C).  In the special 
case of a trigonal crystal lattice, there is also a Rhombohedral-centred (R) lattice with lattice 
points additional to those at the vertices of a primitive hexagonal lattice.  In each case, 
there is a minimum amount of symmetry required for a successful lattice construct, 
however there are further possible symmetry operations in each case which are described 
by the point group and additional translation operations in the spacegroup.   
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Table 2.1:  Summary of crystal systems and associated Bravias lattices.  The table summarises 
the Bravais lattices, minimum symmetry requirements and unit cell constraints for each of the 
seven crystal systems 
Crystal system Bravais lattices Minimum symmetry 
Unit cell 
constraints 
Triclinic P None None 
Monoclinic P, C One 2-fold axis α=γ=90° or 
α=β=90° 
Orthorhombic P, C, I, F Three 2-fold axesa α=β=γ=90° 
Tetragonal P, I One 4-fold axis α=β=γ=90° a=b 
Hexagonal P One 6-fold axisb α=γ=90°, β=120° a=b 
Trigonal Rb One 3-fold axis α=β=γ=60° a=b=c 
Cubic P, I, F Four 3-fold axes α=β=γ=90° a=b=c 
aParallel to a, b and c 
bSpecial case of a primitive hexagonal system can produce a primitive trigonal lattice with 
a 3-fold axis where α=γ=90°, β=120° and a=b 
 
2.3.3 Point groups 
Each Bravais lattice has a set of minimum rotational symmetry operations required for an 
ordered, three-dimensional array of unit cells to “assemble” into a diffracting crystal.  In 
many cases however, there are additional, but complimentary, rotation axes that enable 
better packing of the protein molecules [table 2.1].  In all cases, the rotational symmetry 
can be described using a “point group”, which describes the n-fold axes in the lattice and, 
importantly, which axis the rotation occurs around.  For example, the point group 222 
would describe a lattice (and unit cell) with 2-fold rotational axes about x, y and z.  There is 
a total of 32 unique point groups that can describe all rotation axes of all the crystal 
lattices.  However, because the point group is determined from the overall lattice topology, 
any translational symmetry relationships are lost. As a result, screw axes (a rotation plus 
translation symmetry operator) are not identified within the point group.  
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2.3.4 Additional symmetry elements 
Beyond unit cell translations and rotation axes, there are a second set of symmetry 
elements that combine a translation with another symmetry operation.  In protein 
crystallography, these secondary elements are limited to screw axes since mirror planes and 
inversion centres are not allowed by the enantiomeric nature of amino acids and other 
biological molecules such as carbohydrates and DNA.  A screw axis describes the 
translation and rotation of an asymmetric unit (and hence the molecules within that unit), 
along a crystallographic n-fold rotation axis.  
The amount of translation and rotation between two molecules are described by the order 
of the rotation axis and the fractional translational shift between them in terms of the unit 
cell.   
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑜𝑜𝑡𝑡 =  1
𝑡𝑡
 𝑤𝑤ℎ𝑒𝑒𝑡𝑡𝑒𝑒 𝑡𝑡 = 2,3,4 𝑜𝑜𝑡𝑡 6 
𝑡𝑡𝑜𝑜𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑜𝑜𝑡𝑡 =  360°
𝑡𝑡
 𝑤𝑤ℎ𝑒𝑒𝑡𝑡𝑒𝑒 𝑡𝑡 = 2,3,4 𝑜𝑜𝑡𝑡 6 
 
Therefore, for a screw axis associated with a 2-fold axis, n = 2, the asymmetric unit is 
translated by ½ a unit cell in a positive direction along the axis and rotated 180° about the 
axis.   
The value of n is limited to 2, 3, 4 or 6 according to the seven crystal systems and 
associated Bravais lattices [see table 2.1].  However, both a 5-fold and 7-fold can exist as 
local, non-crystallographic symmetry, within the asymmetric unit. 
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2.3.5 Spacegroup 
The spacegroup of any crystal is defined, primarily, by the Bravais lattice, the point group 
and any additional translations within the crystal, such as screw axes or glide planes.  Thus, 
a crystal with a primitive (P) lattice and point group 222 where each 2-fold axis is a screw 
axis has spacegroup P212121. In protein crystallography, the number of spacegroups is 
reduced from 230 to just 65 because of the enantiomeric properties of amino acids, 
preventing protein crystals from forming with mirror or inversion planes that would require 
the rotameric state of the L-amino acids to change to D-amino acids; which do not 
naturally exist. 
A large proportion of proteins have been solved in the orthorhombic spacegroup, P212121, 
or monoclinic spacegroup, P1211 (written as P21).  This is because these spacegroups are 
more flexible in terms of protein packing, allowing for a larger number of possible spatial 
arrangements of the protein molecules.  Understanding the nomenclature of each 
spacegroup can be broken-down into three sections: (1) the Bravais symbol; (2) the 
crystallographic rotational symmetry operations; and (3) additional translations of the 
asymmetric unit within the unit cell.  All of this information makes it is also possible to then 
derive the crystal system from the spacegroup.  Taking the recombinant fragments of hSP-
D, previously solved in spacegroup P21, as an example: P is representative of the Bravais 
lattice of the crystal, in this case primitive; 1 2 1 represents the crystallographic symmetry 
operations, in this case a 2-fold axis in the b direction; and 21 representing a screw axis with 
a translation of ½ a unit cell along b [Håkansson et al., 1999; Shrive et al., 2003; Crouch, 
McDonald, et al., 2006].   
In lower symmetry spacegroups, such as triclinic, monoclinic and orthorhombic, the 
symmetry operations describe the three axes, a, b and c, whereas in higher symmetry 
spacegroups this is not necessarily the case; for example, P422 indicates a 4-fold axis 
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parallel to c with 2-foldaxes along a and b and half way between.  In all cases, where the 
axes of the unit cell have no associated symmetry operator, it is common for the axes to be 
removed from the spacegroup name and for the name to abbreviated to the axes where 
there is a symmetry operation, P21 in the rfhSP-D example. 
2.3.6 Disorder and twinning 
So far, the ideal crystalline array has been introduced, where all of the unit cells align along 
symmetry elements and form a consistent crystal lattice [Figure 2.3a].  However, protein 
crystals have a range of problems with the lattice that directly affect data collection.  For 
simplicity, two of the difficulties experienced during this body of work are described here; 
disorder and twinning.  Disorder is caused by the proteins not packing together in a 
repeating, symmetry related lattice, preventing the unit cell from fulfilling the basic 
requirement of a repeating environment [Figure 2.3c].  This results in poor diffraction as the 
requirement that the Bragg planes h, k, l within different unit cells throughout the crystal 
are aligned with each other is not met, which will limit the overall resolution of a dataset or, 
in the worst cases, prevents a crystal from diffracting. 
Twinning refers to a crystal anomaly where two or more parts of the crystal have grown in 
two distinct orientations often related by a symmetry operator that is not part of the crystal 
point group. True twinning can only form in spacegroups where the two unit cell 
orientations can occupy the same three-dimensional space [Figure 2.3b].  In protein 
crystals, twinning is common because the protein molecules in the asymmetric unit have 
the potential to make more than one set of crystal contacts as they are arranged in the 
crystal, which can then nucleate a new domain based on the new crystal contacts.  This is 
called pseudo-merohedral twinning.  A very similar effect is also observed in merohedral 
twinning however the crystal domains are smaller and more dispersed through the crystal.  
In pseudo-merohedral and merohedral twins, the diffraction intensities from the two 
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domains (which diffract independently, producing their own diffraction patterns) form an 
average of the two diffraction patterns with no strong or weak intensities.  As a result, the 
diffraction pattern is difficult to interpret. 
 
 
Figure 2.3:  Examples of crystal lattice pathologies.  An overall approximation of crystal lattice 
pathologies common in protein crystallography. (a) shows a well-ordered protein crystal with all 
unit cells sharing an identical environment; (b) shows an example of a twinned lattice, where 
two differently oriented unit cells can occupy the same 3D space; and (c) shows a disordered 
crystal, with each unit cell unaligned and orientated differently.  In all cases, the abc axes are 
approximately in the same orientation with the ac face in plane with the paper. 
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2.4  X-ray diffraction methods 2.4.1 Electromagnetic waves and the X-ray 
Electromagnetic waves are a spectrum of sinusoidal waves that interact and disrupt both 
electronic and magnetic environments and carry a fixed amount of energy.  Sinusoidal 
waves oscillate through 360° (phase, φ) to complete a whole wavelength (λ), extending to a 
specific amplitude at the peak of the oscillation.  X-rays are a short wavelength 
electromagnetic waves with a wavelength (λ) between 1x10-11m and 1x10-8m, or 0.1 to 
100Å.  This makes them useful for structure determination because the distance between 
two atoms ranges from 1.2Å to 1.5Å, allowing a wavelength of approximately 1.0Å to 
provide resolution of the atoms and therefore their positions in three dimensional space. 
The amount of energy a wave carries depends on the amplitude of the wave, with larger 
amplitudes delivering more energy to any material the waves are incident on.  The amount 
of energy delivered is the intensity of a beam.  The incidence of an electromagnetic wave 
with electrons surrounding the atoms of a protein causes the electrons to absorb the 
energy from the electromagnetic wave, promoting the electrons to a higher energy orbital 
around the atom.  However, the electrons are unable to maintain the excited state and 
rapidly return to their original energy state, emitting a photon in a random direction that 
has an equal energy and wavelength to the incident beam.  The emitted photon is the 
scattered X-ray. 
As with other electromagnetic waves, the emitted X-rays are able to have a summative 
effect on the overall emitted wave, exclusively affecting the amplitude of the waves without 
changing the overall wavelength of the outgoing wave.  Any summation of waves is 
interference and can have three effects: (1) Constructive interference, whereby the waves 
are in phase and have an additive effect on the amplitude [Figure 2.4a]; (2) Incomplete 
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interference, where the waves are less than 180° out of phase causing the overall wave to 
shift along the wave-path (change of phase) as a function of the two (or more) waves and 
the amplitudes of the waves to be higher than either original wave but not increase in an 
additive fashion [Figure 2.4b] and; (3) Destructive interferences, where the two waves are 
180° out of phase and cancel each other out, losing all amplitude [Figure 2.4c].  In 
crystallography, the effects of summation are evident from diffraction as each reflection is a 
sum of all the diffracted waves in that direction, leading to spots of different intensities.  
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Figure 2.4:  Summation of sinuosoidal waves and the resulting interference.  Each figure shows 
two incoming waves (orange and green) and the resulting sum of those two waves (purple).  
Figure (a) shows constructive interference; (b) shows two sinusoidal waves 90° out of phase 
resulting in incomplete interference; and (c) shows two sinusoidal waves 180° out of phase 
resulting in destructive interference. 
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2.4.2 X-ray diffraction and Bragg’s Law 
Bragg’s law (1) describes the conditions under which a crystalline material produces a 
reflected X-ray, called a Bragg’s reflection. It ascertains that a plane of atoms is able to act 
as a mirror, reflecting an X-ray at the same angle as the incident beam meets the atomic 
plane.  Therefore, if two monochromatic X-rays that are in the same phase interact with two 
atomic planes, with the correct distance (d) between them, the difference in path length (2d 
sinθ) will be a whole number of wavelengths and n will an integer.  If this is true, then the 
outgoing X-ray beams remain in phase and crystal will successfully diffract [Figure 2.5]. 
𝑡𝑡𝑛𝑛 = 2𝑑𝑑 𝑡𝑡𝑡𝑡𝑡𝑡𝑠𝑠             (1) 
 
Figure 2.5:  Proof of Bragg's Law.  The figure demonstrates that for the two outgoing X-ray 
beams to be in phase, following reflection, the distance travelled by the second beam (d sinθ + 
d sinθ) must be a whole number (n) of wavelengths (λ), where θ is the angle of incidence. 
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A complete set of diffraction data comprises the diffraction maxima from each and every 
set of planes h, k, l in the crystal which, therefore, requires rotating so that all the planes are 
illuminated and allowed to diffract.  Rotation changes the angle of incidence with the 
planes, resulting in a change in d and the set of miller indices h, k, l diffracting, allowing for 
a complete set of data to be collected.  However, because the X-rays illuminate every atom 
in the crystal, the outgoing X-rays are a summation of all the diffracting atoms, both in the 
Bragg planes and between them, resulting in the information about the individual 
intensities and, most importantly, the phase of the outgoing X-ray being lost.  Instead, the 
intensity provides some information about the average position of every atom associated 
with that reflection but without the phase, the individual positions cannot be determined.  
The lack of phase information is described as The Phase Problem and is biggest obstacle in 
solving a crystal structure (discussed further in section 2.4.3). 
2.4.3 Importance of the crystal lattice at high resolution 
The intensity of the reflections is also directly affected by the crystal lattice and the 
robustness of that lattice, particularly for high resolution data.  For perfect diffraction, all of 
the atoms in the crystal would be completely stationary and in identical positions 
throughout the crystal to maximise the summative intensity of the diffracted X-ray.  
However, in a real crystal this can never be achieved because there is a fundamental 
amount of thermal energy in the highly conserved atomic positions and flexible regions in 
the protein that will not be in exactly the same position throughout the crystal, which will 
affect each and every diffraction spot and hence the information that can be extracted from 
them.  In practice, the inherent flexibility of macromolecules limits the resolution of the 
data by compounding the natural drop off in scattering factor that results from increasing 
the scattering angle at high resolution.  This is observed as a sharp drop, or edge, in a 
diffraction pattern beyond which there are no detectable spots. 
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The lattice also becomes increasing important at resolutions better than 2.0Å (where there 
are larger diffraction angles, θ) because there are more observations being made as a result 
of the large numbers of closely spaced Bragg planes in the crystal that meet Bragg’s law 
and successfully diffract.  As the interplanar spacing, d, falls, the angle of incidence must 
increase proportionally for successful reflection of an in-phase X-ray according to Bragg’s 
law.  The effect of this is to generate more microenvironments within each unit cell, as the 
miller indices increase, causing the position of equivalent atoms to have a larger impact on 
the overall crystal diffraction as very small differences in atomic position represent a large 
fraction of d at high diffraction angles.  
2.4.4 Structure factors, Fourier transforms and The Phase Problem 
The crystal lattice allows each reflection collected from a single crystal to be treated as an 
average of a near-infinite number of atoms arranged on and between a set of Bragg 
planes, with information about the sum of the individual scattered intensities.  For the 
intensity of each diffracted spot, there is also an associated phase, which is lost during data 
collection, that is taken in combination with the intensity to describe the electron density 
around each atom in a unit cell.  These complex numbers are the structure factors and can 
be expressed as a Fourier transform.  To translate the structure factors back into real space 
(3D space), a second Fourier transform, an inverse Fourier transform, can be used to 
calculate the electron density map using the amplitude and phase for each atom. 
The problem is, without knowing the phase for each reflection, the inverse Fourier 
Transform which requires intensity and phase, cannot be calculated; this is The Phase 
Problem.  For small molecule crystals, the phase can be solved by direct methods based on 
atomic properties and probability, however for larger structures like protein crystals 
alternative methods must be used using either known properties of heavy atoms that can 
be soaked into the crystals, providing a reference phase, or molecular replacement using a 
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previously solved structure that is comparable to the protein in question, using the phase 
calculated from the known structure to solve the new protein structure.  Molecular 
replacement by rigid-body refinement was used throughout this set of experiments. 
2.4.5 Data collection techniques 
The phase problem is created by the data collection methods necessary in crystallography.  
Unlike other microscopy techniques that use visible light or electrons, X-rays cannot be 
refocussed to generate a coherent image of the object and, as a result, the data must be 
collected from the diffracted X-rays and the image calculated computationally, using 
Fourier Transformations [Figure 2.6].  To make this possible, a range of methods and 
detectors have been developed to gather the diffraction data.  Originally, data collection 
was collected using photo-reactive films that would permanently change colour when 
exposed to X-rays.  However, this technique has been superseded by photon counting 
detectors such as charge-coupled detectors (CCDs) and silicon pixel detectors (DECTRIS 
Pilatus series) that measure the electrical changes associated with an incident X-ray.  This 
has led to a huge reduction in overloads from the high intensity diffraction and maximised 
the amplification of the weak diffraction, so they can be measured above background.  The 
improvements in detection hardware have also massively reduced the time taken to collect 
a dataset; from many hours for a single dataset to a few minutes with a live read out of the 
data as it is collected. 
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Figure 2.6:  Comparison of microscopy and X-ray diffraction experiments.  The figure compares 
the X-ray diffraction experimental set-ups to traditional and electron microscopy set ups.  In 
microscopy, the diffracted rays/electrons (e-) are collected by a refractive lens that refocuses the 
rays into an image of the sample.  In X-ray diffraction, it is currently impossible to refocus X-rays 
sufficiently to produce the image, so the inverse Fourier Transform is calculated to find the 
image from the diffraction pattern. 
  
Chapter 2  X-ray diffraction methods 
89 | P a g e  
 
All of the data collected during the experimented presented in this work were collected 
using DECTRIS Pilatus 6M detectors at the synchrotron radiation source, Diamond Light 
Source, in Oxfordshire.  Synchrotron radiation is beneficial to protein crystallography 
because of the high brilliance of the X-rays it produces and the consistent wavelengths that 
they are able to produce, by controlling the high-energy electrons very accurately; allowing 
for variables in the incident X-rays to be minimised.  This, in turn means the data collected 
from the synchrotron beamlines are reliable at a wavelength of approximately 1Å, which is 
shorter than the interatomic distance of two carbon atoms (approximately 1.54Å).  This 
means that at wavelengths of 1Å, data can be collected at subatomic resolution as a shorter 
wavelength means the distance between Bragg planes can be as small as 1Å, creating the 
conditions for the highest possible resolution.  It is important for the detector to be at the 
correct distance from the crystal to maximise the separation between diffraction spots but 
also maximising the amount of data collected from the high-resolution diffraction shells.  
In all of the experiments here, the crystals were also rotated by 0.1 – 0.2°, on a goniometer, 
between each data capture to ensure all of the Bragg planes were illuminated throughout 
the crystal, to ensure that a full set of reflections hkl were collected so that a full three-
dimensional reconstruction of the asymmetric unit can be successfully made.  The total 
oscillation of each crystal is determined by the symmetry of the spacegroup, with higher 
order symmetry requiring a smaller amount of rotation.  For all of the data collections 
completed, a minimum of 180° were collected, enough for all spacegroups to be fully collected, 
but in many cases additional degrees were collected to ensure high completeness in the final 
dataset.  
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2.4.6 Radiation damage and the benefits of cryocooling 
The strength of the high-resolution reflections can be improved by longer exposure times, 
effectively increasing the amount of energy delivered to the electron shells, increasing the 
chance of photon emission, however larger radiation doses increase the risk of radiation 
damage.  Primary radiation damage occurs in a dose-dependent manner because some of 
the X-ray energy, carried by the photons, is absorbed by the atoms in the crystal, causing 
the atoms to lose electrons from their higher energy orbitals, often breaking covalent 
bonds and producing ionised radicals [Murray, Garman and Ravelli, 2004; Ravelli and 
Garman, 2006].   
The ionised radical species then become mobile, causing secondary radiation damage to 
charged or highly energetic side chains in a time and thermal energy dependent manner.  
This is because the reactive species are able to move through the solvent channels, 
affecting other protein molecules in the crystal and exponentially increasing the number of 
reactive species in the crystal.  Eventually this leads to degradation of the crystal and 
eventual collapse of the crystal lattice as every protein molecule is damaged beyond 
recognition, described as the Garman limit  [Owen, Rudino-Pinera and Garman, 2006]. 
Primary radiation damage can be minimised by reducing the dose of radiation to the 
crystal, however this then limits the potential resolution of the data because a smaller dose 
prevents the high-resolution diffraction events from summing to an appropriate level, 
making this impractical for protein structure determination; particularly in ligand 
recognition studies where high resolution definition of bound ligands and their interaction 
with the protein is the goal.  Secondary radiation damage, on the other hand, can be much 
more easily limited.  As the damage is both time and temperature dependent, if the time 
taken for the dose to be delivered to the crystal can be reduced, and that dose can be 
delivered at low temperatures, the effects of secondary radiation damage can be 
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minimised.  Synchrotrons have now made it possible to reduce data collection to a number 
of minutes by increasing the brightness of the X-ray beam, reducing the time that 
secondary radiation can have its effects.  This leaves temperature as the final factor. 
At room temperature, the reactive species are able to rapidly penetrate the crystal because 
of the thermal energy in the species itself and the surrounding solvent [Figure 2.7].  
However, if the temperature can be reduced to absolute zero, there is no thermal energy 
present in the crystal system and the reactive species are unable to move from their initial 
positions.  To achieve absolute zero, though, is impossible so the crystals are, instead, 
cooled to 100K in liquid nitrogen [Owen, Rudino-Pinera and Garman, 2006].  Cooling in 
liquid nitrogen substantially reduces the progression of the reactive species, localising it to 
the worst affected outer part of the crystal, whilst maintaining an unaffected core in the 
crystal.  With modern synchrotron radiation, it is common to still see evidence of radiation 
damage in the electron density because of the intensity of the beam, however cryocooling 
has proven successful in limiting the amount of secondary radiation damage. 
 
 
Figure 2.7:  Radiation damage schematic.  Figure shows three identical crystal systems (blue 
arrows) exposed to X-ray radiation (purple) causing primary radiation damage (yellow) and 
releasing reactive ionised species (red) that go onto create secondary events (orange).  The 
speed of the diffusion is represented by the thickness of the directional arrows (black arrows), 
with thicker arrows corresponding to higher thermal energy.  
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Chapter 3: General materials and methods 
3.1 Introduction 
Much of the work completed used the same set of techniques and, therefore, those 
techniques can be generalised to ease understanding.  This chapter describes the general 
methods used throughout the experimental work presented in this thesis.  The fine details 
of each experiment are presented separately in their respective chapters which provide full 
details of the work carried out during the individual experiments. 
3.2 Protein preparation 
The recombinant fragment of human surfactant protein D was expressed, extracted and 
purified by Howard W. Clark, Rose-Marie Mackay and Jens Madsen and kindly provided for 
use in the structural studies.  The methods used for preparing the protein are briefly 
described below. 
 3.2.1 Protein expression, extraction and purification 
The recombinant fragment of human surfactant protein D, used throughout the ligand 
studies, contains a homotrimer consisting of 177 residues at the C-terminal of the native 
human SP-D, beginning at Gly179 [Shrive et al., 2003].  This fragment, rfhSP-D, includes 
eight Gly-Xaa-Yaa repeats of the collagen domain (residues 179 – 202) at the N-terminal of 
the fragment, the α-coiled coil neck region (residues 203 – 235) and the carbohydrate 
recognition domain (residues 236 – 355).  The protein sequence for the fragment is 
consistent with the native amino acid sequence of SP-D, with the exception of a 
substitution at residue 180 where proline is replaced with serine. 
The fragment was overexpressed in Escherichia coli using a bacteriophage T7 expression 
system, expressed in the inclusion bodies [Madan et al., 2001].  Denaturation and 
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renaturation allowed for the extraction of the correctly folded rfhSP-D.  The protein was 
subsequently purified using ion-exchange, affinity and gel-filtration chromatography.  The 
purity of the protein was confirmed by SDS-PAGE, immunoblotting and amino-terminal 
sequencing.  Once the purified protein was received, it was buffer exchanged to remove the 
EDTA where necessary, then concentrated to a suitable concentration for crystallisation.  
Buffer exchange and concentration was completed by Ian Burns. 
3.3 Crystallisation and cryoprotection 
Following receipt and preparation of the recombinant fragment, crystallisation trials were 
carried out around the conditions that have previously grown diffracting crystals at high 
resolution [Shrive et al., 2003].  The individual well conditions are given in the relevant 
chapters. 
3.3.1 Sitting drop vapour diffusion method 
In all of the studies in this thesis, the crystals were grown in 24-well linbro crystallisation 
trays (Jena Biosciences) using the sitting drop method (discussed in section 2.2.1).  The 
reservoirs were prepared such that the required well conditions were achieved in a final 
volume of 1.0ml using 0.2µM filtered solutions.  2µl of the reservoir was then taken and 
added to the microbridge in a 1:1 ratio with the protein.  The crystals were then stored at 
ambient temperature and monitored for crystal growth using light microscopy. 
The sitting drop method was used because the materials are readily available in the 
laboratory where the work was completed, it allows for easy manual manipulation of the 
conditions as the wells are accessible and is historically the method preferred in the 
research group.  Importantly, it allows for effective cryoprotection of the crystals in situ, 
removing the need to unnecessarily move the crystals between wells to facilitate effective 
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protection for cryocooling.  This ensures the crystals are in the best condition for data 
collection as only one mounting is required. 
3.3.2 Cryoprotection of crystals 
The formation of ice during the cooling of protein crystals can be detrimental to both data 
quality and, in the worst case, can lead to the crystals fracturing or shattering as they are 
exposed to the cryo-temperatures of liquid nitrogen.  However, cryocooling to around 
100K is very beneficial for data collection as it reduces the degradation of the crystals by 
radiation damage and allows for easier transportation to the beamline.  As a result, it is 
necessary to replace a proportion of the water in the solvent channels with a higher 
molecular weight solvent that does not form crystals at low temperatures. 
Common cryoprotectants are short, hydrophilic molecules that can access the solvent 
channels in the crystal, replacing some of the water in the crystal and making hydrogen 
bonds to the remaining water molecules and protein in the crystal.  This is important to 
avoid disrupting the matrix of interactions between the protein molecules that allow the 
protein to crystallise.  Disruption of these interactions causes the crystals to dissolve.  As a 
result, choosing the correct cryoprotectant is essential to maintain crystallinity and 
effectively protect the crystal. 
In all the datasets presented in the following chapters, the cryoprotectant 2-methyl-2,4-
pentandiol (MPD) was used.  MPD was selected because it has previously been shown to 
effectively cryoprotect crystals of the rfhSP-D fragment used in these studies and has been 
shown on several occasions to allow the collection of high quality, high resolution data 
without affecting the crystal.   
The cryoprotectant buffer was added to the well in 2µl aliquots, beginning with a 5% v/v 
MPD diluted in the conditions that the crystals were grown in to ensure there was no 
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chemical shock to the crystal system.  Additional aliquots of 2µl were added in increasing 
increments of 5% v/v until a final concentration of 20% v/v MPD was achieved in the well.  
A final exchange was completed prior to mounting and cooling, where a volume equal to 
that added (usually 8µl) is removed from the well and replaced with 20% v/v MPD to 
ensure a final concentration approaching 20% v/v MPD.  Throughout the additions, the 
crystals were monitored for any changes to the edges and faces. 
3.3.3 Ligand soaking (general case) 
To investigate the interactions of surfactant protein D with a range of ligands, crystals of 
the native recombinant fragment of human SP-D, described previously, were grown and 
the ligands of interest were subsequently soaked into the best crystals that formed.  For all 
of the ligands used in these studies, the ligand additions were completed in the following 
way. 
Soaking of the native protein crystals was completed during cryoprotection through 
additions of the ligand of interest to the cryobuffers used to protect the crystals, described 
in section 3.3.2.  The ligand was added to the cryobuffer, at the concentrations described in 
each chapter, so that there was an excess of the relevant ligand compared to the number 
of rfhSP-D ligand-binding sites present in the well.  The excess in all of the studies was 
more than 10-fold, based on the estimated concentration of the ligand and the 
approximate number of ligand-binding sites, following cryoprotectant exchange.  This 
excess ensured that the majority of binding sites where binding was possible would be 
occupied in the crystal, thus ensuring that the electron density for the ligand would be 
strong enough for ligand fitting and determination of the binding mechanism.   
The ligand was added to each aliquot of cryobuffer from the lowest concentration (5% v/v) 
to the highest (20% v/v) to achieve the desired ligand excess in each cryobuffer.  This 
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allows for a gradual addition of the ligand to the well, ensuring the ligand is in a higher 
concentration in the well than the crystal, driving the diffusion gradient into the crystals.  
Gradually adding the ligand also minimises the risk of shocking the crystal with a high 
concentration of ligand, maintaining crystal quality.  The overall time for the soak (and 
cryoprotection) is recorded in each chapter. 
3.4 Data collection, processing and refinement 3.4.1 Data collection 
Diffraction data was collected at Diamond Light Source, Harwell Science & Innovation 
Campus, Didcot, Oxfordshire on the macromolecular beamlines: I03, I04 and I04-1.  All of 
the data was collected using the Dectris Pilatus 6M-F detectors, installed at the beamlines, 
which use hybrid photon counting technology to record the diffraction data  [Henrich et al., 
2009].  This allowed for the rapid collection of a large number of diffraction images, 
ensuring complete datasets were collected.  Specific details of the wavelength used to 
collect data and the number of images collected in each case are described in each chapter. 
3.4.2 Data processing 
Processing of the diffraction data was completed using a number of programs in the CCP4 
suite [Winn et al., 2011]  to generate a set of structure factors that can be used to solve the 
structure of the ligand-bound protein structures The programs, and how they are used, are 
briefly described in this section. 
MOSFLM, accessed and controlled using the iMOSFLM GUI, was used to initially index the 
unit cell of the protein crystal from two separate diffraction images, separated by 90°, to 
ensure a good estimate of the cell parameters can be determined [Battye et al., 2011].  The 
Laue group was also determined at this stage, allowing for the data collection strategy to 
be optimised to maximise the completeness of the dataset when it is finally integrated.  The 
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data presented in this thesis was all optimised to deliver a completeness of more than 90% 
where possible, with most datasets being processed to a completeness of close to 100% in 
strategy optimisation.  Before integration and measurement of the individual intensities of 
the images, a final refinement of the cell parameters was completed using partial 
integration of two segments of data that are 90° apart [Battye et al., 2011].  This allows for 
refinement of the cell parameters, but also improves the estimation of mosaicity and crystal 
orientation which is used to inform the predictions of the spot positions during integration.  
It was important at this stage to ensure that the spot predictions generated following cell 
refinement were correctly overlaying the diffraction spots in the images, to ensure that 
integration would succeed. 
The final stage of MOSFLM is integration of the diffraction images [Leslie, 2006; Battye et 
al., 2011].  In each image, the pixel density of each spot was measured and compared to 
the automatically calculated background scattering on the image.  The pixel density was 
then used to integrate the images and derive the intensities for each diffraction spot.  
MOSFLM completes the integration in batches of ten images at a time, allowing for an 
average spot profile to be determined, so that quality of the data can monitored 
throughout the integration.  Importantly, as part of the monitoring, each image undergoes 
refinement of the crystal position and mosaicity to ensure that there are not problems with 
the data collection but also to allow for a better summation of the spots which are partially 
recorded on multiple images.    
Following integration of the images, the resulting intensity files were then analysed using 
the POINTLESS-AIMLESS pipeline [Evans, 2011].  POINTLESS uses the integrated intensity 
data to test the Laue group and spacegroup produced from MOSFLM, analysing the 
correlation coefficient between all related intensity pairs and potential symmetry elements 
[Evans, 2006, 2011].  The pairs are then grouped based on unrelated symmetry elements 
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and compared to each other, generating a Z-score. The scores can then be ranked, 
favouring the lowest symmetry, to determine the Laue and space group.  For all of the 
crystals presented here, the space group was confirmed as P21 by POINTLESS and the data 
were automatically ran through AIMLESS for scaling and merging.  AIMLESS utilises the 
scaling and merging algorithms first written for SCALA, but has additional parameters for 
assessing the data quality [Evans, 2006, 2011; Evans and Murshudov, 2013].  Briefly, 
AIMLESS scales each intensity to minimise error introduced by data collection, increasing 
internal consistency by minimising differences in intensities.  This is completed by 
generating a common scale for all of the intensities based on a scaling model.  The 
merging algorithms, as the name suggests, merges the partial intensities generated by the 
rapid data collection, into a single intensity.  
In most cases, a number of AIMLESS runs were completed to ascertain what resolution the 
data was limited to, to maximise the data quality without losing too much high-resolution 
data.  In all cases, the data were assessed for quality based on values for Rmerge; I/σ(I); 
completeness; and the correlation coefficient (CC½).  Rmerge rationalises the convergence of 
all of the observations for a single unique reflection into a single hkl, with a lower Rmerge 
representing better agreement between the observations.  However, Rmerge is dependent on 
the multiplicity, the number of repeated observations of the same reflection, of the data.  
I/σ(I) is an estimation of signal to noise in the data, with a higher I/σ(I) indicating that the 
data has a good signal and, therefore, is more accurate and more likely to be a genuine 
reflection.  For the purposes of using I/σ(I) as a measure of data quality, a cut off of 
between 2.0 and 3.0 was used in selecting the resolution cut off. Completeness of the data 
is calculated by comparing the observed data to the calculated data and determining how 
many of the calculated reflections are present in the observed data.  The final data quality 
test used to assess the data was the correlation coefficient (CC½).  CC½ is calculated by 
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dividing the unmerged data for each unique reflection into two random halves, averaging 
the intensities from each subset and comparing the two values, where a unique reflection is 
the product of averaging multiple observations of the same reflection and its symmetry 
related reflections.  This removes any bias introduced by multiplicity.  CC½ is expressed as 
a fraction and, therefore, a value closer to one represents better agreement between the 
two subsets for each unique reflection and, therefore, across the whole dataset. 
The data was divided into resolution ranges (bins) and statistics based on the four quality 
measures were calculated for the overall datasets and the highest resolution bin.  The 
statistics from the highest resolution bin were used to determine the resolution of the data 
so that the structure can be reliably solved at high resolution.  The data was interrogated 
and resolution bins where the Rmerge was higher than 10% of the resolution were removed 
during the scaling and merging to improve the statistics.  However, bins were not removed 
if they were detrimental to the overall completeness of the data. 
Once merged, the intensities were converted to structure factors (amplitudes) using 
CTRUNCATE [French and Wilson, 1978].  The algorithm allows for the calculation of all the 
amplitudes from both positive and negative intensities, which can then be used to assess 
the data for any problems that can only be identified in merged data.  Using the cumulative 
frequency distribution, Wilson plot and L-test, the data can be tested for any 
crystallographic twinning.  If any twinning was detected, the dataset was not taken any 
further as untwinned crystals are readily available.  
Following CTRUNCATE, the structure factors are ready to be used for structure solution.  
However, a 5% test set, comprising a random 5% of the data which do not contribute to 
subsequent refinements, needs to be selected to prevent the structure model from 
becoming biased during refinement.  Uniqueify was used to randomly select the 5% test set 
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from the structure factors and record them in a separate column in the structure factor file, 
using FreeR_Flag to select and assign the flag [Winn et al., 2011].  This test set will be 
refined separately the main dataset to ensure internal consistency. 
The final stage of data processing is sorting the structure factor file into columns that can 
be read by the downstream programs used for structure refinement and validation.  
SortMTZ was used for all of the data presented here [Winn et al., 2011].  It is worth noting 
that sorting the file is not strictly necessary, but it may prevent problems in the future. 
3.4.3 Structure solution, refinement and validation 
All the structures were solved using the high-resolution, native structure of the same 
recombinant fragment of human surfactant protein D, solved at 1.60Å [Shrive et al., 2003].  
This structure had all of the calcium ions and waters removed to avoid biasing the 
occupancy of the calcium binding sites (Ca1, Ca2, Ca3 and Ca4) and any ligand density that 
may be present in the electron density.  Using a 100% homogenous protein structure for 
the replacement allows for a rigid-body refinement, a constrained coordinate refinement of 
a group of atoms that rotate and translate as a single “rigid” body, to be used to solve the 
structure, avoiding the time-consuming process of a more traditional molecular 
replacement method.  The phases derived from the native structure were sufficient to solve 
the structures for the cellotriose-, isomaltotriose-, laminaritriose-, muramyl disaccharide-, 
and the Salmonella enterica Minnesota R7 oligosaccharide proteins. 
Each of the ligands were fitted using single carbohydrate monomers from the monomer 
library, a library of known small molecules commonly associated with macromolecular 
crystallography, using the molecular model building program, Coot [Emsley and Cowtan, 
2004].  In general, the glycosidic linkages were described in the monomer library, 
mon_lib.cif, that is built into Coot and the structure refinement program REFMAC5.  
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However, if the linkage was not defined in the monomer library, a restraint library was 
generated by REFMAC5 during the first round of restrained refinement [Murshudov et al., 
2011].  The restraint library, also called a ligand dictionary, provides a comprehensive list of 
bond lengths, bond angles, torsion angles and linkages between monomers based on the 
optimal topology from small molecule structures.  For all of the ligands, the ligand 
dictionary was manually updated to include a full description of the glycosidic linkages 
using data from the monomer library (mon_lib.cif).  For the S. enterica sv. Minnesota R7 
polysaccharide complex, one of the carbohydrates was not described by the monomer 
library and had to be generated using a combination of ChemDraw® (PerkinElmer 
Informatics) and JLigand to generate a library [Lebedev et al., 2012]. 
Restrained refinement of each structure was completed using REFMAC5, a robust 
refinement tool provided as part of CCP4 [Murshudov et al., 2011; Winn et al., 2011].  
Refinement aims to match the atomic model to the experimental data by making small 
adjustments to the model, whilst maintaining the correct geometry of the protein 
backbone, side chains and ligands.  This is completed based on two components: (1) prior 
knowledge of protein, ligand and other monomer geometry (𝑓𝑓𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔) and; (2) the 
experimental X-ray data (𝑓𝑓𝑥𝑥𝑥𝑥𝑥𝑥𝑥𝑥) [Murshudov et al., 2011].   
𝑓𝑓𝑡𝑡𝑔𝑔𝑡𝑡𝑥𝑥𝑡𝑡 =  𝑓𝑓𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 + 𝑤𝑤𝑓𝑓𝑥𝑥𝑥𝑥𝑥𝑥𝑥𝑥         (1) 
The initial phases, provided by the starting model used in the rigid-body solution, are 
refined using maximum likelihood methods to improve the electron density for manual 
model building and minimise 𝑓𝑓𝑡𝑡𝑔𝑔𝑡𝑡𝑥𝑥𝑡𝑡.  The phases are then combined with the experimental 
and calculated structure factors using the methods described by Murshudov and 
colleagues (2011). 
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𝑓𝑓𝑡𝑡𝑔𝑔𝑡𝑡𝑥𝑥𝑡𝑡 also requires the geometry component to be calculated from the chemical dictionary, 
available in the program files.  The geometry for the protein and ligand must be maintained 
for the model to be correct.  As a result, equation 1 includes a weighting factor, 𝑤𝑤, that can 
be set to ensure good geometry is maintained in the final stages of model building by 
reducing the weight of the X-ray component. 
To monitor each refinement cycle, a set of calculated structure factors, based on the current 
model of the structure, are compared to the experimentally observed structure factors to 
generate reliability factors (Rfactor and Rfree).  Both of the reliability factors are calculated 
using equation 2: 
𝑅𝑅 =  ∑|𝐹𝐹𝑜𝑜𝑜𝑜𝑜𝑜−𝐹𝐹𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐|
∑|𝐹𝐹𝑜𝑜𝑜𝑜𝑜𝑜|                 (2) 
By calculating R for the working set (Rfactor), excluding the 5% test set added by Uniqueify, 
and R for the 5% test set (Rfree) independently, the reliability of the model, and how well the 
model predicts the experimental data, can be monitored [Brunger, 1992].  Due to the 
independent nature of the two Rfactors, they should both converge during refinement as the 
model should be supported by the experimental data however, due to the small set of data 
used for Rfree, the Rfree value tends to be higher than the Rfactor.   
Refinement was completed in rounds of ten cycles, followed by manual rebuilding of the 
model.  In the final refinement rounds, the number of cycles was reduced to prevent over 
refinement, leading to the divergence of the two Rfactors.  In some cases, a round of 
refinement was completed using phenix.refine for comparison of the refinement statistics, 
with approximate agreement being confirmed in all the cases it was used [Afonine et al., 
2012]. 
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Model building was completed using the macromolecular model building software, Coot, 
which is distributed with CCP4 [Emsley and Cowtan, 2004; Emsley et al., 2010; Winn et al., 
2011].  Two weighted electron density maps equivalent to the observed map (2Fo-Fc where 
Fo are the observed structure factors and Fc are the calculated structure factors based on 
the current model), and the difference map (Fo-Fc), traditionally generated using a fast 
Fourier transform in the program FFT, are generated from the MTZ file directly.  The real-
space refinement function, where the position of atoms is refined based on electron density 
peaks, and manual manipulation of the protein backbone were then used to fit the atoms 
into the electron density, ensuring that any side chains that were not well defined by the 
density were modelled into one of the commonly observed conformations (rotamers).  
Where it was necessary, atoms were moved out of negative density in the difference map 
and moved into the available density, while ensuring that the geometry was correct.  
Similarly, the ligands were fitted by manual manipulation of the atomic positions and 
torsion angles followed by rigid-body fitting into the density.  Real space refinement was 
not used for the ligands as the carbohydrate rings would regularly be distorted. 
Structure validation was completed throughout refinement of the structure to minimise any 
erroneous model building from the outset.  To do this, the MolProbity server, hosted by 
Duke University, was used to carry out geometric and clash analysis following the addition 
of riding hydrogens (hydrogens that complete atomic valency) to all of the atoms [Chen et 
al., 2010].  The Ramachandran plot, which plots the backbone dihedral angles against 
energetically favourable regions, was also checked for outliers and any outliers were 
corrected before the next round of refinement [Hooft, Sander and Vriend, 1997].  When the 
final structure with good Rfactors and geometry was completed, a final validation using 
MolProbity was carried out.  
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Additional validation of the polysaccharide ligands was completed using the new validation 
tool, Privateer; distributed as part of CCP4i2 [Agirre and Cowtan, 2015].  Privateer uses the 
Cremer-Pople algorithm to analyse the ϕ and θ, to check they are correct, and generates a 
total puckering amplitude value (Q value) for each monosaccharide, based on the energetic 
favourability of the ring pucker [Cremer and Pople, 1975].  In ligand binding studies like 
these, the ligands should be in the lowest energy state; 4C1 chair conformation for the 
pyranoses and OE envelope conformation for the furanoses.  A second stage of validation is 
also carried out using the published stereochemistry of monosaccharides in the wwPDB 
database and a real space correlation is calculated to ensure the electron density supports 
the anomeric form in the model.  There is also additional validation of any glycosidic 
linkages found in the model structure which checks the geometry of the linkages to ensure 
they are accurate. 
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Chapter 4: Structural insights into recognition of small glucosyl 
ligands by a recombinant fragment of human surfactant protein D 
4.1 Introduction to alternative glucose oligosaccharides 
Since the discovery of surfactant protein D, there has been a wide variety of ligands 
identified that SP-D can recognise through its carbohydrate recognition domains.  The 
mechanism for this recognition has previously been investigated for a range of small 
mono-, di- and trisaccharides which have identified a calcium ion as being the main 
mediator of binding [discussed in sections 1.5 and 1.6; Shrive et al. 2003; Crouch et al. 2006; 
Wang et al. 2008; Shrive et al. 2009].  Many of these ligands have focussed on either 
lipopolysaccharide-derived polysaccharides or α(1→4)-linked glucose chains such as 
maltose and maltotriose [Shrive et al., 2003; Crouch, McDonald, et al., 2006; Clark et al., 
2016].  However, there is a catalogue of natural ligands for SP-D that utilise different 
glycosidic linkages and the anomeric form of D-glucose, β-D-glucose. 
4.1.1 Anomeric glucoses 
Glucose has two major anomeric forms, α-D-glucose and β-D-glucose, related through the 
chiral position of the hydroxyl on carbon one [C1'OH, Figure 4.1; Rao et al., 1998].  These 
result in two distinct, non-superimposable glucose molecules that share functionality but 
do not share the same geometry; giving rise to different glucose chains.  Many of the 
naturally occurring β-D-glucose chains have been identified in plants, fungi and bacteria 
and form part of the recognition motifs that the immune system can utilise to differentiate 
between self and non-self.  Importantly, the arrangement of the anomeric glucoses and 
their associated chains allow molecules such as SP-D to recognise and agglutinate 
potentially pathogenic species and prevent an infection taking hold [Fakih et al., 2015]. 
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Figure 4.1:  Anomeric forms of D-glucose with each carbon numbered.  The alpha-anomer (left) 
has the hydroxyl group in an axial position and the beta-anomer (right) has the hydroxyl in the 
equatorial position.  Carbon 5 is the anomeric reference in glucose 
 4.1.2 Alternative glycosidic linkages 
The alternative anomers of glucose give rise to a variety of glucose chains that contain 
familiar glycosidic linkages, such as (1→4)-linkages, that form through the hydroxyl of the 
chiral C1 of glucose [Figure 4.1].  An α-linkage extends from the hydroxyl in an axial 
position, causing the second glucose to drop below the ring of the first glucose, and a β-
linkage extends from the hydroxyl when it is in an equatorial position, creating a more 
planar bond to the next glucose [Rao et al., 1998].  These alternate linkages can result in a 
considerable change in the overall topology of the oligosaccharide chain and the way that: 
(a) the organism interacts with its surroundings and; (b) how the immune system is able to 
interact with the carbohydrate array. 
The α- and β-linkages are able to form between any of the hydroxyls on the adjacent 
glucose, allowing for further variations on the possible chain conformations.  Most 
commonly found linkages include (1→4), (1→3) and (1→6) glycosidic linkages, usually as 
part of large, enzyme-mediated scaffolds such as starch or cellulose [Figure 4.2; Hehre, 
1956; O’sullivan, 1997; Fujimoto et al., 2009; Fesel and Zuccaro, 2016].  In many cases, the 
large glucose scaffolds form important structural components that are integral to the 
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survival of the organism, making them an ideal target for immune molecules during 
pathogen recognition and clearance. 
 
Figure 4.2:  Structures of common carbohydrate structures on pathogens and other allergenic 
particles.  Amylose is an α(1→4)-linked glucose polymer; cellulose is a β(1→4)-linked glucose 
polymer; dextran is an α(1→6)-linked glucose polymer; β-glucan is a β(1→3)-linked glucose 
polymer.  Based on data from [Hehre, 1956; O'Sullivan, 1997; Rao et al., 1998; Remaud-Simeon 
et al., 2000; Fujimoto et al., 2009] 
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4.1.3 Cellulose and β(1→4)-linked cellotriose 
Cellulose is a large polymer of β-D-glucoses found in the cell walls of most plants, some 
algae and in the connective material of a number of bacterial biofilms, including species of 
Salmonella [Solomon et al., 2005].  It has also been identified in the wall of pollen grains.  
The β-D-glucoses are linked together by β(1→4) glycosidic linkages in mostly linear chains 
of up to 15 000 β-D-glucoses, extending away from the surface of the membrane, forming 
large parallel chains arranged into microfibrils [Brown Jr and Montezinos, 1976; O’Sullivan, 
1997; Brown Jr, 2004].  The microfibrils are then able to stack together, forming large 
hydrogen bond networks between the microfibrils, creating strong, insoluble complexes 
that are able to exclude water and other solutes.  
Cellotriose is a small, β(1→4)-linked tri-glucose unit of cellulose that is produced during 
acid hydrolysis of naturally occurring cellulose I [Figure 4.3; Poletto, Ornaghi Júnior and 
Zattera, 2014].  This makes cellotriose a useful analogue for investigating the immune 
recognition of cellulose as it is more soluble than intact cellulose and is readily available 
from commercial sources. 
 
 
Figure 4.3:  Structure of cellotriose.  Three β-D-glucoses linked by β(1→4) glycosidic bonds. 
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4.1.4 Dextran and α(1→6)-linked isomaltotriose 
Dextran is a large polymer of α-D-glucoses linked through a number of linkages depending 
on their biological source [Sloan et al., 1954].  The main backbone is formed from a series 
of α(1→6) glycosidic linkages of variable lengths, with branches formed by either α(1→2), 
α(1→3) or α(1→4) linkages [Naessens et al., 2005; Kasaai, 2012].  Branching occurs at 
different points depending on the species and strain of the bacteria producing a range of 
topologies.  In most linear dextrans there are a small number of α(1→3)-linked branches to 
long α(1→6)-linked chains however there are examples of α(1→3) branches at regular 
intervals along the main backbone [Naessens et al., 2005].  There are also a subset of 
dextrans, the alternans, that have an alternating backbone of α(1→6), α(1→ 3) linkages that 
are less common [Misaki et al., 1980]. 
Isomaltotriose is an α(1→6)-linked tri-glucose unit analogous to the mostly linear dextran 
backbone [Figure 4.4].  A family of exocellular bacterial enzymes have been identified that 
hydrolyse dextrans into smaller isomaltose and isomaltotriose units [Jeanes et al., 1953; 
Chludzinski, Germaine and Schachtele, 1974; Naessens et al., 2005].  Isomaltotriose 
provides a useful insight into how the immune system is able to recognise these large, 
extracellular carbohydrate structures.   
 
Figure 4.4:  Structure of isomaltotriose.  Three α-D-glucoses linked by α(1→6) glycosidic bonds. 
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4.1.5 β-glucans and β(1→3)-linked laminaritriose 
β-glucans can be found in a huge range of organisms, including: euglenoid protozoa, 
certain species of algae, yeasts and fungi, higher order plants and, most importantly, 
potentially pathogenic bacteria that affect humans [McIntosh et al., 2004; Stone and Clarke, 
1992].  The roles of these β-glucans range from storage polysaccharides in protozoa and 
algae to cell wall components in fungi and yeast.   In higher order plants, a linear form of β-
glucan, callose, forms an important part of the growth plates in the cell wall and is intrinsic 
to the cell wall of pollen grains [Ferguson et al., 1998; Edlund, Swanson and Preuss, 2004; 
Schneider et al., 2016].  A similar, largely linear form of β-glucan, curdlan, has been 
identified in the extracellular capsule of a number of bacteria that are medically important 
and has been implicated in the virulence of the bacteria in other animals [Nakanishi, 1976; 
Sutherland, 2001]. 
There are three main forms of β-glucan: a linear β(1→3)-linked polymer with minimal 
β(1→6) branches; a cyclic β(1→3)-, β(1→6)-linked β-D-glucose polymer; and a highly 
branched β(1→3)-, β(1→2)-linked form [Rolin et al., 1992; Kasai and Harada, 1980; Knecht 
et al., 1970].  Linear β-glucans form large, insoluble structures of up to 12 000 glucose units 
that crosslink via β(1→6) linkages between the chains to form an extracellular capsule and 
contribute to the formation of biofilms [Sutherland, 2001; Saito et al., 1968; Futatsuyama et 
al. 1999].  Cyclic β-glucans occur more commonly in symbiotic soil bacteria, forming large 
rings of β-D-glucoses of up to 15Å in diameter [Rolin et al., 1992; Miller et al., 1990].  In a 
number of species, the O6’ position of some of the β-D-glucoses are substituted with either 
phosphocholine or a laminaribiose molecules [Rolin et al., 1992; Bhagwat et al., 1999].  The 
highly branched forms of β-glucan have been identified in the capsules of a number of 
streptococcal and pneumococcal species and in some cases have a β(1→2)-linked β-D-
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glucose substitution on the majority of β-D-glucoses in the β(1→3) backbone [Knecht et al., 
1970; Henrichsen, 1995; Adeyeye et al., 1988]. 
Laminaritriose is a β(1→3)-linked tri-glucose unit of the linear backbone of β-glucan that 
can be produced by laminarinase, an endo-(1→3)-beta-glucanase originating from brown 
algae [Figure 4.5; Salyers et al., 1977].  This small, soluble unit of the β-glucans provides an 
opportunity to investigate the recognition of potentially pathogenic bacteria and fungi by 
surfactant protein D in the interstitial space of the alveoli.  It also allows the effects of 
blocking the most well documented binding of carbohydrates by the O3’ and O4’ hydroxyls 
to be explored, as the β(1→3)-linkage prevents O3’ being recognised.   
 
 
Figure 4.5:  Structure of laminaritriose.  Three β-D-glucoses linked by β(1 →3) glycosidic bonds. 
 
4.1.6 Reducing and non-reducing ends of polysaccharide chains 
The two terminal glucoses of a polysaccharide chain can be described as reducing and 
non-reducing based on their biochemical properties.  The reducing terminal is 
characterised by the O1’ hydroxyl being available for further linkages or additions by other 
substituents that undergo nucleophilic attack.  The non-reducing terminal does not have 
the O1’ hydroxyl available and, therefore, gives the polysaccharide directionality; as the 
chain can only be assembled in one direction [Figure 4.6].  
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Figure 4.6:  Identification of the non-reducing and reducing termini of oligosaccharides 
 
Previous rfhSP-D structural studies using the glucosyl oligosaccharides maltose and 
maltotriose, two α(1→4)-linked oligosaccharides, revealed recognition by their non-
reducing terminal glucose, allowing the reducing end to either project away from the 
binding site (maltose) or form a tentative π-interaction with Phe335 [Shrive et al., 2003; 
Crouch, McDonald, et al., 2006].  Using cellotriose, isomaltotriose and laminaritriose, the 
importance of the termini can be explored in more detail as the different linkages and β-D-
glucoses affect the availability of O3’ and O4’ in the non-reducing residue. 
4.1.7 Non-terminal recognition of glycosyl ligands by rfhSP-D 
The potential for non-terminal recognition of small glucosyl ligand by surfactant protein D 
was extensively investigated using computational docking studies by Allen (2001), who 
identified a number of ligands that could be recognised through a non-terminal glucose 
[Allen et al., 2001].  Of these ligands, isomaltotriose and the β-isoform, gentiotriose, are of 
particular interest as their longer polymers have been shown to effectively inhibit binding 
to A. fumigatus (IC50 values of 4.8±2.4µM and 1.0±0.3µM, respectively) [Allen, Voelker and 
Mason, 2001].  As a result, the experiments presented here can test the computational 
results crystallographically and provide direct evidence of any non-terminal binding in 
these triose ligands. 
Chapter 4  Materials and methods 
113 | P a g e  
 
4.2 Materials and methods 4.2.1 Cellotriose soaking of native rfhSP-D 
Cellotriose was soaked into native rfhSP-D crystals grown in a sitting drop as described in 
section 3.3.1.  A final concentration of 20mM was achieved in the drop following an 
exchange of the drop volume (10μl) with 2μL of the cryoprotecting solution.  Cryocooling 
to 100K was completed following cryoprotection with consecutive additions of 5%-20% 2-
methyl-2,4-pentanediol (MPD) solutions, diluted with the well conditions to maintain the 
equilibrium that permitted crystal formation.  The well conditions are detailed in table 4.1.   
Crystal cryoprotection, at the highest concentration of MPD, was completed for between 19 
and 20 minutes, allowing sufficient time for the cellotriose and MPD to soak through the 
solvent channels and into the calcium binding sites.   
Table 4.1:  Table of well conditions for IB264C32 and IB264C33 
IB264C32 
and 
IB264C33 
16% Polyethylene Glycol 6000 
0.1M Tris pH 6.0 
10mM CaCl2 
 
Data collection was carried out at Diamond Light Source, Oxfordshire on macromolecular 
crystallography beamline I02.  A total of two high resolution datasets were collected 
between 1.4Å and 1.6Å from a total of two crystals.  Processing of the diffraction data was 
completed according to section 3.4.2. 
4.2.2 Isomaltotriose soaking of native rfhSP-D 
Isomaltotriose was also soaked into native crystals of rfhSP-D, achieving a final 
concentration of 20mM in the drop by the same methods used in the cellotriose soaking.  
Cryoprotection was completed using 5%-20% MPD solutions, added in four aliquots of 2μL 
of increasing MPD concentration.  The well conditions are detailed in table 4.2.  Soaking of 
the ligand and MPD into the native crystals took between 12 and 19 minutes, allowing for 
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complete cryoprotection and time for the ligand to penetrate the solvent channels of the 
crystals. 
Table 4.2:  Table of well conditions for crystals IB254C12 and IB254C14 
IB254C12 
and 
IB254C14 
16% Polyethylene Glycol 6000 
0.1M Tris pH 6.0 
10mM CaCl2 
 
Data collection was carried out at Diamond Light Source, Oxfordshire on macromolecular 
crystallography beamline I03 and I04-1.  A total of two high resolution datasets were 
collected between 1.5Å and 1.7Å from two crystals.  Processing of the diffraction data was 
completed according to section 3.4.2. 
4.2.3 Laminaritriose soaking of native rfhSP-D 
Laminaritriose was initially soaked into native rfhSP-D crystals in the same way as the 
previous ligands, as part of the cryoprotection to achieve a final concentration approaching 
20mM, however the original crystals degraded and re-dissolved following the addition of 
the 15% MPD solution.  Following monitoring of the cryoprotected well over the next two 
weeks, new crystals were identified in the drop and successfully cryocooled to 100K prior to 
data collection.  The details of the well conditions prior to the initial laminaritriose soak, 
and the conditions that the new crystals later grew in, are detailed in table 4.3.  As a result, 
the laminaritriose-bound crystals can be considered co-crystals of the rfhSP-D-
laminaritriose complex. 
Table 4.3:  Table of well conditions for crystals IB319A53-A55 
IB319A53 – 
A55 
16% Polyethylene Glycol 6000 
0.1M Tris pH 7.0 
10mM CaCl2 
Following 
initial soak 
15% 2-methyl-2,4-pentanediol 
20mM laminaritriose 
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Data collection was carried out at Diamond Light Source, Oxfordshire on macromolecular 
crystallography beamline I04-1.  A total of three high resolution datasets were collected 
between 1.5Å and 1.66Å from three crystals.  Processing of the diffraction data was 
completed according to section 3.4.2. 
4.3 Results of small ligand binding 4.3.1 Data processing and data selection 
Two high resolution datasets were collected from two separate cellotriose-soaked crystals, 
IB264C32 and IB264C33.  The diffraction images from IB264C32 were indexed into the 
monoclinic primitive spacegroup P21, the spacegroup previously determined for the high 
resolution native structure of the same recombinant fragment of hSP-D used in these 
studies, with the final unit cell [Shrive et al., 2003]: 
a = 55.39 b = 108.14 c = 55.67 α = γ = 90.0° β = 90.86° 
The spacegroup was confirmed by Pointless as part of the Pointless-Aimless pipeline that 
was used to scale the integrated images generated by MOSFLM [Leslie, 2006; Battye et al., 
2011; Evans and Murshudov, 2013].  Scaling and merging of the data at a resolution of 
1.59Å generated good overall Rmerge statistics of 0.051 and 0.359 in the outershell.  The 
overall I/σ and CC½ were 10.8 and 0.996, respectively, with the outershell being 2.9 and 
0.846.  Completeness was 99.5% overall and 99.3% in the outershell.  Structure factors were 
generated by Truncate and twinning was assessed by cumulative frequency distribution 
and L-test.  The data was not twinned. 
IB264C33 was also indexed into monoclinic primitive P21, as was expected from previous 
structures.  The final unit cell was refined in MOSFLM to: 
a = 55.40 b = 107.92 c = 55.58 α = γ = 90.0° β = 91.11° 
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Pointless confirmed the spacegroup and aimless scaled and merged the data.  Rmerge 
statistics were good at 0.061 overall and 0.255 in the outershell, at a resolution of 1.64Å.  
Overall I/σ was 8.4, outershell 2.6, and CC½ was 0.989, outershell 0.896.  Overall 
completeness was 98.9% and completeness in the outershell was 98.8%.  Structure factors 
were generated by Truncate, as before, and the twinning analysis revealed there was no 
twinning in the data. 
Both structures were successfully solved by rigid-body refinement using the native 
structure of the same hSP-D fragment solved to 1.6Å with the calcium ions and solvent 
molecules removed [1PW9, Shrive et al., 2003].  Assessment of the two maps showed 
comparable levels of information about the ligand binding, position of the ligand density 
compared to the coordinating calcium density and the number of residues present in the 
N-terminus.  As a result, the highest resolution dataset collected from IB264C32 was carried 
forward for completion at a resolution of 1.59Å.   
Two high resolution datasets were collected from two native crystals of rfhSP-D soaked 
with 20mM isomaltotriose during cryoprotection.  The diffraction images from the two 
crystals, IB254C12 and IB254C14, were integrated and scaled using MOSFLM and Aimless 
as described section 3.4.2.  In both cases the crystals were automatically indexed into the 
previously determined monoclinic spacegroup, P21 [Shrive et al., 2003, 2009]. 
The unit cell of IB254C12 was subsequently refined to: 
a = 55.26 b = 107.81 c = 55.47     α = γ = 90.0° β = 91.32° 
The spacegroup was confirmed by Pointless, as part of the Pointless-Aimless pipeline in 
CCP4, as P21 and the intensities generated by MOSFLM were scaled and merged at a 
number of resolution cut offs.  Unfortunately, the statistics for Rmerge, I/σ(I) and CC½ did not 
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become acceptable until the data was limited to over 2.3Å.  As a result, the dataset was 
discarded because the data from IB254C14 had good statistics at a higher resolution. 
IB254C14 was indexed by MOSFLM into P21 with the following unit cell parameters: 
a = 55.21 b = 107.14 c = 55.44     α = γ = 90.0° β = 91.29° 
As before, the spacegroup was confirmed by Pointless before the integrated intensities 
were scaled and merged by Aimless at a resolution of 1.96Å.  The merging statistics were 
good with the overall Rmerge and Rmerge in the outershell calculated to be 0.073 and 0.291, 
respectively.  Data quality was confirmed by I/σ(I), 8.6 and 3.0 respectively, and CC½ was 
calculated to be 0.977 overall and 0.869 in the highest resolution shell, showing there is a 
high level of internal agreement in the data.  Completeness for the dataset was found to be 
89.4% overall and 84.2% for the outer shell.  Structure factors were generated by Truncate 
and the analysis of twinning, using the tests described in section 3.4.2, revealed that there 
was no twinning in the data. 
Due to the data from IB254C12 not merging and the resolution for IB254C14 being sub-
2.0Å with good merging statistics, IB254C14 was taken forward for solution by rigid-body 
refinement.  The structure for IB254C14 was successfully solved using the high resolution 
native structure of the same recombinant fragment (residues 179 – 355) of human SP-D 
with the calcium ions and solvent molecules removed to leave only the protein backbone 
and side chains.  There was clearly density for the ligand in the density. 
A total of six datasets for laminaritriose were collected from two separate wells and at 
different times.  The first three datasets, IB254A51, IB254A52 and IB254A54, were collected 
but later found to be twinned following twinning analysis of the fast-processed data 
(fast_dp) generated on the beamline at Diamond Light Source. As a result, these three 
datasets were discarded as the recombinant fragment readily crystallises.  The remaining 
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three datasets were produced by crystals that initially dissolved during cryoprotection but 
reformed in the following two weeks.  IB319A53, IB319A54 and IB319A55 all diffracted well, 
and the images were indexed in a monoclinic spacegroup, P21, using MOSFLM.   
The unit cell for IB319A53 was refined to: 
a = 56.32 b = 109.89 c = 56.35     α = γ = 90.0° β = 90.11° 
Diffraction images were then integrated using a strategy to maximise completeness and 
the intensities scaled and merged using Aimless.  Pointless confirmed the spacegroup as 
P21 and the images were merged at a resolution of 1.80Å.  The merged statistics showed a 
good Rmerge was achieved overall, 0.052, and the highest resolution shell merged at 0.207.  
I/σ(I) for the overall dataset was 9.0 and 2.7 in the highest resolution shell while the CC½ 
was 0.990 and 0.638, with respect to the overall and outer shell.  Completeness was 96.4% 
overall and 96.1% in the outer shell. 
IB319A54 unit cell parameters were refined similarly to: 
a = 56.18 b = 110.02 c = 56.36     α = γ = 90.0° β = 90.15 
The diffraction images were integrated using MOSFLM, scaled and merged using Aimless 
using a resolution limit of 1.75Å.  Pointless confirmed the spacegroup was P21 so no re-
indexing was necessary.  Data was successfully merged with Rmerge calculated to be 0.052 
overall and 0.328 in the outer shell.  The overall I/σ(I) was 10.1 (outer shell 2.9) suggesting 
signal to noise was good while the correlation coefficient (CC½) was 0.989 overall and 
0.841 in the outer shell.  Completeness was high throughout the data, at 97.6% in the 
overall data and 97.3% in the outer shell. 
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The images collected from IB319A55 were indexed and refined with the following cell 
parameters: 
a = 56.12 b = 109.57 c = 56.26     α = γ = 90.0° β = 90.05° 
During scaling and merging it became apparent that there was a problem with the low 
resolution data that caused the Rmerge and CC½ statistics to be beyond the acceptable 
limits at resolutions any lower than 1.6Å.  As a result, this dataset was discarded as the data 
could not be relied upon and the data from IB319A54 was high resolution.  
Due to the problems with data in IB319A55, no rigid-body solution was derived.  IB319A53 
and IB319A54 were both solved by rigid-body refinement using the native structure of the 
recombinant fragment of hSP-D solved at 1.6Å [Shrive et al., 2003].  There was no 
difference in the information provided by the electron density, using Coot, so the highest 
resolution dataset was selected for refinement.  As a result, IB319A54 was used to refine the 
structure and model laminaritriose into the density. 
4.3.2 Initial map generation and density assessment 
Initial maps for the cellotriose-, isomaltotriose- and laminaritriose-bound structures were 
generated using the rigid-body refinement function of REFMAC5 using the native structure 
of the same recombinant fragment of hSP-D used in this study with any calcium ions or 
water molecules removed, leaving only the protein backbone and sidechains to prevent any 
bias in the final map [1PW9, Shrive et al., 2003].  The resulting weighted maps (equivalent 
to the traditional 2Fobs-Fcalc and Fobs-Fcalc maps) were then displayed, with the solved protein 
structure, in Coot for density assessment and ligand fitting [Emsley and Cowtan, 2004; 
Emsley et al., 2010].   
In cellotriose, the rigid-body map for each carbohydrate binding site, before any rounds of 
refinement, is shown in Figure 4.7 with the rigid-body template displayed to allow for 
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orientation.  The calcium ions in all three binding sites are clearly visible in the density from 
both the 2Fo-Fc map (blue) and the Fo-Fc map (green). The Fo-Fc map, or difference map, 
shows there is strong occupancy of the calcium in all three sites as you would expect in the 
calcium-dependent binding site.  There is also good resolution of the second and third 
calcium ions bound into each subunit of the trimer. However there is no density for the 
calcium, previously described as Ca4, in the neck domain of the trimer that is seen in the 
native structure of rfhSP-D [Shrive et al., 2003].   
In all three subunits, there is evidence for a terminal β-D-glucose of cellotriose binding the 
calcium, Ca1, in both of the maps [Figure 4.7].  In subunits B and C, the density covers the 
whole ring with good definition of the glycosidic linkage extending from the top of the 
bound glucose residue.  In subunit A the whole ring is not defined, however the density 
clearly describes a glucose ring.  Density for the remaining rings is not present in the rigid 
body maps in subunits A and C, beyond a small amount of density for where the glycosidic 
linkage to the second glucose would be.  In subunit B there is some density for the second 
glucose and the glycosidic linkage however how the second ring will fit is unclear.  There 
was no density for the third glucose ring in any of the subunits.   
Definition at the N terminal of the recombinant hSP-D fragment extends to Ala205 in 
subunits A and B, with good density for the backbone throughout.  The density does not 
extend as far in subunit C where definition does not extend beyond Ser206.  There is no 
density for the remaining amino acids in the fragment, residues 179 to 204/5, and they 
were not modelled. 
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Figure 4.7:  Rigid-body electron density maps for the cellotriose in complex with rfhSP-D.  The observed electron density map displayed at 1.0σ (2Fobs-Fcalc, 
blue) and difference map at ±3.0σ (Fobs-Fcalc, green (+) and red (-)) from the rigid-body solution.  The template structure is displayed to allow for 
orientation of the binding site.  Electron density shows the presence of cellotriose in all three chains, coordinated by the clearly defined calcium ion. 
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Figure 4.8:  Rigid-body electron density maps for the isomaltotriose in complex with rfhSP-D.  The observed electron density map at 1.0σ (2Fobs-Fcalc, blue) 
and difference map at ±3.0σ (Fobs-Fcalc, green (+) and red (-)) from rigid-body solution.  The template structure is displayed to allow for orientation of the 
binding site.  Electron density shows the presence of isomaltotriose in all three chains, with additional density extending towards Glu347 and Arg349.  
Coordinating calcium (Ca1) is clearly present in the electron density from both maps. 
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Figure 4.9:  Rigid-body electron density maps for the laminaritriose in complex with rfhSP-D.  The observed electron density map at 1.0σ (2Fobs-Fcalc, blue) 
and difference map at ±3.0σ (Fobs-Fcalc, green (+) and red (-)) from rigid-body solution.  The template structure is displayed to allow for orientation of the 
binding site.  Electron density shows the presence of laminaritriose in all three chains and the coordinating calcium (Ca1) in both maps. 
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Both rigid-body maps (2Fo-Fc in blue, Fo-Fc in green) from the isomaltotriose-bound 
structure, for all three carbohydrate recognition sites and the Ca4 binding site, are shown in 
Figure 4.8.  As with the cellotriose-bound structure, there is no density in the neck of the 
trimer for the fourth calcium.  The remaining calcium ions in each subunit are clearly 
defined in the electron density, confirmed by the strong positive signal in the difference 
weighted map, supported by the positions of the coordinating side chains described by 
Shrive (2003) [Shrive et al., 2003].   
There is clear density for a terminal glucose residue, at coordinating distances to the 
density for Ca1, in all three subunits and in both electron density maps [Figure 4.8].  In 
subunits A and C, the density continues across the second glucose, covering most of the 
ring and, importantly, the glycosidic linkage.  The third glucose has some density from the 
second glycosidic linkage, extending across Arg343 and back towards the protein surface at 
Arg349.  The positive density in the difference map shows that the occupancy is best for 
the primary coordinating glucose in all three chains whereas the density is less good for the 
second and third glucoses.  In subunit B, there is clear density for a glucose in a similar 
position to the first and second glucose residues in subunits A and C however the density 
extending beyond the second glucose is more extensive.   
Electron density extends across the backbone to residue 206 in the N-terminal direction in 
subunit A, 204 in subunit B and 205 in subunit C.  The side chains are less well defined in 
the N-terminal of the visible fragment compared to the CRD.  The remaining N-terminal of 
the recombinant fragment (residues 179 – 204/5/6) is not defined by the density and 
therefore cannot be determined in the structure. 
The laminaritriose-bound maps for each carbohydrate binding site and the Ca4-binding 
site, from the rigid-body refinement, are presented in Figure 4.9.  Density for all three 
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calcium ions in subunits A, B and C is present in positions comparable to the native rfhSP-D 
structure, suggesting that the three main calcium ions are present in the structure.  Positive 
density confirms that the calcium ions are present in the difference map.  There does not 
appear to be any density in the position where Ca4 is present in the native structure, with 
limited evidence for the associated changes in the side chains of Tyr228 and Lys232 [Shrive 
et al., 2003, 2009]. 
There is density for a glucose in the binding site of subunits B and C in the observed map 
(blue) with good density for the glucose in the difference map (green), confirming that 
there is ligand bound into B and C subunits [Figure 4.9].  There is some evidence in the 
density that there are extensions from the glucose in subunit B, extending away from ring 
above Glu321 and, potentially from the top of ring, away from the protein.  Interestingly in 
subunit C, the limited extensions appear to be from both sides of the binding glucose.  It is 
not clear, however, if there are any further glucoses visible in the density as the observed 
density is fragmented.  The density in subunit A is less conclusive in either map, as a 
glucose ring is not completely covered by the density, however the density present is of a 
sufficient size to fit a β-D-glucose [Figure 4.9].  The difference map in subunit A appears to 
confirm the position of the coordinating hydroxyls as there is positive density supporting 
the observed map.  There is no density beyond the first ring in subunit A.     
Density for the neck domain in the laminaritriose-bound structure is less well defined than 
in the cellotriose- and isomaltotriose-bound structures.  The observed map extends across 
the amino acid backbone to Ala205 in subunit A, Ala205 in subunit B and Ser206 in subunit 
C however there is large amount of negative density around subunit A, suggesting that 
there may not be complete definition to Ala205 in the final model.  As with the other two 
structures, there is no density for the remaining N-terminal amino acids up to and 
including Gly179 that does not readily stabilise in the crystal. 
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4.3.3 Final structures and binding mechanisms 
The overall structure for all three ligand bound structures is a trimeric unit containing the 
carbohydrate recognition domain and neck domain from residue 205 onwards [Figure 4.10 
and 4.11] except for laminaritriose where the N-terminal is disordered to residue 212 in 
subunit A [Figure 4.12].  The calcium ion found in the neck of the trimer in other published 
structures, is not present in any of the structures presented here.  Rounds of refinement 
were completed after the addition of the first β-D-glucose, correction of the protein 
backbone and side chains, and addition of the solvent molecules to the structure, with 10 
cycles of maximum-likelihood phase refinement for each round.  Any additional changes 
made to the structure were then re-refined to check the fit and calculate the final R-factors. 
 
Figure 4.10:  Overall structure of rfhSP-D in complex with cellotriose.  The overall orientation of 
cellotriose (green) in all three ligand binding sites shows the ligand extending away from the 
surface of the CRD of each subunit (red, A; yellow, B; cyan, C).  Calcium ions are represented in 
yellow. 
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Figure 4.11:  Overall structure of rfhSP-D in complex with isomaltotriose.  The overall orientation 
of isomaltotriose (green) in all three ligand binding sites shows the ligand extending across the 
surface of the CRD of each subunit (red, A; yellow, B; cyan, C).  Calcium ions are represented in 
yellow. 
 
Figure 4.12:  Overall structure of rfhSP-D in complex with laminaritriose.  The overall orientation 
of laminaritriose (green) in all three ligand binding sites shows a single reducing terminal 
glucose bound in the CRD of each subunit (red, A; yellow, B; cyan, C).  Calcium ions are 
represented in yellow. 
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Table 4.4:  Data collection and refinement statistics from the small ligand bound structures.  
Data collected on beamlines I02, I03 and I04-1. 
 Cellotriose Isomaltotriose Laminaritriose 
Data collection    
Wavelength (Å) 0.9795 0.9200 0.9795 
Temperature (K) 100 100 100 
Space group P21 P21 P21 
Cell Dimensions    
     a (Å) 55.39 55.21 56.18 
     b (Å) 108.18 107.14 110.02 
     c (Å) 55.61 55.44 56.36 
      β (°) 90.86 91.29 90.15 
Maximal resolution (Å) 1.59 1.96 1.75 
Observations 290 585 (14 509) 134 991 (8 047) 184 804 (10 054) 
Unique reflections 87 424 (4 288) 41 033 (2 722) 67 179 (3 663) 
Completeness (%) 99.5 (99.3) 89.4 (84.2) 97.6 (97.3) 
Rmergea 0.051 (0.359) 0.073 (0.291) 0.052 (0.328) 
I/σ(I) 10.8 (2.9) 8.6 (3.0) 10.1 (2.9) 
    
Refinement    
Protein atomsb 3 478 3 471 3 365 
     Residues, chain A 205 - 355 205 - 355 212 - 355 
     Residues, chain B 205 - 355 204 - 355 209 - 355 
     Residues, chain C 206 - 355 206 - 355 208 - 355 
Other atoms    
     Calcium ions 9 9 9 
     Ligand A = 2, B = 2, C = 2 A = 2, B = 2, C = 2 A =1, B = 1, C = 1 
     Water 405 350 430 
Resolution range (Å) 55.6 – 1.59 55.43 – 1.96 50.16 – 1.75 
Rworkc 0.1879 0.1664 0.1808 
Rfreed 0.2106 0.2084 0.2193 
Average B-values (Å2)    
     Protein main chain 25.77 24.46 28.21 
     Ligand 40.68 32.34 32.41 
     Water 36.54 35.50 39.02 
Ramachandron plot 
valuese (%) 
   
     Favoured 97.98 97.76 97.69 
     Allowed 2.02 2.24 2.31 
     Disallowed 0.00 0.00 0.00 
aRmerge= ΣhΣj|Ih,j-Ih| / ΣbΣj|Ih,j|, where Ih,j is the jth observation of reflection h and Ih is the 
mean of j for reflection h 
bTotal number of protein atoms used in refinement 
cRwork= Σh||Foh|-|Fch|| / Σh|Foh|, where Foh and Fch are the observed and calculated 
structure factor amplitudes, respectively, for reflection h. 
dRfree= Rwork but for a random 5% subset of reflections 
edefined by MolProbity analysis 
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Table 4.5:  Calcium coordination distances in the cellotriose-bound, isomaltotriose-bound and 
laminaritriose-bound complexes with recombinant fragment of human surfactant protein D 
 Cellotriose Isomaltotriose Laminaritriose 
Atom 1 Atom 2 A B C A B C A B C 
Ca1 Glu321 
OE1 
2.66 2.59 2.59 2.52 2.67 2.64 2.67 2.61 2.60 
 Asn323 
OD1 
2.41 2.38 2.33 2.46 2.43 2.48 2.47 2.44 2.43 
 Glu329 
OE1 
2.42 2.44 2.42 2.38 2.35 2.30 2.42 2.38 2.41 
 Asn341 
OD1 
2.40 2.39 2.39 2.47 2.45 2.37 2.46 2.42 2.45 
 Asp342 
OD1 
2.41 2.34 2.38 2.38 2.37 2.30 2.47 2.30 2.33 
 Asp342 
O 
2.53 2.52 2.54 2.58 2.57 2.57 2.57 2.52 2.58 
 Glc1 
O3’/ 
Glc3 O2’ 
2.35 2.35 2.39 2.36 2.36 2.37 2.42 2.39 2.44 
 Glc1 
O4’/ 
Glc3 O1’ 
2.36 2.42 2.41 2.37 2.38 2.35 2.43 2.49 2.44 
Glc1 O3’/ 
Glc3 O2’ 
Glu321 
OE1 
3.02 3.04 3.08 3.06 3.09 2.97 3.12 3.04 3.04 
 Glu321 
OE2 
2.56 2.60 2.57 2.66 2.59 2.81 2.69 2.47 2.56 
 Asn323 
OD1 
2.97 2.97 2.95 2.95 2.95 2.92 3.13 2.99 3.05 
 Asn323 
ND2 
2.76 2.92 2.86 2.97 2.81 2.87 2.95 2.96 2.95 
 Asn341 
OD1 
3.17 3.15 3.20 - - - 3.20 3.19 - 
Glc1 O4’/ 
Glc3 O1’ 
Glu329 
OE1 
3.01 3.00 3.04 2.88 3.01 2.98 3.02 3.06 2.97 
 Glu329 
OE2 
2.55 2.53 2.57 2.59 2.53 2.58 2.57 2.56 2.61 
 Asn341 
ND2 
2.97 3.01 2.99 3.08 3.05 2.94 3.09 3.08 3.03 
 Asn341 
OD1 
- - 3.16 - 3.18 3.11 - - - 
 Asp342 
O 
2.84 2.94 2.90 2.90 2.94 2.84 2.92 2.98 2.92 
Glc1 O6’ Arg343 
NH1 
2.64 - 2.99 - - - - - - 
Glc3 O6’ Arg343 
NH1 
- - - - - - - 3.06 3.09 
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Table 4.5 continued 
  Cellotriose Isomaltotriose Laminaritriose 
Atom 1 Atom 2 A B C A B C A B C 
Glc3 O5’ Arg343 
NH1 
- - - 3.07 3.18 3.05 - - - 
 Arg343 
NH2 
- - - 3.17 - 3.15 - - - 
Glc2 O3’ Glc1 O5’ 2.83 3.10 3.18 - - - - - - 
 Glu347 
OE1 
- - - 3.03 - 2.57 - - - 
Glc2 O3’ Glu347 
OE2 
- - - 2.80 2.64 - - - - 
Glc2 O4’ Glu347 
OE1 
- - - 2.51 2.86 - - - - 
 Arg349 
NH2 
- - - 2.72 2.99 2.97 - - - 
Glc1 O4’ Arg349 
NH1 
- - - - 2.93  - - - 
Ca2 Asp297 
OD1 
2.60 2.68 2.61 2.65 2.62 2.69 2.64 2.64 2.68 
 Asp297 
OD2 
2.52 2.47 2.47 2.37 2.38 2.44 2.54 2.47 2.54 
 Glu301 
OE1 
2.52 2.52 2.46 2.54 2.51 2.52 2.49 2.53 2.52 
 Glu301 
OE2 
2.41 2.51 2.45 2.51 2.51 2.52 2.47 2.50 2.51 
 Asp324 
OD1 
2.51 2.52 2.63 2.54 2.52 2.65 2.55 2.58 2.57 
 Glu329 
O 
2.43 2.39 2.41 2.54 2.43 2.44 2.49 2.49 2.40 
 Asp330 
OD1 
2.41 2.38 2.41 2.32 2.30 2.43 2.38 2.40 2.49 
 W 2.43 2.34 2.37 2.30 2.30 2.32 2.40 2.38 2.30 
Ca3 Glu301 
OE1 
2.32 2.37 2.38  2.31  2.42 2.36 2.36 
 Asp330 
OD1 
2.55 2.50 2.53  2.52  2.56 2.49 2.54 
 Asp330 
OD2 
2.44 2.50 2.46  2.45  2.42 2.53 2.56 
 W 2.30 2.39 2.30  2.30  2.42 2.36 2.30 
 W 2.30 2.42 2.30  2.33  2.45 2.38 2.36 
 W 2.34 2.30 2.35  2.35  2.30 2.41 2.39 
 W 2.35 2.34 2.43  2.44   2.43 2.30 
All numbers quoted are in Å.  Ca1 refers to the non-reducing glucose terminal.  Ca3 refers to 
the reducing glucose terminal.  W represents water molecules in important binding positions 
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Final refinement statistics for the cellotriose-bound structure were 0.1879 and 0.2106 for 
Rfactor and Rfree respectively.  Initially, the structure only showed density for the coordinating 
β-D-glucose with some definition of the glycosidic linkage.  Following refinement, 
additional density for the second β-D-glucose became apparent, enabling fitting of the 
second sugar in all three subunits.  Coordination to Ca1 is through the O3’ and O4’ 
hydroxyls, of the non-reducing glucose, at distances of 2.35Å and 2.36Å in subunit A; 2.35Å 
and 2.42Å in subunit B; and 2.39Å and 2.41Å in subunit C [Figure 4.13].  As with previously 
solved ligand-bound structures, interactions with the first glucose are completed by 
protein-ligand interactions between the O3’ and O4’ hydroxyls and side chains of Glu321 
(2.57Å, 3.08Å), Asn323 (2.86Å, 2.95Å), Glu329 (2.57Å, 3.04Å), Asn341 (2.99Å, 3.16Å, 3.20Å) 
and the carbonyl of Asp342 (2.90Å).  Additional protein-ligand interactions occur between 
O6’ hydroxyl and Arg343 in subunits A (2.64Å) and C (2.99Å).  This interaction is not present 
in subunit B. 
Density for the second glucose is best defined in subunit A where a water bridge between 
the O6’ hydroxyl and the main ring oxygen (O5’) stabilises the ring and minimises its 
movement, allowing it to be seen in the density.  One further hydrogen bond is formed 
between the O3’ hydroxyl of the second glucose and the O5’ oxygen in the binding glucose 
(2.83Å).  Density for the second glucose in subunits B and C is less well defined, particularly 
in subunit C where only half of the ring is defined.  In subunit B, the only interaction for the 
second ring is a 3.10Å hydrogen bond to the O5’ oxygen in the first glucose whereas in 
subunit C this interaction is 3.18Å.  At 1.0rmsd, there is no density for the glycosidic linkage 
in any of the subunits in the cellotriose-bound structures suggesting that there is mobility 
in the reducing residue as it projects into the space between the molecules in all three 
subunits. 
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The overall orientations of the rings in subunit A are comparable to the maltose-bound 
structure however there is a general shift in the binding glucose to accommodate the β-
linkage.  The second glucose is rotated 180° with respect to the glycosidic linkage and 
approximately 24.5° towards GlnB282 of the symmetry related molecule.  The orientation of 
Arg343, an important binding-site flanking residue, is rotated towards the ligand in all 
three subunits whereas Asp325 is in a more comparable position to that previously seen 
and makes no direct interactions with the ligand. 
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Figure 4.13:  Stereo view of calcium coordination in the cellotriose-bound rfhSP-D complex.  The binding calcium (Ca1, yellow) is coordinated by the O3’ 
and O4’ hydroxyl groups of the non-reducing terminal β-D-glucose (GlcI) with additional interactions with Glu321, Asn323, Glu329, Asn341 and Arg343.  
Representative of all three chains in the cellotriose-bound complex. 
    Chapter 4  Results of small ligand binding 
134 | P a g e  
 
 
 
 
Figure 4.14:  Stereo view of the calcium coordination in the isomaltotriose-bound rfhSP-D complex.  The binding calcium (Ca1, yellow) is coordinated by 
the O1’ and O2’ hydroxyls of the reducing terminal β-D-glucose (GlcIII) with additional interactions with Glu321, Asn323, Glu329 and Asn341.  The 
interactions with the protein are completed by Arg343 and O5’ ring oxygen and a hydrogen bond network between the non-terminal glucose (GlcII), 
Glu347 and Arg349.  Representative of all three subunits in the isomaltotriose-bound rfhSP-D complex. 
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Figure 4.15:  Stereo view of calcium coordination in the laminaritriose-bound rfhSP-D complex.  The binding calcium (Ca1, yellow) is coordinated by the 
O1’ and O2’ hydroxyls of the reducing terminal glucose (GlcIII) with additional interactions with Glu321, Asn323, Glu329 and Asn341.   
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Restrained refinement for the final model of isomaltotriose-bound rfhSP-D refined with 
statistics of 0.1664 for the Rfactor and 0.2084 for the Rfree.  These two statistics support the 
structure being an accurate representation of the data as both of the R statistics converged 
throughout refinement.  The final structure contains two reducing terminal α(1→6)-linked 
glucose residues (GlcII and GlcIII) in each subunit, coordinating Ca1 in a novel O1’ and O2’ 
hydroxyl mediated mechanism.  Interestingly, the coordinating glucose (GlcIII) is not only 
the reducing terminal of the glucose chain, it is also in the anomeric beta form.  This allows 
the two coordinating hydroxyls to acquire the same position as the O3’ and O4’ hydroxyls 
in the cellotriose-bound structure presented here and in a variety of previously published 
ligand-bound structures [Shrive et al., 2003, 2009; Crouch, McDonald, et al., 2006].  O1’ 
coordinates Ca1 at 2.37Å and O2’ is coordinated at 2.36Å (table 4.5, figure 4.14).  The 
remaining coordination to the binding glucose (GlcIII) is completed by a series of protein-
ligand interactions of between 2.59Å and 3.17Å, mostly between calcium coordinating 
residues (Glu321, Asn323, Glu329, Asn341 and Asp342) and the O1’ and O2’ hydroxyls, with 
additional hydrogen bonds between the O5’ oxygen and Arg343 (3.07Å, 3.17Å).  
Interestingly, the alternative hydroxyl coordination results in the α(1→6) linkage extending 
away from the binding site in an alternative direction to other malto-N-oses, completing 
the protein interactions at a secondary binding site with Glu347 and Arg349. 
The second glucose (GlcII) is positioned above Arg343, forcing it into a more compressed 
conformation, forming a hydrogen bond network between the O3’ and O4’ hydroxyls, NH2 
of Arg349 and both oxygen groups of Glu347 [Figure 4.14].  The O2’ hydroxyl completes 
the interactions with a water bridge to the main chain of the symmetry related molecule in 
subunit A.  In subunits B and C, O2’ completes this water bridge with Asp325 and Asp329 
due to a small rotation in the plane of the coordinating glucose that brings the second 
glucose (GlcII) closer to the protein surface.  The density for the non-reducing terminal 
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glucose (GlcI) was not sufficient to confidently model the glucose residue however it is 
suggested that there are transient interactions with the protein because of a concerted 
rearrangement of Glu289 towards a pocket where GlcI would tentatively recognise the 
protein; potentially explaining the electron density seen in the crystal structure. 
The laminariotriose-bound structure was refined with only a single glucose, achieving an 
Rfactor of 0.1808 and Rfree of 0.2193 which converged during refinement.  The calcium 
coordination occurred via the O1’ and O2’ hydroxyls, of the reducing terminal, in the same 
orientation as isomaltotriose, with coordinating distances between 2.39Å and 2.49Å 
respectively [Figure 4.1].  The O1’ interactions with protein are completed by Glu329 (2.56Å 
– 3.06Å), Asn341 (3.03Å – 3.09Å) and the carbonyl of Asp342 (2.92Å – 2.98Å); for O2’ the 
interactions are completed by Glu321 (2.47Å - 3.12Å) and Asn323 (2.95Å - 3.13Å).  In 
addition, there is an interaction between Asn341 and O2’ in subunits A and B which is not 
present in subunit C.  However, there is a long hydrogen bond between the O6’ hydroxyl 
and side chain of Arg343. 
Beyond the density for the β-D-glucose binding to Ca1, there is very little density for the 
remaining two glucosyl residues in subunits A and C, apart from a small amount of positive 
density, supported in the 2Fo-Fc equivalent map, where you would expect the next glucose 
to be; however, there is insufficient density for confident fitting.  In subunit B, there is better 
definition of the glycosidic bond with density coming off the bound glucose at C3’ and 
extending into a patch positive density.  The density does not extend across enough of the 
second glucose ring, however, so no fitting could be completed. 
 
Chapter 4 Discussion 
138 | P a g e  
 
4.4 Discussion 
4.4.1 Novel interactions with β-D-glucose and β-linked oligosaccharides 
This is the first time that interactions between human surfactant protein D and β-glucosyl 
ligands have been investigated.  Two alternative binding mechanisms have been identified 
in β-D-glucose ligands: (1) by the well documented O3’ and O4’ mannose-type interaction 
first seen in maltose and; (2) by the novel O1’ and O2’ hydroxyls.  Cellotriose coordinates 
the calcium in the binding site via the O3’ and O4’ hydroxyls, of the non-reducing glucose, 
in a similar manner to maltose and maltotriose, whereas both laminaritriose and 
isomaltotriose  both reveal recognition by O1’ and O2’ of the reducing terminal glucose 
[Shrive et al., 2003; Crouch, McDonald, et al., 2006]. 
The orientation of the O1’ and O2’ hydroxyls in laminaritriose and isomaltotriose are 
comparable to the mannose-type, equatorial hydroxyls that coordinate the calcium in other 
α-D-glucoses, allowing them to coordinate to Ca1.  In both of these ligands bound 
structures, the binding glucose is rotated, compared to the terminal glucose of maltose, by 
180° about the plane of the ring, presenting the binding hydroxyls to Ca1.  There is a 
further rotation compared to the terminal glucose in maltose that moves the oxygen in the 
glucosyl ring into the proximity of Arg343, in a similar position to that seen in the 
galactose-bound structure [Shrive et al., 2009].  As expected, the hydroxyls in all three 
structures superimpose with each other and adopt a position similar to the equatorial 
hydroxyls, however their overall position is an average of 0.18Å closer to the calcium in 
comparison to maltose. 
Initially it was surprising that a β-D-glucose was the coordinating glucose in the 
isomaltotriose-bound structure as dextran is an α-D-glucose polysaccharide.  However, 
during acid hydrolysis of the glycosidic linkage to produce the triose, carried out by the 
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supplier (dextra laboratories), the O1’ hydroxyl can undergo an unpredictable 
rearrangement resulting in a mixture of reducing terminal glucose types.  More 
interestingly, the O3’ and O4’ hydroxyls of the non-reducing terminal glucose were 
available for binding in the crystal but the O1’ and O2’ hydroxyls were selected.  This may 
be a result of the crystal artificially orientating the ligand into the binding site in subunit A, 
however there is a sufficient space around subunits B and C which may suggest the 
selection is genuine and that SP-D has a higher affinity for β-D-glucose ligands compared 
to its α-D-glucose equivalent.  Further work is necessary to determine whether this is the 
case or not using binding affinity studies.  
It was suggested by Allen and colleagues (2001) that surfactant protein D is able to 
recognise non-terminal glucoses through calcium coordination following molecular 
docking simulations [Allen et al., 2001].  One of the objectives of this study was to 
investigate these interactions crystallographically using one of the identified ligands, 
isomaltotriose.  The results here did not provide any insight into the non-terminal 
interactions however they do not rule out the possibility that they could occur and simply 
highlight the affinity for the terminal glucoses.  To investigate this further, substitutions of 
the terminal glucose hydroxyls with groups that cannot donate coordinate bonds, 
promoting coordination of the non-terminal glucose. 
4.4.2 Extended binding site on surfactant protein D 
An extended binding site was first suggested by Crouch and colleagues who identified an 
interaction between the terminal residue of maltotriose and Phe335 which is positioned at 
the bottom of a shallow cleft on the surface of surfactant protein D [Crouch, McDonald, et 
al., 2006].  The isomaltotriose structure also presented a secondary binding site but 
extending from the other side of the binding site, across the flanking residue, Arg343, and 
extending to Glu347 and Arg349 where the second glucose in the ligand forms at least two 
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interactions with the side chains.  This appears to be, in part, because of the alternative 
coordination of Ca1 that forces isomaltotriose to exit the binding site in the direction of 
Arg343, potentially aided by the increased height and flexibility in the α(1→6)-linkage.  This 
appears to allow isomaltotriose to form a ‘bridge’ across Arg343, which is in a retracted 
position compared to the native and other known ligand-bound structures [Shrive et al., 
2003, 2009; Crouch, McDonald, et al., 2006; Wang et al., 2008; Clark et al., 2016].   
Sequence analysis reveals that Glu347 and Glu349 are both highly conserved across the 
collectins and a range of mammalian and non-mammalian species.  This suggests that the 
extended binding site, identified in the isomaltotriose-bound structure, is important in the 
recognition of longer polysaccharide ligands found on the surface of pathogenic and 
allergenic species.  However further investigation with longer ligands is necessary to 
completely characterise the mid to long distance binding surface of SP-D. 
Neither cellotriose or laminaritriose completed any interactions beyond the calcium 
binding site, particularly because cellotriose only differs from maltotriose by the topology 
of the glycosidic bond [Pendrill, Säwen and Widmalm, 2013].  However, the binding affinity 
of rfhSP-D for  maltotriose is higher than for maltose (0.94mM compared to 2.3mM) whilst 
full length cellulose was found not to inhibit SP-D binding to its natural ligand from A. 
fumigatus [Allen, Voelker and Mason, 2001; Crouch, McDonald, et al., 2006].  The difference 
between maltotriose and cellulose may suggest that the more planar chain in cellotriose, as 
a result of the equatorial β-linkage, prevents the Phe335 interaction which is present in the 
maltotriose-bound structure [Crouch et al., 2006], however data for cellotriose affinity is 
necessary to confirm this.  The small amount of density for the two undefined β-D-glucoses 
in the laminariotriose-bound structure projects above Glu321 in the direction of Pro319, 
where there is little to coordinate the undefined glucoses.   
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Gentiotriose, a β(1→6)-linked unit of pustulan, was also soaked into native crystals and 
successfully diffracted, however there was no ligand present in the binding site  of any 
subunits (data not shown).  It was later determined by the supplier of the ligand that the 
product did not contain the expected ligand and lacked the small chain 
gentiooligosaccharides.  If the soak had been successful, the extending binding site, and 
influence of the flanking residues, could have been further characterised. 
This adds to evolving understanding of how SP-D recognises longer ligands and merited 
revisiting previous data using longer malto-N-oses that contain α(1→4) glycosidic linkages 
[Shaw, 2009].  Two rfhSP-D complexes with maltotetraose (four α-D-glucose) and 
maltoheptaose (seven α-D-glucoses) were reinterpreted following the identification of a β-
D-glucose in the calcium binding pocket and revealed a β-D-glucose in the binding site of 
subunits B and C in the heptose-bound complex [Figure 4.16, to be published].  The 
coordination of Ca1 occurs by a similar mechanism to the isomaltotriose-bound and 
laminaritriose-bound complexes, mediated through coordination bonds from the O1’ and 
O2’ hydroxyls, from the reducing terminal glucose, in the equatorial positions permitted by 
the β-anomeric form of glucose.  In subunit A, recognition occurs through the non-
reducing terminal glucose by the well-established O3’ and O4’ hydroxyl mechanism first 
observed in the maltose-bound and seen here in the cellotriose-bound complexes [Figure 
4.17]. 
The new analysis of the maltotetraose-bound complex also revealed an extended binding 
site in subunit A.  Calcium recognition occurs by the same mechanism as maltose, by the 
O3’ and O4’ equatorial hydroxyls, but the remaining three glucose residues extend across 
the surface of the CRD in a similar orientation to the maltotriose-bound complex and make 
additional hydrogen bonds to Thr336 and the main chain of Asn337 through non-reducing 
glucoses [GlcIV, Figure 4.18; Crouch et al., 2006].  The additional glucose in maltotetraose 
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causes the oligosaccharide to form a higher “arch” over the surface, stabilised by hydrogen 
bonds between the glucose residues, and prevents Phe335 from interacting with the ligand.  
Interestingly, the fourth glucose was also in its β-anomeric form, suggesting that the 
method for producing the smaller oligosaccharides from longer polysaccharides causes a 
rearrangement of the reducing terminal monosaccharide as it appears in all of the ligands 
α-oligosaccharides in this study. 
 
 
Figure 4.16:  Calcium coordination in subunit B of the maltoheptaose-bound rfhSP-D complex.  
Coordination of the calcium (Ca1, yellow) is by O1’ and O2’ hydroxyls of the reducing terminal 
glucose (Glc7).  Recognition is completed by interactions with Glu321, Asn323, Glu329 and 
Asn341.  Representative of subunit C. 
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Figure 4.17:  Calcium coordination in subunit A of the maltoheptaose-bound rfhSP-D complex.  
Coordination of the calcium (Ca1, yellow) is by O3’ and O4’ hydroxyls of the non-reducing 
glucose (Glc1).  Recognition is completed by interactions with Glu321, Asn323, Glu329 and 
Asn341 with a single interaction to the second α-D-glucose (Glc2) between the two O6’ 
hydroxyls. 
 
Figure 4.18:  Calcium coordination in subunit A of the maltotetraose-bound rfhSP-D complex.  
Coordination of the calcium (Ca1, yellow) is by the O3’ and O4’ hydroxyls, completed by 
interactions with Glu321, Asn323, Glu329 and Asn341.  Glc4 completes the interactions with the 
protein through hydrogen bonds to Thr336 and the backbone of Asn337   
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4.4.3 Importance of the flanking residues 
Since the earliest ligand binding studies, the importance of the, widely conserved, Asp325 
and Arg343 side chains as selection factors for ligands has been investigated through 
numerous ligand binding studies and mutation studies [Shrive et al., 2003, 2009, Crouch et 
al., 2007, 2009; Wang et al., 2008; Clark et al., 2016; Reinhardt et al., 2016].  These studies 
have revealed that Asp325 and Arg343 are able to effectively select and direct the ligands 
into the calcium binding site due to their key positions either side of the binding pocket, 
forming two oppositely charged islands on the surface that orientates the ligand, 
presumably to allow the coordinating hydroxyls to interact with Ca1 in the correct 
positions.  The significance of this selectivity was demonstrated using D325A + R343V and 
R343K mutants, which showed increased affinity for a range of ligands, including manno-N-
oses that are typical of viral glycoproteins, that usually have significantly lower affinity in 
the native CRD of SP-D [Crouch et al., 2009; Goh et al., 2013]. 
The structures presented, and in particular the isomaltotriose-bound structure, 
demonstrate a more direct role for Arg343 in the recognition of β-D-glucoses, where it 
interacts with both isomaltotriose and laminaritriose.  This data also suggests that Arg343 
may be more dynamic and flexible, allowing simple glucosyl ligands access to the extended 
binding surface.  Interestingly, altered positions of Arg343 still maintain the interaction with 
Glu333 (first reported in the maltose-bound structure), suggesting that the Glu347/Arg349 
binding surface is semi-rigid and that SP-D is predisposed to exposing the extended 
recognition surface to natural polysaccharide ligands [Shrive et al., 2003].   
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Chapter 5: Recognition of cell wall muramyl disaccharide from 
gram-positive bacteria 
5.1 Introduction to gram-positive cell wall and peptidoglycan 
Surfactant protein D is best known for recognising gram-negative bacteria and viral 
particles, including rough variants of Haemophilus influenzae and human influenza A virus 
[Hillaire et al., 2013; Clark et al., 2016].  However, the recognition role of SP-D has been 
shown to extend to gram-positive bacteria, a structurally distinct group of bacteria that are 
characterised by a cell wall that contains high levels of peptidoglycan and lacks the 
lipopolysaccharides found in gram-negative bacteria [Hartshorn et al., 1998; Palaniyar, 
Nadesalingam and Reid, 2002; Kishore et al., 2006; Vollmer, Blanot and De Pedro, 2008].  
For the first time, the molecular basis of the recognition of muramyl disaccharide, a primary 
unit of peptidoglycan, has been determined and is presented here. 
5.1.1 The gram-positive cell wall 
The gram-positive cell wall is primarily composed of peptidoglycan, a long chain 
polysaccharide crosslinked by short peptide chains, forming a strong, semi-rigid structure 
that protects the cell from changes in turgor pressure and controls the size and shape of 
the cell; expanding and contracting in response to the environment to maxima and minima, 
preventing the cells from bursting [Schleifer and Kandler, 1972].  There are also other, 
highly glycosylated structures that cross the peptidoglycan layer and interact with the host, 
including lipoteichoic acids (LTAs), which are membrane-anchored, and peptidoglycan-
anchored teichoic acids (TAs).  The cell wall is completed by a range of transport and 
synthetic proteins that are involved in nutrient transport and peptidoglycan maintenance 
[Schleifer and Kandler, 1972; Park and Uehara, 2008].   
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An important part of cell wall maintenance is shedding of peptidoglycan from the cell wall 
surface, releasing between 5% and 50% of the total peptidoglycan as the cell wall matures 
[Park and Uehara, 2008].  In gram-negative bacteria, the outer membrane prevents the 
release of the peptidoglycan, allowing it to be recycled into new peptidoglycan, but the 
lack of the outer membrane in gram-positive bacteria allows the peptidoglycan to be 
released into its surroundings in a soluble form.  It is the soluble form of peptidoglycan 
that has been shown to be immunogenic, stimulating a strong response from phagocytes 
and macrophages and stimulating a release of chemokines and cytokines leading to 
inflammation and further recruitment of immunocytes [De Kimpe et al., 1995]. 
The number of exposed carbohydrate structures on the surface of gram-positive bacteria 
provide possible recognition sites for surfactant protein D as peptidoglycan and 
lipoteichoic acid are both known to be pathogen-associated molecular patterns used by 
numerous innate immune molecules to recognise gram-positive bacteria [van de Wetering 
et al., 2001; Bertsche et al., 2015].  It was suggested by  Palaniyar in 2002 that both soluble 
and insoluble, cell wall-bound peptidoglycan that are exposed to the environment are 
targets for surfactant protein D via interactions between the core polysaccharide and 
carbohydrate recognition domain [Palaniyar, Nadesalingam and Reid, 2002]. 
5.1.2 Recognition of gram-positive cell wall components 
A number of gram-positive bacteria have been identified as targets for surfactant protein 
D; many of which are known to be medically important in respiratory tract infections, 
including Staphylococcus aureus and Streptococcus pneumoniae [Table 1.3; Hartshorn et 
al., 1998].  It has been shown that recognition of S. pneumoniae by SP-D causes extensive 
agglutination and, in a strain dependent manner, increases uptake by neutrophils 
[Hartshorn et al., 1998; Jounblat et al., 2004].  A similar effect was also seen in S. aureus but 
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to a lesser extent, suggesting that neutrophilic uptake varies between species as well as 
strains.   
How these important gram-positive species are recognised by SP-D and SP-A was further 
characterised by van de Wetering and colleagues in 2001, who successfully showed that 
both surfactant proteins were able to recognise and adhere to LTAs and an insoluble, 
unmodified fragment of peptidoglycan [van de Wetering et al., 2001].  For SP-D, the 
recognition of LTA extracted from Bascillus subtilis occurred via the carbohydrate 
recognition domain, in a calcium dependent mechanism, by a limited number of 
recognition motifs on the LTA.  Similarly, the unmodified peptidoglycan from S. aureus was 
also recognised by the CRD of hSP-D but with lower affinity compared to LTA.  
Interestingly, a soluble fraction of peptidoglycan has also been recognised by SP-D 
however the details of this recognition are not clear [Palaniyar, Nadesalingam and Reid, 
2002]. 
Peptidoglycan was shown to be recognised via the N-acetylglucosamine moiety by the 
related collectin mannose binding protein (MBP), through the CRD interaction that is 
suggested to be responsible for recognising peptidoglycan in SP-D [Nadesalingam et al., 
2005].  Interestingly, this study also suggested that MBP has a higher affinity for the soluble 
form of peptidoglycan compared to the insoluble peptidoglycan and, in fact, competed 
closely with the high affinity MBP ligand, mannan.  As MBP shares the characteristic CRD 
with SP-D, it is proposed that SP-D may also interact with the two forms of peptidoglycan 
through the N-acetylglucosamine and to test this, a muramyl disaccharide unit extracted 
from Micrococcus luteus¸ another gram-positive species, has been soaked into native 
crystals of a biologically and therapeutically active recombinant fragment of human SP-D 
(rfhSP-D) to identify which of the two available saccharide moieties SP-D recognises. 
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5.1.3 Muramyl disaccharide 
Muramyl disaccharide is the repeating unit of the polysaccharide at the core of 
peptidoglycan and is formed from alternating units of N-acetyl-β-D-glucosamine (GlcNAc) 
and N-acetyl-β-D-muramic acid (MurNAc), linked by a β(1→4) glycosidic linkage.  In 
peptidoglycan, this disaccharide unit then repeats up to 60 times, linked by further β(1→4) 
glycosidic linkages, to form long, structurally strong polymers that are then cross-linked by 
the O-linked tetra- or penta-peptides that extend from the lactyl group attached to 
position three of the main saccharide ring  [Figure 5.1; Schleifer and Kandler, 1972; Yang et 
al., 2017].  The crosslinked polysaccharides then form the characteristic cell wall observed in 
gram-positive bacteria.   
 
Figure 5.1:  Representation of Muramyl Disaccharide from Gram-Positive Cell Wall.  Figure 
shows a representation of muramyl disaccharide extracted from the gram-positive bacteria, 
Micrococcus luteus.  It comprises an N-acetyl-β-D-glucosamine linked to an N-acetyl-β-D-
muramic acid by a β(1→4) glycosidic linkage.  
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The aim of this study is to characterise how human surfactant protein D recognises the 
natural muramyl disaccharide from Micrococcus luteus at the atomic level and infer how a 
longer fragment of peptidoglycan, soluble or insoluble, may be recognised during an 
immune challenge by gram-positive bacteria such as Streptococcus pneumoniae.  This will 
also provide further insight into which carbohydrate moiety of the muramyl disaccharide is 
the primary recognition target of rfhSP-D. 
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5.2 Materials and methods 5.2.1 Protein preparation 
The rfhSP-D was received from the Southampton group at a concentration of 8.53mgml-1, 
following purification using affinity chromatography.  The protein was subsequently buffer 
exchanged into phosphate-buffered saline (PBS) before crystallisation.  See section 3.2.1 for 
full details. 
5.2.2 Muramyl disaccharide soaking of native rfhSP-D 
Bacterial cell wall muramyl disaccharide, from Micrococcus luteus (Dextra Laboratories), was 
soaked into native rfhSP-D crystals grown in a sitting drop (see section 3.3.1).  Cryocooling 
to 100K was completed following cryoprotection with consecutive additions of 5%-20% 2-
methyl-2,4-pentandiol (MPD), diluted with the well conditions (table 5.1) to maintain the 
equilibrium that permitted crystal formation.  A final concentration of 20mM was achieved 
in the drop following an exchange of the drop volume, 12μl, with 5μl of the cryoprotection 
buffer.  The well conditions are detailed in table 5.1.  Crystals were exposed to the highest 
concentration cryoprotectant for a total of nine minutes before the crystal was mounted, 
allowing sufficient time for the muramyl disaccharide and MPD to soak through the solvent 
channels and into the calcium binding sites of the protein. 
Table 5.1:  Table of well conditions for crystal IB264A53 
IB264A53 16% Polyethylene Glycol 6000 
0.1M Tris pH 6.0 
10mM CaCl2 
 
Data collection was carried out at Diamond Light Source, Oxfordshire on macromolecular 
crystallography beamline I03.  One high resolution dataset was collected at a resolution of 
1.69Å.  Processing of the diffraction data was completed according to section 3.4.2. 
Chapter 5  Results of Muramyl Disaccharide Binding 
151 | P a g e  
 
5.3 Results of muramyl disaccharide binding 5.3.1 Data processing and data selection 
High resolution data was collected from one muramyl disaccharide-soaked crystal, 
IB264A53.  The diffraction images from this crystal were indexed into monoclinic primitive 
spacegroup P21, the spacegroup previously determined for the high resolution native 
structure of the same recombinant fragment of human SP-D used in these studies, with a 
final unit cell of [Shrive et al., 2003]: 
a = 55.28Å     b = 108.18Å     c = 55.74Å 
α = γ = 90.0°     β = 91.14° 
The spacegroup was confirmed using Pointless during the Pointless-Aimless pipeline which 
was used to scale the integrated data, generated from the raw diffraction data by MOSFLM; 
all distributed as part of the CCP4 suite of programs for macromolecular structure solution 
[Leslie, 2006; Winn et al., 2011; Evans and Murshudov, 2013].  Scaling and merging the data 
at a maximum resolution of 1.95Å generated good overall Rmerge statistics of 6.6% and 
21.1% in the outer shell.  The overall I/σ(I) and CC½ were 8.0 and 0.990, respectively, with 
the outershell values calculated to be 3.3 and 0.889.  Completeness for the dataset was 
92.5% overall and 93.5% in the outershell.  Structure factors were generated using Truncate 
and twinning was assessed using cumulative frequency distribution and L-test.  The data 
was not twinned. 
The structure was successfully solved by rigid-body refinement (REFMAC5) using the native 
structure of the same hSP-D fragment solved to 1.6Å with the calcium ions and solvent 
molecules removed [1PW9, Shrive et al., 2003; Murshudov et al., 2011].  As there was only 
one dataset, the resulting electron density maps were assessed to identify if ligand was 
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present in the binding site before continuing restrained refinement.  As there was density 
for the ligand in the calcium-binding pocket, the data was selected for further restrained 
refinement and model building [Håkansson et al., 1999; Shrive et al., 2003]. 
5.3.2 Initial map generation and density assessment 
The initial maps for the muramyl disaccharide-bound structure were generated using the 
rigid-body refinement function of REFMAC5 using the native structure of the same 
recombinant fragment of hSP-D as used in this study as the starting model.  All of the 
calcium ions and solvent molecules were removed from the model, leaving the protein 
backbone and side chains of residues 205-355 to prevent any bias in the final electron 
density maps [1PW9, Shrive et al., 2003].  This was sufficient to solve the protein structure 
and generate two weighted maps (equivalent to the 2Fobs-Fcalc and Fobs-Fcalc) that were 
displayed in Coot for density assessment and ligand modelling [Emsley and Cowtan, 2004; 
Emsley et al., 2010]. 
The resulting electron density maps of the carbohydrate binding pocket for each subunit 
are shown in Figure 5.2 with the template rfhSP-D structure displayed to allow for 
orientation of the binding site.  There is good electron density, in both the 2Fo-Fc and Fo-Fc 
maps, for the three primary calcium ions in the CRD in all three subunits, suggesting there 
is good occupation in these three calcium binding sites.  The fourth calcium binding site, 
identified in the neck domain of the native structure, does not appear to have any density 
in the observed map (2Fo) or the difference map (Fo). 
In the carbohydrate binding site of subunit A, there is some evidence for calcium 
coordinating atoms in the observed map [Figure 5.2].  However, the density does not 
extend beyond the coordinating atoms and suggests that there is no ligand bound in 
subunit A, allowing for water molecules to coordinate the calcium as in the native structure 
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[Shrive et al., 2003].  In subunits B and C, both maps describe the primary binding N-acetyl-
β-D-glucosamine, with strong density for all of the atoms of the ring and the N-acetyl 
extension at position 2 of the ring [Figure 5.2].  There is also good resolution for the 
glycosidic linkage and the main ring N-acetyl-α-D-muramic acid in the observed map of 
both subunits and some density defining the orientation of the ring in the difference map 
in subunit B.  The O-linked carboxymethyl side chain, in subunit B, has some definition in 
the initial observed map however the other side chain, the N-linked acetyl group, is not 
clearly defined.  The definition of the two side chains in subunit C is considerably better 
and the positions of the two side chains is clearly defined, despite the density for the ring 
being less complete than in subunit B. 
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Figure 5.2:  Electron density maps from initial rigid body refinement to solve the muramyl disaccharide structure.  The 2Fobs-Fcalc map (1.0 sigma; blue) from 
subunits B and C show that the ligand is successfully bound, whereas in subunit A, there is no evidence of ligand.  This is also the case for the Fobs-Fcalc map 
(3.0 sigma; green, red), or difference maps, which show strong peaks for the ligand in subunits B and C.  
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5.3.3 Final structures and binding mechanisms 
The overall structure is a trimeric unit containing the alpha-helical coiled coil neck domain 
and the carbohydrate recognition domain from residue 205 onwards in subunits A and B 
and 206 in subunit C [Figure 5.3].  The remaining the N-terminal residues (179 - 204) of the 
recombinant fragment used are not defined in the electron density.  The three main 
calcium ions (Ca1, Ca2 and Ca3) are present in all three subunits however Ca4, identified in 
the native and other ligand-bound structures, is not present in the structure presented here 
[Shrive et al., 2003, 2009].  Rounds of refinement were completed following manual 
corrections of the protein backbone and side chains, addition of the N-acetyl-β-D-
glucosamine (GlcNAc) and N-acetyl-α-D-muramic acid (MurNAc), and addition of solvent 
molecules, with up to 10 cycles of maximum-likelihood phase refinement in each round.  
Additional rounds of refinement were completed following any further changes to the 
structure, and the final R-factors were calculated. 
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Figure 5.3:  Overall structure of rfhSP-D in complex with muramyl disaccharide.  The overall 
orientation of muramyl disaccharide (green) in the ligand binding sites of subunits B (yellow) 
and C (cyan).  Figure shows the ligand extending away from the surface of the CRD of each 
subunit where it is bound.  Calcium ions are represented in yellow and Ca1 coordinating water 
molecules in blue.  Subunit A is represented in red. 
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Table 5.2:  Data collection (DLS I04-1) and refinement statistics from the muramyl disaccharide-
bound structures of a recombinant fragment of human surfactant protein D. 
 Muramyl Disaccharide 
Data collection  
Wavelength (Å) 0.9763 
Temperature (K) 100 
Space group P21 
Cell Dimensions  
     a (Å) 55.28 
     b (Å) 108.18 
     c (Å) 55.74 
     β (°) 91.14 
Maximal resolution (Å) 1.95 
Resolution Range (Å) 49.54 – 1.95 (8.94 – 1.95) 
Observations 106 081 (6 906) 
Unique reflections 44 108 (3 156) 
Completeness (%) 92.5 (93.5) 
Rmergea 0.066 (0.211) 
I/σ(I) 8.0 (3.3) 
CC½ 0.990 (0.889) 
  
Refinement  
Protein atomsb 3 464 
     Residues, subunit A 205 – 355 
     Residues, subunit B 205 – 355 
     Residues, subunit C 206 - 355 
Other atoms  
     Calcium ions 9 
     Ligand A = 0, B = 2, C=2 
     Water 336 
Resolution range (Å) 55.73 – 1.95 
Rworkc 0.1708 
Rfreed 0.2169 
Average B-values (Å2)  
     Protein main chain 28.41 
     Heteroatoms 32.11 
     Water 36.39 
Ramachandron plot valuese 
(%)  
Favoured 97.98 
Allowed 2.02 
Disallowed 0 
aRmerge= ΣhΣj|Ih,j-Ih| / ΣbΣj|Ih,j|, where Ih,j is the jth observation of 
reflection h and Ih is the mean of j for reflection h 
bTotal number of protein atoms used in refinement 
cRwork= Σh||Foh|-|Fch|| / Σh|Foh|, where Foh and Fch are the 
observed and calculated structure factor amplitudes, 
respectively, for reflection h. 
dRfree= Rwork but for a random 5% subset of reflections 
edefined by MolProbity analysis 
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Table 5.3: Calcium coordination distances and protein-ligand interactions in the muramyl 
disaccharide bound recombinant fragment of human surfactant protein D. 
 Muramyl 
Disaccharide 
  Muramyl 
Disaccharide 
Atom 1 Atom 2 A B C  Atom 1 Atom 2 A B C 
Ca1 Glu321 
OE1 
2.67 2.55 2.71  Ca3 Glu301 
OE1 
2.35 2.38 2.53 
 Asn323 
OD1 
2.38 2.46 2.44   Asp330 
OD1 
2.57 2.64 2.50 
 Glu329 
OE1 
2.42 2.46 2.33   Asp330 
OD2 
2.38 2.77 2.49 
 Asn341 
OD1 
2.49 2.35 2.38   W 2.26 2.38 2.29 
 Asp342 
OD1 
2.28 2.28 2.29   W 2.27 2.40 2.46 
 Asp342 
O 
2.61 2.53 2.55   W 2.29 - 2.46 
 GlcNAc1 
O3’ / W 
2.53 2.57 2.51   W 2.50 - - 
 GlcNAc1 
O4’ / W 
2.51 2.53 2.56       
GlcNAc1 
O3’ / W 
Glu321 
OE2 
- 2.49 2.60       
 Asn323 
ND2 
- 3.08 2.86       
GlcNAc1 
O4’ / W 
Glu329 
OE2 
- 2.63 2.47       
 Asn341 
ND2 
- 3.06 3.01       
GlcNAc1 
O6’ 
Arg343 
NH1 
- 3.04 2.74       
Ca2 Asp297 
OD1 
2.54 2.79 2.65       
 Asp297 
OD2 
2.45 2.49 2.29       
 Glu301 
OE1 
2.57 2.73 2.62       
 Glu301 
OE2 
2.61 2.89 2.64       
 Asp324 
OD1 
2.46 2.78 2.66       
 Glu329 
O 
2.46 2.46 2.47       
 Asp330 
OD1 
2.39 2.47 2.47       
 W 
 
2.28 2.22 2.25       
All numbers quoted in Å.  GlcNAc represents the coordinating N-acetyl-β-D-glucosamine.  
W represents waters in key binding positions. 
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The final refinement statistics following completion of the model were 0.1708 and 0.2169 
for Rwork and Rfree respectively, showing good overall agreement between the model and 
data (table 5.2).  The difference in Rfactors (0.0461) is larger than expected at 1.95Å however, 
as that difference was constant throughout the refinement and both Rfactors fell equally 
throughout refinement cycles, it can be accepted.  The density for both monosaccharides 
and the glycosidic β-linkage was well defined from the initial electron density maps in 
subunits B and C, allowing for the whole ligand to be fitted, including the N-linked acetyl 
groups and the O-linked lactyl group of the muramic acid.  There was no density for the 
ligand in subunit A. 
In subunits B and C, calcium-dependent recognition occurs via the N-acetyl-β-D-
glucosamine (GlcNAc1) through the O3’ and O4’ equatorial hydroxyl groups at 2.57Å and 
2.53Å, respectively, in subunit B and 2.51Å and 2.56Å in subunit C (table 5.3, Figures 5.4 and 
5.5).  The recognition is completed by a number of protein-ligand interactions that are 
common to other ligand-bound structures of rfhSP-D, where O3’ is bound via hydrogen 
bonds by Glu321 (2.49Å in B, 2.60Å in C) and Asn323 (3.08Å in B, 2.86Å in C) and O4’ is 
coordinated by Glu329 (2.63Å in B, 2.47Å in C) and Asn341 (3.06Å in B, 3.01Å in C).  The 
protein interactions are completed by Arg343 and O6’ hydroxyl of GlcNAc1, through a 
single hydrogen bond of 3.04Å and 2.74Å (B and C, respectively); an interaction not always 
present in other glucosyl ligands.  In addition, there is also a conserved water bridge 
between O7’ of GlcNAc1 and Asp325. 
Interestingly, the water involved in forming the water bridge between Asp325 and O7’ also 
interacts with the O10’ on the carboxylethyl side chain of the N-acetyl-α-D-muramic acid 
(MurNAc1), forming the only major interaction between the protein and the second 
monosaccharide residue.  It was not expected that the second monosaccharide would be in 
its α-anomeric form, as naturally it is in the β-form, however the density clearly showed the 
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hydroxyl on carbon 1, the anomeric carbon, was in an axial position in relation to the ring.  
The remaining coordination between the protein and the MurNAc occurs through an 
extensive water network that connects the protein, O6’ of MurNAc and N2 of GlcNAc.  The 
N-linked acetyl group of the MurNAc residue does not appear to interact with the protein 
in the asymmetric unit, however it appears to be stabilised in the crystal through weak 
interactions with a polar pocket formed by the main chain oxygens of Thr262 and Gln263 
(3.53Å to 4.80Å). 
The overall orientation of the GlcNAc in the binding site is conserved across both subunits 
with the exception of two small rotations about the N-acetyl linkage and the C5-C6 bond 
as a result of an additional water bridge between O6’ and the O-linked lactyl group of the 
MurNAc residue in subunit B.  Interestingly, the rotation of the O6’ position in the C subunit 
also results in an additional water bridge, not present in subunit B, to the side chain of 
Glu347, bringing O6’ closer to Arg343 (2.74Å compared to 3.04Å) which may suggest 
variability in the position of O6’ during recognition [Figures 5.4 and 5.5].  This is 
compounded by an apparent shift in the side chain of Glu347 in subunit B, which, when 
compared to the native structure or subunit C of the muramyl disaccharide-bound 
structure, moves closer to the binding site and interacts with Arg343 but with no direct or 
indirect interaction with the ligand.  The MurNAc residue is rotated approximately 100° 
with respect to the plane of the GlcNAc residue, around the glycosidic bond, in both 
subunits where the ligand is present.  Importantly, the O1’ hydroxyl, where the next 
repeating unit of GlcNAc-MurNAc would be in a longer ligand, is completely accessible and 
positioned so that a longer peptidoglycan unit would be able to extend from away from 
the protein surface [Figure 5.6].  Furthermore, the lactyl group of the MurNAc is also 
available and positioned away from the protein surface where, in peptidoglycan, the tetra- 
or pentapeptide would be linked [Vollmer and Seligman, 2010]. 
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There is very little movement in the side chain of the major binding-site flanking residue 
Arg343 to facilitate recognition of the O6’ compared to the native structure of rfhSP-D, 
however, in the opposing flanking residue, Asp325, there is a substantial rotation of 90° in 
both subunits where the ligand is present [Shrive et al., 2003].  This is surprising since the 
interactions with the ligand are water mediated in both cases, especially as in other bound 
structures this is not the case.  Furthermore, the proximity of the symmetry related 
molecule to Asp325, where it forms a crystal contact with Lys230, appears to prevent the O-
linked lactyl side chain of MurNAc from rotating (67°) and directly interacting with the 
Asp325; as is the case in other natural ligand-bound structures [Clark et al., 2016].   
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Figure 5.4:  Stereo view of the binding mechanism by muramyl disaccharide in subunit B.  Binding is through coordination of the calcium ion in the main 
binding pocket (Ca1, yellow) in muramyl disaccharide complex with rfhSP-D.  The main coordination is via the O3’ and O4’ hydroxyls of GlcNAc residue.  
Recognition is completed by Glu321, Asn323, Glu329, Asn341 and Arg343 (which interacts with the O6’ hydroxyl.  The interactions with the MurNAc 
residue are completed by a water bridge (red sphere) between Asp325, GlcNAc and the lactyl group of MurNAc. 
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Figure 5.5:  Stereo view of the binding mechanism by muramyl disaccharide in subunit C.  Binding is through coordination of the calcium ion in the main 
binding pocket (Ca1, yellow) in muramyl disaccharide complex with rfhSP-D. The main coordination is via the O3’ and O4’ hydroxyls of the GlcNAc residue.  
Recognition is completed by Glu321, Asn323, Glu329 and Asn341, with an additional hydrogen bond with Arg343.  Distance to Arg343 is shorter in subunit 
C compared to subunit B.  The water bridge (red sphere) between Asp325, GlcNAc and the lactyl group of the MurNAc residue. 
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Figure 5.6:  Subunit C of the muramyl disaccharide complex showing the muramyl disaccharide extending away from the surface of the protein.  The figure 
shows that the ligand extends away from the protein surface (cyan, transparent), showing a longer ligand can be accommodated.  (star) position of the 
MurNAc where further disaccharides extend from in longer ligands. 
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5.4 Discussion 5.4.1 Recognition of muramyl disaccharide 
Recognition of gram-negative bacteria has previously been investigated using both 
naturally derived inner core polysaccharides and other synthetic analogues such as α(1→3)-
diheptose [Wang et al., 2008; Clark et al., 2016; Reinhardt et al., 2016].  For the first time, 
the structure presented here provides a much-needed insight into how hSP-D recognises 
the structurally distinct group of gram-positive bacteria that have a peptidoglycan-rich cell 
wall which is exposed to the surrounding environment [van de Wetering et al., 2001; 
Palaniyar, Nadesalingam and Reid, 2002].  Muramyl disaccharide is the repeating unit of the 
structural polysaccharide in cell wall peptidoglycan, containing a β(1→4)linked N-acetyl-β-
D-glucosamine and N-acetyl-β-D-muramic acid (GlcNAc-β(1→4)-MurNAc), that, in this 
case, was extracted and hydrolysed from the gram-positive bacteria, Micrococcus luteus; 
making it a suitable and natural analogue for a longer peptidoglycan molecule [Dextra 
Laboratories].   
The muramyl disaccharide was primarily recognised through the O3’ and O4’ hydroxyls of 
the GlcNAc residue.  This conforms to the well-established recognition pattern of the 
calcium ion in the primary binding site, Ca1, coordinating with two equatorial hydroxyls on 
adjacent carbon atoms of the main carbohydrate ring or, in the case of heptose, the 
dihydroxyethyl side chain [Shrive et al., 2003, 2009; Wang et al., 2008; Crouch et al., 2009].  
Coordination by these two hydroxyls of GlcNAc results in the possible ring orientations 
being restricted by the N-linked acetyl group at carbon 2 because of the proximity of 
Arg343 to the binding pocket.  This confirms the findings of Allen and his colleagues in 
2004, who described an R343V mutant with increased affinity for GlcNAc [Allen et al., 2004].  
A similar effect is also alluded to in the N-acetyl-D-mannose-bound (ManNAc-bound) 
structure, where the ManNAc is recognised in a comparable way to GlcNAc, with O3’ and 
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O4’ functioning as the calcium coordinating atoms, and the flanking Arg343 forcing the N-
acetyl group into a small pocket above Glu321 and Asn323 [Figure 5.4; Crouch et al., 2007].  
However, there is no direct interaction between the N-acetyl side and any of the side chains 
in the GlcNAc pocket here, other than a weak interaction between the carbonyl group of 
the acetate and ND2 of Asn323 (up to 3.59Å) that is not present in the ManNAc-bound 
structure. 
Interestingly, the ManNAc structure does have an extra interaction between the nitrogen of 
the mannosamine moiety and Asp325, in all three chains as a result of the axial position of 
the nitrogen [Crouch et al., 2007], compared to the equatorial position in GlcNAc.  This is 
despite a much larger rotation of Asp325 in the GlcNAc-bound structure.  The rotation 
moves the interacting oxygen (OD2) closer, overall, to the GlcNAc, possibly suggesting that 
the carbonyl of the N-linked acetyl group, which interacts weakly with Asn323, is also 
interacting weakly with Asp325 through a long hydrogen bond (~4.0Å) and brings about 
this change in orientation, reinforcing the suggestion that Asp325 is directly involved in 
selecting and orientating ligands in the binding site of hSP-D. 
Beyond the well characterised interactions present in many other ligand-bound structures 
of rfhSP-D, GlcNAc also interacts with Glu347 through a water bridge in subunit B.  The 
importance of this water bridge is unclear as it is not present in subunit C, however it is 
sufficient to cause the side chain of Glu347 to move towards the binding site, suggesting 
that Glu347 may have larger role in ligand recognition than was originally thought, as this 
is the first structure to demonstrate this shift in position.  It has been previously suggested 
that Glu347 may play a role in ligand recognition due to its close proximity to the main 
binding site, potentially working in tandem with Arg349, as both groups are conserved in 
surfactant protein A and D, however this is the first evidence of any involvement and 
something that requires further investigation [Håkansson et al., 1999]. 
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The N-acetyl-muramic acid residue does not appear to make any direct interactions with 
the protein which is perhaps surprising considering the good definition of the ring in the 
electron density.  It appears that the extensive, water-mediated hydrogen bond network is 
sufficient to stabilise the MurNAc.  The strongest of these interactions (2.82 Å) is a single 
water bridge between Asp325, the lactyl side chain of MurNAc and the acetyl group of the 
GlcNAc residue which is conserved in subunits B and C.  It is interesting, however, that the 
proximity of the symmetry related molecule to the MurNAc potentially exerts a stabilising 
effect on the ring through long interactions between the N-acetyl group and the main 
chain carbonyls.  This has not been identified in previous disaccharide-bound structures, 
where definition of the second ring is usually present in subunit A, suggesting that the size 
of the muramyl disaccharide unit and its side chains probe this polar pocket of the 
symmetry related molecule where smaller, glucosyl ligands, are unable to [Shrive et al., 
2003, 2009].  The size of muramyl disaccharide may also explain why the ligand was unable 
to bind in subunit A as the symmetry related molecule restricts the binding site.   
There is also a rotation of the MurNAc in relation to the plane of the GlcNAc ring, in 
subunits B and C, which may be an artefact from the natural peptidoglycan backbone 
source of the disaccharide unit used in this study. A 3-fold and 4-fold screw axis around the 
oligosaccharide core has been observed in complete sulci, peptidoglycan fragments and 
synthetic peptidoglycan fragments from various gram-positive and gram-negative species, 
with pentapeptides extending away from the core every 120° and 90°, respectively [Vollmer, 
Blanot and De Pedro, 2008; Ślusarz, Szulc and Madaj, 2014; de Pedro and Cava, 2015; Kim, 
Chang and Singh, 2015].  This is further supported by the positions of the N-linked acetyl 
groups that are rotated approximately 120° in relation to each other, which would produce 
the 3-fold screw axis in a longer chain.  However, the proximity of the symmetry related 
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molecule will also be exerting an effect on this orientation and any rotation may be more 
directly associated with the accessibility of the binding site. 
5.4.2 Possible rotation of MurNAc and an extended role for Asp325 
The role of Asp325 in ligand recognition has been well studied using both native and 
D325A/R343V mutants and has been shown to have a selective role for ligands through 
either blocking the main calcium binding site, in combination with Arg343, or directly 
interacting with the ligand to improve binding affinity [Crouch et al., 2005, 2009; Clark et al., 
2016].  It is suggested here that Asp325 may also be involved in recognising muramyl 
disaccharide and, by extension, peptidoglycan from bacterial cell wall.  It is proposed that 
the proximity of the symmetry related molecule, whilst stabilising the MurNAc residue and 
making it visible in the electron density map, may also be preventing the carboxylic acid of 
the O-linked side chain from interacting with Asp325; with which it would otherwise 
interact naturally.  In more general terms, Asp235 is an important recognition residue for 
longer, naturally derived ligands and may contribute to the selection of peptidoglycan as a 
ligand through the positioning of the terminal N-acetyl-glucosamine in the correct 
orientation for the calcium to coordinate with the O3’ and O4’ hydroxyls.   
The role of the Asp325 rotation in the muramyl disaccharide-bound structure is not clear 
because in other ligand-bound structures, including the H. influenzae Eagan 4A 
polysaccharide-bound structure, the rotation is not observed [Crouch et al., 2006; Wang et 
al., 2008; Shrive et al., 2009; Goh et al., 2013; Clark et al., 2016].  This is particularly of 
interest because it is conserved in both subunits where muramyl disaccharide is bound, 
with the Asp325 accommodating the native position in subunit A where no ligand is bound. 
This suggests an active role in the recognition of the disaccharide despite not making any 
direct interactions with the GlcNAc or MurNAc beyond a water bridge to the acetyl side 
chain of GlcNAc.  It is worthy of note, however, that out of the many ligand-bound rfhSP-D 
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structures checked by model superposition, the water involved in the water bridge to 
GlcNAc only appears to be present in the muramyl disaccharide structure, suggesting that 
Asp325 may be rotating to fulfil this water interaction specifically for GlcNAc [Shrive et al., 
2003, 2009, Crouch et al., 2007, 2009; Wang et al., 2008; Clark et al., 2016].   
5.4.3 Longer peptidoglycan chain recognition 
 
Figure 5.7:  Simple model of a longer fragment of peptidoglycan.  Model of a longer fragment 
of peptidoglycan, produced by superposition of the fragment onto the crystal structure, 
demonstrates a longer peptidoglycan can be accommodated by the surface of rfhSP-D (cyan).  
The lactyl group of MurNAc is able of interacting directly with Asp325 whilst still allowing the 
oligopeptide to extend above the surface (two amino acids shown).  (star) oligosaccharide core 
extension; (*) position where remaining peptide extends.   
 
Peptidoglycan is naturally a long chain polymer of muramyl disaccharide linked by β(1→4) 
glycosidic bonds with tetra- or pentapeptides O-linked to the lactyl moiety of the N-acetyl-
muramic acid [Schleifer and Kandler, 1972].  Therefore, it is important to consider whether 
longer peptidoglycan chains could be accommodated by surfactant protein D.  Simple 
modelling by superposing a longer peptidoglycan fragment onto the muramyl disaccharide 
structure reveals that the polysaccharide backbone of the peptidoglycan extends away 
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from the surface of the carbohydrate recognition domain without making any further 
interactions with the protein [Figure 5.7].  Similarly, the oligopeptide extensions of the 
peptidoglycan can also be accommodated by the surface of hSP-D, as the peptide would 
extend above Asp325 and the rest of the protein based on the lactyl group position in the 
disaccharide-bound structure.  Moreover, if the lactyl group is able to directly interact 
physiologically with Asp325, as is proposed here, the position of the carboxyl group of the 
lactyl side chain would also permit the peptide extension without clashing with the CRD 
[Figure 5.7]. 
This model suggests that the shorter, soluble peptidoglycan and the longer, insoluble 
peptidoglycan could both be recognised by hSP-D if a GlcNAc residue is available at the 
non-reducing termini of the polymer.  The GlcNAc residue is clearly available in both types 
of peptidoglycan as MBP was shown to recognise GlcNAc in the soluble and insoluble 
fragments, with high affinity [Nadesalingam et al., 2005].  It is not clear from this structural 
study if the affinity for muramyl disaccharide reflects the high affinity binding observed for 
MBP, however it has previously been shown that the affinity between wildtype hSP-D and 
an insoluble peptidoglycan from S. aureus is lower than the affinity for lipoteichoic acid and 
can be completely blocked by 10 mM maltose, mannose or glucose, suggesting that the 
interaction may be quite weak [van de Wetering et al., 2001].  This is not surprising as hSP-
D has been shown to have a relatively low affinity for GlcNAc, compared to its preferred 
ligand maltose, with an IC50 of between 9.8 mM and 14 mM being reported [Crouch et al., 
2005; Crouch et al., 2006].  The model of the longer peptidoglycan fragment may also go 
some way to explaining the lower affinity, as the peptide extensions may cause some steric 
clashes that cannot be directly observed since they were not included in the actual soaked 
ligand used here.  Conversely, the peptide extensions may increase the affinity of a single 
muramyl disaccharide unit by interacting with other parts of the protein.  However, for any 
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conclusion to be drawn, there is a considerable amount of further work required using 
longer, intact peptidoglycan from soluble and insoluble fragments. 
5.4.4 Implications for GlcNAc recognition 
Recognition of a terminal GlcNAc residue also extends the number of possible ligands and 
their binding modes that hSP-D can recognise, particularly gram-negative 
lipopolysaccharides and other glycosylated proteins.  It is well established that gram-
negative lipopolysaccharides (LPS) contain a range of conserved, LPS-specific 
monosaccharides such as the inner core heptose and 3-deoxy-D-manno-oct-2-ulosonic 
acid residues, but beyond this core motif there are a number of other monosaccharides 
that complete the inner and outer core of LPS, including N-acetylglucosamine [Rund et al., 
1999; Kabanov and Prokhorenko, 2010; Holst, 2016].  These include the LPS of most 
important pathogens such as Escherichia coli, which in some strains contain terminal 
GlcNAc residues in the outer core, and Neisseria meningitidis, where a GlcNAc is bound to 
HepI of the inner core polysaccharide [Michael et al., 2009; Holst, 2011].  In both of these 
examples, the two O3’ and O4’ hydroxyls are thought to be available and unsubstituted, 
making them good targets for hSP-D based on the data presented here. 
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Chapter 6:  Recognition of R7 rough mutant lipopolysaccharide 
from Salmonella enterica sv. Minnesota 
 
As part of the ongoing investigation of LPS/SP-D interactions the structures of rfhSP-D 
complexed with Salmonella enterica sv. Minnesota R5 and R7 polysaccharide (Sm-R5 and 
Sm-R7 respectively) have been revisited in order to resolve several unanswered questions 
and provide a definitive description of both the bound ligand and the interaction with hSP-
D [Smallcombe, 2014; da Silva, 2016].  The fully refined structure of the Sm-R5 complex has 
now been determined by other members of the Research Group and has been provided for 
comparison with the R5 structure whose re-analysis and full refinement is described 
here and in Appendix II which contains Littlejohn et al., 2018, " Structural definition of hSP-
D recognition of Salmonella enterica LPS inner core oligosaccharides reveals alternative 
binding modes for the same LPS.” 
 
6.1 Introduction to rough mutant Salmonella enterica 6.1.1 Gram-negative rough mutants 
Gram-negative bacteria are adorned with a range of glycosylated structures on their outer 
membrane, one of which is the highly immunogenic, lipopolysaccharide (LPS) [Kabanov and 
Prokhorenko, 2010].  There are two major forms of LPS, smooth LPS and rough LPS, which 
vary between species and strains.  Smooth LPS contain the inner core polysaccharide, outer 
core polysaccharide and the O-antigen, a long, repeating, antigen-specific oligosaccharide 
that extends from the surface of the bacteria [Erridge, Bennett-Guerrero and Poxton, 2002; 
Holst, 2011].  Rough LPS strains, on the other hand, lack the repeating O-antigen, leaving 
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the inner and outer core polysaccharides exposed to the immune system [Holst, 2016].  In 
many species, including S. enterica, the core polysaccharides are a conserved motif, 
providing a possible recognition site for the innate immune system and human surfactant 
protein D (hSP-D). 
6.1.2 Rough mutants of Salmonella enterica sv. Minnesota 
While the core polysaccharide is largely conserved in S. enetrica Minnesota, the extent of 
the core varies due to mutations in the synthetic enzymes responsible for assembling the 
LPS, resulting in truncated polysaccharide cores [Lüderitz, Staub and Westphal, 1966; 
Mansfield and Forsythe, 2001].  Synthesis of the LPS is sequential and, therefore, requires 
the correct arrangement of saccharide residues, including any phosphate substitutions, for 
the next monosaccharide to be added.  If there are any interruptions to this, the remaining 
polysaccharide is not attached and the LPS is expressed in its truncated form [Figure 6.1]. 
The R7 mutant of S. enterica Minnestoa is a deep rough mutant strain that lacks the outer 
core oligosaccharides of the Ra mutant and GlcI, GalI and HepIII of the Rb3 mutant, 
equivalent to the Rd1 mutant in Figure 6.1.  This leaves a short inner core of an α(1→3)-
linked diheptose linked to the α(2→4)-linked tri-Kdo through a single α(1→5) between 
HepI and KdoI.  Human SP-D has been shown to recognise both R7 and R5 mutants, Rd1 
and Rc phenotypes respectively, however how this recognition occurs, and by which 
monosaccharide residue, has not been elucidated. 
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Figure 6.1:  Graphical Schematic of the Core Polysaccharide from a Lipopolysaccharide of 
Salmonella enterica.  The figure summarises the core polysaccharide from a lipopolysaccharide 
of Salmonella enterica, including all glycosidic bond donors and acceptors (numbered 
according to the associated carbon atom) and the geometry of the bond (i.e. α).  The lines and 
colours (shades of blue) represent where different mutants of S. enterica extend to in the core 
polysaccharide (i.e. the Ra mutant includes the whole core polysaccharide and is represented by 
the palest blue).  Abbreviations:  Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid; Hep, heptose, Glc, 
glucose; Gal, galactose; GlcNAc, N-acetyl-glucosamine.  Figure based on data from:  [Mansfield 
and Forsythe, 2001] 
 
6.1.3 Recognition of inner core polysaccharides from lipopolysaccharides 
Recently, the structure of a rough mutant H. influenzae Eagan 4A was successfully 
crystallised in complex with a biologically and therapeutically active C-terminal fragment of 
hSP-D [Clark et al., 2016].  The LPS in this study contained three core monosaccharide 
residues: Kdo, heptose and a β-D-glucose linked by α(1→5) and β(1→3) glycosidic linkages, 
respectively.  Recognition occurred through calcium-dependent binding to the 
dihydroxyethyl side chain of the proximal heptose and identified an anhydrous form of Kdo 
which made a further hydrogen bond to the Asp325 side chain, completing the recognition 
of the core.  It is thought that the dominant anhydrous Kdo was a product of mild 
hydrolysis, which was required to cleave the lipid A portion of the LPS, forming an 
enantiomeric 5-membered furanoid derivative of the Kdo as a result of a β-elimination of a 
phosphate group. 
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Recognition of the inner core heptose by hSP-D has also been explored using synthetic LPS 
cores, which showed that the binding affinity for the cores containing a heptose was higher 
than those where a heptose was not available for recognition [Reinhardt et al., 2016].  This 
suggests that the heptose is a key residue for LPS recognition, supporting the findings of 
Clark and colleagues in the Eagan-bound structure [Clark et al., 2016].  The R7 rough strain 
of LPS allows for the fidelity of this proximal heptose recognition where more complex 
inner core LPS oligosaccharides are present that contain more than one heptose residue. 
To complete the characterisation of the R7 polysaccharide and the binding mechanism that 
hSP-D uses to recognise the inner core of rough mutants of S. enterica, the three 
dimensional structure of a biologically and therapeutically active fragment of the C-
terminal of hSP-D (rfhSP-D) in complex with a delipidated LPS from S. enterica Minnesota 
R7 mutant strain has been determined by x-ray crystallography.  The data presented here 
was originally collected by Dr. Carrie Smallcombe and Dr. Ruben da Silva, however the data 
was reprocessed from the raw diffraction images as significant questions remained about 
the interaction between hSP-D and the polysaccharides from Sm-R7 and Sm-R5 
[Smallcombe, 2014; da Silva, 2016]. 
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6.2 Materials and methods 6.2.1 Preparation of S. enterica Minnesota R7 oligosaccharide 
The delipidated R7 oligosaccharide portion of Salmonella enterica sv. Minnesota (Enzo 
Lifesceinces-ALX-581-018-L002) was prepared by a previous PhD student, under mild 
hydrolysis conditions with 2% acetic acid, following the method published by Masoud and 
co-workers and Clark et al. [Masoud et al., 1994; Smallcombe, 2014; Clark et al., 2016].  The 
molecular weight of the whole R7 LPS was calculated to be 2863 Da by the addition of all 
glycoconjugates and Lipid A.  The lipid A portion accounted for approximately 1800 Da, 
making up ≈63% of the total LPS [Que et al., 2000].  2 mg of R7 LPS were hydrolysed, 
yielding approximately 0.57 mg of the oligosaccharide which represents a hydrolysis 
efficiency of 77%.  The resulting R7 oligosaccharide was dissolved in deionised water to 
give a final KdoI-HepI-HepII (accounting for the β-elimination of the KdoII-KdoIII extension, 
see section 6.3.3) concentration of ≈18 mM stock that was used for crystal soaking and 
cryoprotection. 
6.2.2 Protein preparation 
The rfhSP-D was received from the Southampton group at a concentration of 8.8 mg ml-1 
in phosphate buffered saline (PBS), following purification by affinity chromatography.  An 
additional 10 mM CaCl2 was added to the protein before crystallisation to ensure the 
protein was calcium-bound and able to bind the R7 ligand. 
6.2.3 R7 Oligosaccharide soaking of native hSP-D crystals 
The delipidated R7 oligosaccharide was soaked into native rfhSP-D crystals grown in a 
sitting drop (see section 3.3.2).  A final concentration of ≈13 mM of the KdoI-HepI-HepII 
portion of the oligosaccharide was achieved in the drop following an exchange of the drop 
volume, 6 μl, with 6 μl of cryoprotection buffer.  Flash cryocooling to 100 K was completed 
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following cryoprotection with consecutive additions of 5%-15% 2-methyl-2,4-pentandiol 
(MPD), diluted with the well conditions, in 2 μl aliquots.  The well conditions are detailed in 
table 6.1.  Crystals were soaked with the R7 oligosaccharide for six minutes before 
cryocooling to allow the ligand to saturate the crystal. 
Table 6.1:  Table of Well Conditions for Crystal CCS16A11 
CCS16A11  16% Polyethylene Glycol 10 000 
0.1 M Tris pH 7.0 
10 mM CaCl2 
 
6.2.4 Data collection 
Data for the rfhSP-D in complex with R7 oligosaccharide were collected at 100K at 
Diamond Light Source, Oxfordshire, on macromolecular crystallography beamline I03, using 
the Dectris Pilatus 6M hybrid photon counting detector.  A single, high resolution dataset 
was collected from crystal CCS16A11 which was processed following the protocol outlined 
in section 3.4.2.  
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6.3 Results 6.3.1 Data processing 
The high resolution dataset collected from the crystal CCS16A11, soaked with the 
delipidated R7 oligosaccharide, has been reprocessed following recent results in the 
research group [Smallcombe, 2014].  The diffraction images were indexed in monoclinic 
primitive spacegroup P21 using MOSFLM [Leslie, 2006; Battye et al., 2011].  This is in 
agreement with the previously solved native structure of the same recombinant fragment 
of hSP-D used in these studies [Shrive et al., 2003].  The final unit cell was refined to: 
a = 55.33Å    b = 108.14Å     c = 55.67Å 
α = γ = 90°     β = 91.82° 
Pointless confirmed the spacegroup during the Pointless-Aimless pipeline and was used to 
scale the integrated data, distributed as part of the CCP4 suite of programs for 
macromolecular structure solution [Evans, 2006; Winn et al., 2011; Evans and Murshudov, 
2013].  Scaling and merging the data at a maximum resolution of 1.75Å generated an Rmerge 
of 35.9% in the highest resolution bin (6.6% overall); an I/σ(I) of 7.3 overall and 2.2 in the 
outer bin; CC½ of 0.991 overall and 0.774 in the outer bin.  Structure factors were 
generated using Truncate and the twinning was assessed using cumulative frequency 
distribution and L-test statistics.  The data was not twinned and was taken forward for 
further refinement. 
The structure was successfully solved using the rigid-body refinement function in REFMAC5 
using the native structure of hSP-D, solved to 1.6Å with the calcium ions and solvent 
molecules removed [1PW9, Shrive et al., 2003; Murshudov et al., 2011].  The resulting 
electron density maps were assessed, using the native structure of hSP-D for orientation, to 
identify if there was density for the ligand in the binding pocket.  The density for the ligand 
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was present in subunits B and C so the dataset was selected for further restrained 
refinement and model building. 
6.3.2 Initial map generation and density assessment 
The initial maps for the R7 oligosaccharide-bound complex were generated using the rigid-
body refinement function of REFMAC5 using the native structure of the same recombinant 
fragment of hSP-D used in this study with all calcium ions and water molecules removed, 
leaving only the protein backbone and sidechains to prevent any bias in the final map 
[1PW9, Shrive et al., 2003].  The resulting weighted maps (equivalent to the 2Fobs-Fcalc and 
Fobs-Fcalc maps) were displayed, with the solved protein structure as a template, in Coot for 
density assessment and ligand fitting [Emsley and Cowtan, 2004; Emsley et al., 2010]. 
The rigid-body map for each carbohydrate binding site, prior to any refinement, is shown in 
Figure 6.2 with the rigid-body template displayed to allow for orientation.  The calcium ions 
in all three binding sites are clearly visible in the electron density from both maps, 2Fo-Fc 
(blue) and Fo-Fc (green), in a similar position to the native rfhSP-D structure.  There is also 
good resolution of the remaining two calcium ions in the CRD which also appear to occupy 
the same positions as the native.  There was no density for the calcium, Ca4, in the neck 
domain that has previously been present in the native and other bound structures of rfhSP-
D [Shrive et al., 2003, 2009]. 
In subunits B and C, there is evidence for a non-terminal heptose coordinating the calcium 
in the main binding pocket (Ca1) with good electron density for the heptose in the 
difference map of both subunits (green, Figure 6.2).  There is further density in the 
observed map (blue) for the two additional monosaccharides that make up the R7-
oligosaccharide.  The density for the second heptose (HepII) is less well defined than the 
calcium coordinating heptose but the main ring has good definition in the electron density 
Chapter 6  Results 
180 | P a g e  
 
with some density extending in the direction of the hydroxylethyl side chain (C6’ and C7’).  
There is also evidence for the Kdo in the density of both subunits, extending between the 
two flanking residues, Asp325 and Arg343.  From the density, the Kdo appears to be in an 
anhydrous furanose form, with some density extending in the direct of the 2-oxobutanoic 
acid.  In both subunits, the difference map supports the occupancy of all three 
monosaccharides that make up the R7 oligosaccharide.  There was no clear density for any 
ligand bound into subunit A. 
Electron density extends across the protein backbone from residue 205 in subunits A and C, 
with extra density for residue 204 being present in subunit B.  At the N-terminal, the side 
chains are less well defined than the highly ordered side chains associated with the lectin 
fold of the CRD.  The remaining N-terminal of the recombinant fragment (residues 179 – 
204/3/4) is not defined in the electron density and cannot be determined in the structure. 
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Figure 6.2:  Rigid-body electron density maps for the Salmonella enterica R7-oligosaccharide in complex with rfhSP-D.  The observed electron density map 
is displayed at 1.0σ (2Fobs-Fcalc, blue) and difference map at ±3.0σ (Fobs-Fcalc, green (+) and red (-)) from the rigid body solution.  The template structure is 
displayed to allow for orientation of the binding site.  The electron density shows that subunit A does not have any ligand in the binding site whereas there 
is clearly electron density for the Salmonella enterica R7 oligosaccharide in the calcium (Ca1) binding site. 
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6.3.3 Ligand characterisation 
The electron density for the R7 oligosaccharide clearly defines the KdoI-HepI-HepII [Figure 
6.3] and the Kdo is in the anhydrous form first reported by Clark and coworkers in the H. 
influenzae Eagan 4A bound rfhSP-D structure [Clark et al., 2016].  However, more detail of 
the 5-membered anhydro-Kdo ring substituents are present in the R7 oligosaccharide, with 
definition of the 2-oxobutanoic acid sidechain at C4 in a beta conformation, with respect to 
the glycosidic bond [Figure 6.4].  The anhydro-Kdo is indicative of a β-elimination of the 
KdoII-KdoIII which, as would be expected, is not present in the electron density at position 
4 of the Kdo as the hydroxyl group is now involved in completing the furanose ring. 
Both heptose residues (HepI and HepII) are in their α-anomer, as you would expect for the 
R7 oligosaccharide core.  The anhydro-Kdo is in its β-form, where the 2-oxobutanoic acid 
side chain extends from the main 5-membered ring equatorially, following the plane of the 
ring.  This suggests the β-form predominates the α-form following β-elimination of the 
KdoII-KdoIII fragment. 
 
 
Figure 6.3: Structure of the R7 Oligosaccharide Product of Mild Acid Hydrolysis.  Mild hydrolysis 
of the R7 LPS removes the lipid A and KdoI-KdoII, leaving the product with an *anhydro-Kdo.  
Hep, L-D-heptose; KdoI*, 4,7-anhydro-3-deoxy-D-manno-oct-2-ulosonic acid furanose. 
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Figure 6.4:  Structure and Numbering of the 4,7-anhydro-3-deoxy-D-manno-oct-2-ulosonic acid 
Furanoid Derivative.  Numbering is retained from the KD5 structure associated with PDB entry 
4E52 [Clark et al., 2016]. 
 6.3.4 Final structures and binding mechanisms 
Restrained refinement was completed in rounds following protein backbone and side chain 
corrections, addition of HepI, HepII and anhydro-Kdo, and addition of solvent molecules; 
with up to 10 cycles of maximum-likelihood phase refinement in each round.  Additional 
rounds were completed following any further changes to the structure, and the final R 
factors were calculated [table 6.2]. 
The overall structure of the rfhSP-D and R7 oligosaccharide complex is a homotrimer of 
three identical subunits, A, B and C, which contain residues 205-355, 204-355 and 205-355, 
respectively, of the α-coiled coil neck domain and the complete carbohydrate recognition 
domain at the C-terminus [Figure 6.5].  The remaining N-terminal residues (179-204 in 
subunits A and C, 179-203 in subunit B) are disordered.  All three subunits of the rfhSP-D 
contain three calcium ions (Ca1, Ca2 and Ca3) in the CRD but there is no calcium (Ca4) 
present in the neck domain [Shrive et al., 2003].  The structure reveals that the 
oligosaccharide ligand is bound in subunit B and C but is not present in subunit A due to 
the constraints of crystal contacts [Figure 6.5].   
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Figure 6.5:  Overall structure of rfhSP-D in complex with Salmonella enterica Minnesota R7 
polysaccharide.  The overall orientation of Salmonella enterica Minnesota R7 polysaccharide 
(green) in the ligand binding sites of subunits B (yellow) and C (cyan).  Figure shows the ligand 
extending away from the surface of the CRD of each subunit where it is bound.  Calcium ions 
are represented in yellow and Ca1 coordinating water molecules in blue.  Subunit A is 
represented in red. 
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Table 6.2: Data Collection and Processing Statistics for CCS16A11 
 R7 Oligosaccharide 
Data collection  
Wavelength (Å) 0.97625 
Temperature (K) 100 
Space group P21 
Cell Dimensions  
     a (Å) 55.33 
     b (Å) 108.14 
     c (Å) 55.67 
     β (°) 91.82 
Maximal resolution (Å) 1.75 
Resolution Range (Å) 55.3 – 1.75 (1.78 - 1.75) 
Observations 143 142 (7 653) 
Unique reflections 61 250 (3 299) 
Completeness (%) 93.2 (91.2) 
Rmergea 0.066 (0.359) 
I/σ(I) 7.3 (2.2) 
CC½ 0.991 (0.774) 
  
Refinement  
Protein atomsb 3483 
     Residues, subunit A 205 – 355 
     Residues, subunit B 204 – 355 
     Residues, subunit C 205 - 355 
Other atoms  
Calcium ions 9 
Ligand A = 0, B = 3, C=3 
Water 479 
Resolution range (Å) 55.3 – 1.75 
Rworkc 17.3 
Rfreed 19.6 
Average B-values (Å2)  
     Protein main chain 23.1 
     Heteroatoms 31.1 
     Water 34.2 
Ramachandron plot valuese 
(%)  
Favoured 97.8 
Allowed 2.2 
Disallowed 0 
aRmerge= ΣhΣj|Ih,j-Ih| / ΣbΣj|Ih,j|, where Ih,j is the jth observation of 
reflection h and Ih is the mean of j for reflection h 
bTotal number of protein atoms used in refinement 
cRwork= Σh||Foh|-|Fch|| / Σh|Foh|, where Foh and Fch are the 
observed and calculated structure factor amplitudes, 
respectively, for reflection h. 
dRfree= Rwork but for a random 5% subset of reflections 
edefined by MolProbity analysis 
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Table 6.3: Coordination distances to calcium and R7 Oligosaccharide from S. enterica Minnesota 
in the ligand-bound recombinant fragment of human surfactant protein D 
 R7 
Oligosaccharide 
  R7 
Oligosaccharide 
Atom 1 Atom 2 A B C  Atom 1 Atom 2 A B C 
Ca1 Glu321 
OE1 
2.65 2.60 2.64  Ca2 Asp297 
OD1 
2.67 2.62 2.70 
Asn323 
OD1 
2.49 2.44 2.38   Asp297 
OD2 
2.44 2.40 2.45 
Glu329 
OE1 
2.51 2.41 2.34   Glu301 
OE1 
2.51 2.57 2.53 
Asn341 
OD1 
2.37 2.43 2.44   Glu301 
OE2 
2.53 2.58 2.52 
Asp342 
OD1 
2.35 2.34 2.28   Asp324 
OD1 
2.43 2.60 2.64 
Asp342 
O 
2.54 2.52 2.51   Glu329 
O 
2.50 2.32 2.37 
HepI 
 O6’ / W 
- 2.36 2.37   Asp330 
OD1 
2.34 2.39 2.39 
HepI 
O7’ / W 
- 2.35 2.34   W 
 
2.36 2.31 2.32 
HepI  
O6’ / W 
Glu321 
OE2 
- 2.64 2.52  Ca3 Glu301 
OE1 
2.30 2.43 2.32 
 Asn323 
ND2 
- 3.03 2.93   Asp330 
OD1 
2.50 2.50 2.55 
HepI  
O7’ / W 
Glu329 
OE2 
- 2.64 2.57   Asp330 
OD2 
2.43 2.45 2.45 
 Asn341 
ND2 
- 2.94 3.07   W 2.23 2.26 2.17 
KdoI 
O1’ 
Arg343 
NH2 
- 3.46 3.51   W 2.35 2.33 2.31 
KdoI 
O2’ 
Arg343 
NH1 
- 3.10 3.07   W 2.34 2.38 2.33 
KdoI 
O6’ 
Asp325 
OD2 
- 2.76 2.69   W 2.38 2.42 2.34 
All numbers quoted in Å.  Abbreviations: Hep, L-D-manno-heptose; Kdo, furanoid derivative 
4,7-anhydro-3-deoxy-D-manno-oct-2-ulosonic acid (anhydro-Kdo).  W represents waters in 
key binding positions. 
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Recognition of the R7 oligosaccharide occurred in a calcium dependent interaction 
between Ca1 and the hydroxyethyl side chain of HepI, coordinated by O6’ and O7’ that are 
positioned in a similar position to other carbohydrate-bound structures of rfhSP-D 
fragments.  In subunits B and C, the calcium coordination distances to O6’ are 2.36Å and 
2.37Å, respectively, and 2.35Å and 2.34Å to O7’ (table 6.3).  Recognition in the primary 
binding pocket is completed by the usual amino acid side chains first identified in the 
rfhSP-D-maltose complex: Glu321 and Asn323 coordinate with O6’ through hydrogen 
bonds (2.64Å and 3.03Å, respectively in subunit B; 2.52Å and 2.93Å in subunit C); and 
Glu329 and Asn341 (2.64Å and 2.94Å in subunit B; 2.57Å and 3.07Å in subunit C) [Shrive et 
al., 2003].  These four side chains also coordinate the calcium, Ca1, that coordinates the 
ligand through interactions that range between 2.34Å and 2.64Å in each subunit, with 
Asp342 completing the calcium coordination through two coordinating atoms, one in the 
side chain (2.34Å in B, 2.28Å in C) and the other in the main chain carbonyl (2.52Å in B, 
2.51Å in C).  Ca1 coordination is completed in a similar manner in subunit A (table 6.3).   
Recognition of the R7 oligosaccharide is completed by a series of hydrogen bond mediated 
interactions with the flanking residues of the Ca1 binding pocket, mainly with the anhydro-
Kdo residue [Figure 6.6, 6.7].  The main ring hydroxyl, O6’, directly interacts with the side 
chain of Asp325 through a single hydrogen bond at a distance of 2.76Å in subunit B and 
2.69Å in subunit C.  This does not disrupt the critical crystal contact between Asp325 and 
the symmetry related molecule.  The final direct contacts with the protein are between the 
2-oxobutanoic acid side chain at position 4 of the anhydro-Kdo, which interacts with the 
flexible side chain of Arg343 in both side chains, through hydrogen bonds to the O2’ α-
keto group [Figure 6.6, 6.7] at a distance of 3.10Å in subunit B and 3.07Å in subunit C.  
There are also additional weak interactions with O1 of the Kdo side chain which are 3.46Å 
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and 3.51Å in length, in subunits B and C respectively.  These stabilise the side chain in the 
crystal, making them observable in the electron density. 
The second heptose residue (HepII) does not make any direct contacts with the protein, 
allowing to take up two different orientations in the two subunits where it is bound.  In 
subunit B, a single water bridge mediates an interaction between O7’ of HepII and O2’ of 
HepI, which goes on to hydrogen bond to the ND2 group of Asn323 (3.15Å).  The only 
other major interaction of HepII in the crystal is a water mediated interaction between O6’ 
and the amide group of Ser239C.  In subunit C, the position of the main heptose ring is 
rotated approximately 45° around the α(1→3) linkage in relation to HepII in subunit B, 
moving HepII away from the surface of the protein and allowing it to interact directly with 
the symmetry related molecule of rfhSP-D [Figure 6.7].  O6’ and O7’ make direct 
interactions with the main chain carbonyl (3.01Å) and the amide linkage (2.99Å) of Gly241A, 
respectively, in the crystal contact.  The interaction of HepII with the symmetry related 
molecule is completed by a water molecule network to Lys229A. 
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Figure 6.6:  Stereo view of calcium coordination in subunit B of the Salmonella enterica R7 oligosaccharide-bound rfhSP-D.  Ligand recognition occurs 
through O6' and O7' hydroxyls of the proximal heptose (HepI) coordinating the calcium ion (Ca1, yellow).  Recognition of HepI is completed by 
interactions with Glu321, Asn323, Glu329 and Asn341.  The anhydro-kdo (KdoI) interacts with both flanking residues, Asp325 and Arg343.  HepII interacts 
with the symmetry related molecule. 
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Figure 6.7:  Stereo view of calcium coordination in subunit C of the Salmonella enterica R7 oligosaccharide-bound rfhSP-D complex.  Ligand recognition 
occurs through O6' and O7' hydroxyls of the proximal heptose (HepI) coordinating the calcium ion (Ca1, yellow).  Recognition of HepI is completed by 
interactions with Glu321, Asn323, Glu329 and Asn341.  The anhydro-kdo (KdoI) interacts with both flanking residues, Asp325 and Arg343.  HepII interacts 
with the symmetry related molecule.  Note the change in rotation of HepII compared to HepII in Figure 6.6. 
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6.4 Discussion 6.4.1 Comparison of the R5 and R7 mutants of S. enterica Minnesota 
As a way of comparing more complex inner core polysaccharides from LPS, the delipidated 
inner core polysaccharide of the R5 mutant of S. enterica sv. Minnesota, equivalent to the 
Rc mutant, has also been successfully crystallised in complex with the same biologically 
active recombinant fragment of hSP-D by a former PhD student in the research group at a 
resolution of 1.65Å [da Silva, 2016; Littlejohn et al., 2018].  This was used for comparison 
and elucidation of the wider recognition mechanism of S. enterica sv. Minnesota LPS.  The 
R5 mutant contains an additional α(1→3)-linked α-D-glucose at position 3 of HepII 
compared to the R7 mutant but is otherwise identical, including the formation of the 
furanoid anhydro-Kdo seen in the R7 complex and the previously published H. influenzae 
Eagan 4A complex [Figure 6.8; Clark et al., 2016]. 
 
 
 
Figure 6.8:  Structure of the R5 and R7 Oligosaccharide Products from Mild Hydrolysis.  Mild 
hydrolysis of the R5 LPS removes the lipid A and KdoI-KdoII, leaving the product with an 
*anhydro-Kdo.  Hep, L-D-heptose; KdoI*, furanoid 4,7-anhydro-3-deoxy-D-manno-oct-2-
ulosonic acid. 
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6.4.2 Recognition of the Hep-Kdo motif 
The high resolution structures of the oligosaccharide portions of LPS from deep rough 
mutants of S. enterica Minnesota R7 and R5 in complex with a recombinant fragment of 
hSP-D reveal that hSP-D targets the proximal inner core Hep-Kdo motif, through calcium-
dependent recognition of the non-terminal heptose residue.  This initial binding via Ca1 is 
supplemented by interactions between heptose and Kdo with the two flanking residues, 
Arg343 and Asp325, revealing for the first time the 2-oxobutanoic acid side chain of an 
anhydro-form of Kdo is able to interact extensively with the side chain of Arg343; providing 
further detail of the anhydro-Kdo itself, which was not fully defined in the H. influenzae 
Eagan 4A complex [Clark et al., 2016].   
The structure presented here confirms the 5-membered furanoid derived structure of the 
previously reported anhydro-Kdo with more details of the long 2-oxobutanoic side chain 
extending from carbon 4 [Figure 6.6, 6.7; Clark et al., 2016].  This provides the first direct 
confirmation that removal of the lipid A from intact LPS, using mild hydrolysis, is 
accompanied by an elimination of the α(2→4)-linked KdoII-KdoIII moiety from carbon 4 of 
KdoI, in a manner equivalent to the β-elimination of the phosphate in the Eagan 4A-bound 
structure [Clark et al., 2016].  The 2-oxobutanoic acid side chain is also present in the R5-
bound structure, superposing very closely with the anhydro-Kdo in the R7-bound structure, 
confirming that the anhydro-Kdo is present in the β-anomer in both structures.  It is unclear 
whether this is due to  rfhSP-D having selectivity for the β-anomer, or whether it is a 
product of the elimination of the KdoII-KdoIII pair that restricts the newly formed anhydro-
Kdo to the β-conformation rather than producing a racemic mixture of α and β anomers 
[Auzanneau, Charon and Szabó, 1991]. 
In subunit B and C of the R7- and the R5-bound structures, recognition of the proximal 
heptose (HepI) is calcium dependent, coordinating the O6’ and O7’ hydroxyls of the 
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hydroxyethyl side chain, with the remaining recognition occurring through further 
interactions of these two hydroxyls with the side chains of Glu321, Asn323, Glu329 and 
Asn341 (2.34Å to 3.38Å).  Recognition of the inner core is completed through the anhydro-
Kdo, which extends between the two flanking residues, Asp325 and Arg343, which directly 
bind to the furanose ring hydroxyl, O6’, and the α-keto/carboxylic acid group of the C4 side 
chain (O2’ and O1’, Figure 6.6, 6.7, 6.9).   
Superposition of all the HepI coordinating subunits, including those from the H. influenzae 
Eagan 4A structures reveal an essentially conserved position for both the furanose Kdo ring 
and the pyranose ring of HepI, including the acidic side chain present in the two 
Salmonella-bound structures.  The conserved topology of the Hep-Kdo (anhydro) results in 
conservation of the Asp325 – O6’ (anhydro-Kdo) interaction across the three structures, 
with only a small variation between the three oligosaccharides (2.56 – 2.76Å).  However, this 
is not the case for the Arg343 – Kdo (anhydro) interaction.  There are large variations in the 
length of the interactions between the carboxylic acid O1’ and the NH2 of Arg343, ranging 
from strong hydrogen bonds (2.87Å) in the subunit C of the R5-bound structure, to long 
range weak interactions (>3.5Å) in subunit C of R7 [Appendix II; Clark et al., 2016; Littlejohn 
et al., 2017].  This suggests that there is an inherent flexibility in the Arg343 – Kdo 
interaction.  It is well documented that Arg343 is able to change the conformation of its 
side chain in response to different ligands, allowing it to influence ligand selection and 
recognition [Allen et al., 2004; Shrive et al., 2009].  There also appears to be some 
conformational variability in the acidic side chain of the anhydro-Kdo which may explain 
why there is very little electron density for the long, acidic side chain in the H. influenzae 
Eagan 4A complex, with the exception of a small amount of density at the terminus of the 
side chain that was tentatively identified as an oxygen [Clark et al., 2016].  In combination, 
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the structural evidence does suggest that the Arg343 – ligand interaction is a flexible 
determinant of specificity. 
 
Figure 6.9:  Calcium coordination in subunit C of the Salmonella enterica sv. Minnesota R5 
oligosaccharide in complex with rfhSP-D.  Calcium (Ca1, yellow) us coordinated by the O6’ and 
O7’ hydroxyls of the proximal heptose (HepI).  Recognition is completed by Glu321, Asn323, 
Glu329 and Asn341.  Additional recognition occurs through interactions with the anhydro-Kdo 
(KdoI) from the two flanking residues, Asp325 and Arg343.  Figure adapted from [Littlejohn et 
al., 2017] 
 6.4.3 Flexibility and versatility of ligand recognition 
The major difference between the rfhSP-D complexes with R7 and R5 oligosaccharides is 
the presence of the ligand in subunit A.  In the R7-bound complex, there is no ligand in 
subunit A.  Instead, the calcium ion in the main binding pocket (Ca1) is coordinated by two 
water molecules which reflects the high resolution native structure [Shrive et al., 2003].  
However, in subunit A of the R5-bound structure, the extended R5 oligosaccharide (GlcI-
HepII-HepI-Kdo(anhydro)) allows Ca1 to recognise and bind to the terminal glucose 
residue in a calcium dependent recognition of the O3’ and O4’ hydroxyl groups, allowing 
the remaining oligosaccharide to extend along the intermolecular solvent channel, over 
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Arg343 and towards the side chain of Arg349 in a direction approximately orthogonal to 
the HepI-bound subunits.  Interestingly, the role of Arg343 remains fundamental to 
recognising the R5 oligosaccharide [Figure 6.10], despite the completely different position 
of HepI, with respect to the protein structure. The side chain of Arg343 forms the only 
direct contact with oligosaccharide outside of the main binding pocket, through a single 
hydrogen bond between NH2 and O4’ of HepI which may be evidence of Arg343 directly 
contributing to directing the glucose in to the calcium binding site [Crouch et al., 2009; 
Shrive et al., 2009].   
It appears that the crystal packing is largely responsible for precluding the recognition of 
the inner core proximal heptose, providing an explanation for the lack of R7-
oligosaccharide in the binding site of subunit A, but it is fortuitous as it clearly 
demonstrates that the same LPS can be recognised by hSP-D using alternative recognition 
strategies and, importantly, shows that hSP-D is able to recognise more than just the inner 
core heptose and Kdo residues in natural LPS ligands.  This potentially provides some 
explanation for the extraordinary ability of hSP-D to recognise such a variety of Gram-
negative bacteria by utilising the Ca1-dependent binding of more than just the inner core 
heptose and extends the recognition to multiple saccharide residues in the LPS [Wang et 
al., 2008; Clark et al., 2016].  This also demonstrates a versatility of recognition in the 
carbohydrate recognition domain, providing evidence that hSP-D is able to target more 
than one saccharide in vivo, allowing it to target the variety of different carbohydrate 
residues on the surface of bacteria. 
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Figure 6.10:  Calcium coordination in subunit A of the Salmonella enterica sv Minnesota R5 
oligosaccharide in complex with rfhSP-D.  Calcium (Ca1, yellow) is coordinated by the O3’ and 
O4’ hydroxyls of the terminal glucose (GlcI).  Recognition of GlcI is completed by Glu321, 
Asn323, Glu329 and Asn341.  Arg343 plays a pivotal role in completing the recognition by 
interacting with HepI.  Figure adapted from [Littlejohn et al., 2017] 
 6.4.4 Accommodation of the full R5 inner core polysaccharide 
Human SP-D is known to recognise and bind to the LPS molecules from S. enterica 
Minnesota deep rough mutants R5 and R7 [Kuan, Rust and Crouch, 1992].  To explore how 
the whole inner core may be accommodated by hSP-D, a simple overlay of the full R5 
oligosaccharide, including the KdoI-KdoII pair and an intact KdoI, onto the Hep-Kdo 
(anhydro) unit of the R5 oligosaccharide in complex with the rfhSP-D was carried out.  The 
intact 6-membered KdoI ring was easily positioned between the two flanking residues 
Asp325 and Arg343 revealing that the ring may be orientated to interact with either 
flanking residue.  A rotation through the α(1→5) glycosidic bond allows the dihydroxyethyl 
side chain of KdoI (O7’ and O8’) to rotate between the two side chains and interact with 
both side chains; based on the position of the α(1→5) glycosidic bond in the R7- and R5-
bound crystal structures [Figure 6.11].  In the position in this simple model, O7’ interacts 
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with the side chain of Asp325, allowing the remaining KdoII-KdoIII chain to be easily 
accommodated by the flexible Arg343 side chain.  The KdoII-KdoIII pair extends across the 
surface of the CRD and can be readily placed in the proximity of Glu349 and the conserved 
side chains of Arg349 and Glu333, which are present in both hSP-A and SP-D [Figure 6.11].  
Importantly, 2’OH of KdoI is positioned to allow the large lipid A moiety to exit the CRD, 
extending out of the CRD and into space.   
 
Figure 6.11:  Model of the complete Salmonella enterica R5 oligosaccharide bound to rfhSP-D 
with the inner core HepI in the calcium binding site.  KdoI (intact) is positioned to interact with 
Arg325, with KdoII and KdoIII interacting with Arg343 and Glu347 respectively.  The star 
indicates the position of O2’ where the lipid A moiety would be attached. 
 
The model also suggests that longer S. enterica mutants with more extensive 
polysaccharide cores, including those from the Rb mutant which is known to be recognised 
by hSP-D, could be accommodated by the protein surface [Kuan, Rust and Crouch, 1992].  
In these longer inner cores, positions 7 and 4 of HepII are phosphorylated and GlcI has 
galactose substitutions [GalI and GalII, Figure 6.1] at positions 1 and 3, which in this model 
would all extend away from the CRD [Mansfield and Forsythe, 2001].  This strongly suggests 
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that the Hep-Kdo motif present in the R7- and R5-bound structures can be recognised in 
other longer LPS ligands from other species that hSP-D, and the recombinant fragment 
used in this study, are able to recognise.  This includes important pathogens such as 
Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae, with the potential 
for increased recognition of the multiple Kdo structures known to be present in their LPS 
cores [Lim et al., 1994; Olsthoorn, Haverkamp and Thomas-Oates, 1999; Holst, 2011].   
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Chapter 7: General discussion and future work 
7.1 General discussion 
The work presented in this thesis provides new insights into how human surfactant protein 
D is capable of recognising a variety of carbohydrate ligands commonly found on the 
surfaces of a number of pathogens.  Surfactant protein D is a member of the highly 
conserved family of C-type lectins, the collectins, that have been identified in 
phylogenetically ancient species including tunicates that share a highly conserved 
carbohydrate recognition domain, usually at their C-terminus [Veldhuizen, Van Eijk and 
Haagsman, 2011; Drickamer and Taylor, 2015].  The carbohydrate recognition domain is 
linked at the N-terminus to an α-coiled coil neck domain which leads to a long, mostly 
flexible collagen-like domain and the N-terminal cysteine-rich domain [Epstein et al., 1996; 
Lu et al., 2002].  The CRDs of the collectins have been shown to have an up to 70% 
conserved sequence identity with differences in the side chains surrounding the calcium 
binding pocket almost completely conserved. changing the carbohydrate specificity of the 
collectin.  
7.1.1 Identification of a new recognition mechanism for β-D-glucoses 
Human SP-D has a high affinity for α(1→4)-linked maltose whereas MBP and hSP-A prefer 
acetylated amino sugars, N-acetylglucosamine and N-acetylmannosamine, respectively 
[Haagsman et al., 1987; Haurum et al., 1993; Crouch et al., 2005].  Interestingly though, 
Allen and colleagues (2001) demonstrated that hSP-D is also able to recognise β-D-glucose 
ligands with relatively high affinity compared to α-D-glucose ligands of a similar size [Allen 
et al., 2001].  β-D-glucose chains are common on the cell surface of a broad range of 
pathogens that hSP-D is known to recognise, including the pathogenic fungus Aspergillus 
fumigatus which is the causative agent in the pulmonary infection aspergillosis [Allen, 
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Voelker and Mason, 2001].  They also form an important part of the cell wall of allergenic 
particles, such as pollen and dust mite allergen, which hSP-D has been suggested to 
recognise and play a functional role in controlling the response [Wang et al., 1996, 1998; 
Ferguson et al., 1998; Schneider et al., 2016].  Alternative glycosidic linkages, for example 
α(1→6) glycosidic linkages, are also common features of the microbial extracellular space in 
biofilms that are exposed to the immune system and, therefore, a potential target for the 
innate immune system.  For the first time, small oligosaccharides (cellotriose, β(1→4)-
linked; isomaltotriose, α(1→6)-linked; laminaritriose, β(1→3)-linked) containing these 
common alternative anomers of glucose and isomeric chains have been complexed with a 
recombinant fragment of hSP-D and the recognition mechanism fully described at the 
atomic level.  Maltotetraose and maltoheptaose (α(1→4)) were also solved for comparison 
to longer α-glucooligosaccharides [Shaw, 2009]. 
In the cellotriose/rfhSP-D complex and the maltoheptaose/rfhSP-D complex, where the 
non-reducing terminal glucose coordinates to Ca1 (all three subunits in cellotriose-bound 
and subunit A of the maltoheptaose complex), recognition occurs through the equatorial 
hydroxyls O3’ and O4’ in a comparable position to the well-documented recognition 
mechanism for a wide range of mono-, di- and trisaccharides [Shrive et al., 2003, 2009; 
Crouch, McDonald, et al., 2006; Shaw, 2009; Goh et al., 2013].  However, where the reducing 
terminal glucose is coordinated by Ca1, or O3’ is unavailable for binding, coordination 
occurs through O1’ and O2’ in a similar mechanism to galactose recognition [Shrive et al., 
2009].  This is possible because the β-anomeric conformation of glucose presents the O1’ 
and O2’ hydroxyls in position analogous to the O3’ and O4’ hydroxyls that are usually 
recognised in maltooligosaccharides.  Interestingly, one of the small α-
glucooligosaccharides, isomaltotriose, was recognised by the novel O1’/O2’ mechanism 
providing the first direct evidence of the isomerism of glucose polysaccharides following 
Chapter 7  General Discussion 
201 | P a g e  
 
chemical degradation.  However, why the β-anomer is selected for over the O3’ and O4’ 
hydroxyls, available on both of the other two glucose residues in isomaltotriose, is unclear.  
This is especially intriguing considering that cellotriose is recognised by the O3’/O4’ 
hydroxyls despite O1’ and O2’ being available in the reducing terminal; unless the same 
isomerism seen in isomaltotriose produces an α-D-glucose following degradation during 
cellotriose production, removing the availability of the O1’ and O2’ hydroxyls. 
7.1.2 Recognition mechanism of muramyl disaccharide is via N-acetylglucosamine 
The major component of the Gram-positive cell wall, peptidoglycan, has also been shown 
to be bound by surfactant protein D in both its insoluble form, found in the cell wall, and its 
soluble form which is shed from the surface of gram-positive, and to a lesser extent gram-
negative, bacteria [Schleifer and Kandler, 1972; Bertsche et al., 2015].  Peptidoglycan is 
composed of repeating units of muramyl disaccharide, an N-acetylglucosamine β(1→4)-
linked to an N-acetylmuramic acid unit, and tetra- or pentapeptides extending in an 
orthogonal direction to the polysaccharide core.  The oligopeptides crosslink with each 
other through a mixture of direct interactions between polar groups, such as lysine, and 
polyalanine bridging peptides, forming an elastic but strong layer that can resist changes to 
turgor pressure in the cell with either 3-fold or 4-fold screw-axes around the 
polysaccharide cores [Vollmer, Blanot and De Pedro, 2008; de Pedro and Cava, 2015].   
The length of the polysaccharide core is dependent on the number of muramyl 
disaccharide repeats and varies across species depending on the direction of the growth in 
the cell wall.  Some of the peptidoglycan potentially presents itself to the immune system 
inside the cell wall, whilst the soluble form of peptidoglycan is exposed to the immune 
system when it is released from the cell wall, stimulating an immune response.  How hSP-D 
recognises either the insoluble form or the soluble forms of peptidoglycan has not 
previously been characterised at the atomic level, but the work presented here provides the 
Chapter 7  General Discussion 
202 | P a g e  
 
first insight into how the muramyl disaccharide repeating unit is recognised by the CRD of 
a recombinant fragment of hSP-D that is therapeutically and biologically active. 
Recognition occurs via the N-acetylglucosamine O3’ and O4’ hydroxyls coordinating with 
the Ca1 in the main binding pocket, with recognition being completed by the usual amino 
acid side chains (Glu321, Asn323, Glu329 and Asn341) in a similar mechanism to maltose 
and ManNAc recognition [Shrive et al., 2003; Crouch et al., 2007].  This allows the N-linked 
acetyl group to extend above the side chains of Glu321 and Asn323, forming a water 
bridge network, with the β(1→4)-linked N-acetylmuramic acid extending away from the 
surface of the protein and distantly interacting with a symmetry related molecule.  A simple 
model of a longer peptidoglycan, including the first three amino acids of the peptide 
crosslinkers, demonstrates that the protein surface could easily accommodate the peptide 
as it extends into space with the remaining polysaccharide chain also extending away from 
the surface of the CRD in a roughly orthogonal direction.  This suggests the possibility that 
hSP-D may be able to recognise peptidoglycan embedded in the insoluble fragments of 
peptidoglycan if the GlcNAc residues are presented at the exposed face of the cell wall.  
Similarly, it also provides much needed insight into how hSP-D recognises soluble 
peptidoglycan, by the terminal GlcNAc, and how this might allow the potential clearance of 
gram-positive bacteria and their breakdown products. 
7.1.3 Flexibility and versatility of rfhSP-D in S. enterica sv. Minnesota recognition 
Surfactant protein D is also able to recognise the core polysaccharide of the gram negative 
lipopolysaccharides found in the outer membrane [Sahly et al., 2002; Wu et al., 2003].  
There has been extensive work showing that hSP-D is capable of recognising a range of 
gram-negative species with highest affinity for rough LPS mutants that lack the long 
repeating O-antigen, which can be highly variable, leaving the more conserved core 
polysaccharide accessible to the immune system and hSP-D.  In particular, heptose-rich 
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inner core oligosaccharides have been shown to be particularly susceptible to recognition 
by hSP-D,  elaborated on by a number of structural investigations into heptose recognition 
by rfhSP-D [Wang et al., 2008; Reinhardt et al., 2016]. This is typified by the successful high-
resolution structure of rfhSP-D in complex with the delipidated oligosaccharide core from 
H. influenzae Eagan 4A LPS. The structure reveals recognition of the inner core 
oligosaccharide via the O6’-O7’ hydroxyl groups of surface-proximal heptose [Clark et al., 
2016].  The work done by Clark and colleagues (2016) also revealed an anhydrous form of 
Kdo, 4,7-anhydro-3-deoxy-D-manno-oct-2-ulosonic acid, produced from the mild acid 
hydrolysis used to cleave the lipid A moiety, however the complete anhydro-Kdo was not 
visible in the electron density.  Building on this work, previous Keele structural biology PhD 
students  [Smallcombe, 2014; da Silva, 2016]  successfully soaked crystals of rfhSP-D with 
delipidated oligosaccharides from the Rc (R5) and Rd1 (R7) rough mutants of S. enterica sv. 
Minnesota. More recent advances in our understanding of the recognition mechanism has 
led to the reinvestigation of the structures reported here.  
The analysis of the structures reveals two binding mechanisms for the longer R5 
oligosaccharide, produced as a result of the crystal system restricting the binding site of 
subunit A.  In subunit B and C, the proximal heptose, HepI, is coordinated by the calcium 
through the O6’ and O7’ of the dihydroxyethyl side chain and the main mannosyl ring 
extends between Asn323 and Glu329 in a comparable conformation to the coordinating 
heptose in the H. influenzae Eagan 4A oligosaccharide complex and the L-D-diheptose 
complex [Wang et al., 2008; Clark et al., 2016].  This is mirrored by the R7 oligosaccharide 
complex where the proximal heptose is the main recognition residue, however, because R7 
lacks the terminal glucose, no ligand is present in subunit A and instead two waters 
complete the coordination of Ca1.  While in all of the subunits where HepI is the primary 
site of recognition, the α(1 →5)-linked Kdo is in the anhydrous form previously identified in 
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the Eagan-bound structure, the re-investigation  provides the first direct evidence of β-
elimination of larger Kdo substituents and the 2-oxobutanoic acid side chain has, for the 
first time, been completely characterised in its β-anomeric form [Auzanneau, Charon and 
Szabó, 1991].  Subunit A of the R5 oligosaccharide complex contains the delipidated R5 
oligosaccharide bound via the terminal α-D-glucose, coordinated by the O3’ and O4’ 
hydroxyls.  The difference in binding may be an artefact of crystallisation but it does 
provide a unique insight into rfhSP-Ds propensity to recognise multiple epitopes in the LPS 
and the versatility to employ multiple binding mechanisms beyond the inner core Hep-Kdo 
mechanism when that epitope is not accessible. 
7.1.4 Asp325, Arg343 and the extended binding surface of hSP-D 
All of the structures presented here confirm the importance of the two flanking residues 
Asp325 and Arg343 in recognising oligosaccharide ligands.  In the small ligand-bound 
structures, Arg343 was involved in recognising the terminal glucose coordinated by Ca1 in 
all three structures and demonstrates the flexibility of this side chain to alter its 
conformation to interact with the O6’ or O5’, in the case of isomaltotriose.  The 
isomaltotriose complex emphasises the inherent flexibility in Arg343, which accommodates 
a much less extended conformation to allow the ligand to extend over the side chain and 
interact with Glu347 and Arg349; all of which is stabilised by a hydrogen bond between 
Arg343 and O4’ of the second glucose.  The importance of Arg343 in ligand recognition 
has been well studied and confirmed using crystallography, in silico modelling and 
biochemical analysis, but it has also been shown that both Arg343 and Asp325 can act as a 
selection factor for ligands by restricting the access to one side of the binding site [Shrive 
et al., 2003, 2009; Allen et al., 2004; Crouch et al., 2009].  This selective role is apparent in 
the muramyl disaccharide complex where the orientation of the terminal GlcNAc is 
restricted so that the N-linked acetyl branch extends above the calcium coordinating side 
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chains of Glu321 and Asn323 whilst maintaining the O3’-O4’ coordination to Ca1.  
Furthermore, subunit A of the R5-bound structure [da Silva, 2016; Littlejohn et al., 2018] 
reveals that Arg343 provides an important anchoring position for HepI in the LPS 
oligosaccharide, potentially directing the terminal glucose into the calcium binding pocket 
and permitting coordination to O3’ and O4’.  In subunits B and C of the two S. enterica 
Minnesota oligosaccharide complexes, where HepI is coordinated by Ca1, Arg343 is 
fundamental in recognising the proximal Hep-Kdo in combination with Asp325, which 
directly interact with the anhydro-Kdo and its 2-oxobutanoic acid side chain by adopting a 
conformation unique to the Hep-Kdo recognition mechanism [Littlejohn et al., 2018]. 
The role of Asp325 in selecting and coordinating ligands has been extensively explored 
using small ligand studies and site directed mutations, demonstrating a clear importance in 
ligand recognition [Crouch et al., 2009; Shrive et al., 2009].  Results presented here support 
the importance of Asp325 as it plays a critical role in recognising the anhydro-Kdo and is 
hypothesised to interact with a complete 6-membered Kdo based on a simple overlaid 
model.  Asp325 may also provide a single contact to the N-acetylmuramic acid of muramyl 
disaccharide, through the lactic acid chain [Clark et al., 2016; da Silva, 2016; Littlejohn et al., 
2018].  The crystal contacts prevent the interaction of MurNAc with Asp325 because of 
steric clashes in the crystal system, however, in vivo, the lactic acid side chain would be free 
to rotate around the O3’ ester bond and form a direct hydrogen bond with Asp325 OE1, 
while maintaining sufficient space for the peptide crosslinker. 
The small ligand complexes and the simple model of the complete R5 oligosaccharide 
complex indicate that the extended binding surface, first suggested by Crouch and 
colleagues in 2006, is more extensive than only Phe335 and extend in multiple directions 
away from the binding site, partly enabled by Arg343 [Crouch et al., 2006].  Maltotetraose 
extends towards Phe335 but is further from the surface of rfhSP-D than maltotriose, 
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forming an extended arch, which allows the reducing terminal glucose to interact with 
Thr336 and Asn337 rather than  stacking with the Phe335 phenyl ring as observed for 
maltotriose [Crouch, McDonald, et al., 2006; Shaw, 2009].  In contrast, isomaltotriose, due to 
the flexibility afforded by the α(1→6) glycosidic linkage, extends above Arg343, causing the 
compressed conformation previously mentioned, towards a pocket created by Glu347 and 
Arg349.  These two side chains coordinate the nonterminal glucose with the non-reducing 
terminal glucose thought to make transient interactions with the protein.  Similarly, the 
KdoII-KdoIII, removed during delipidation in the R5 oligosaccharide bound structure, could 
easily be accommodated by the Glu347/Arg349 pocket that coordinates isomaltotriose.   
The R5 oligosaccharide is particularly interesting as a recent study suggested that synthetic 
LPS oligosaccharides have secondary recognition sites to the main Ca1 binding pocket, 
suggesting that surrounding residues may be important for the recognition of long, 
naturally occurring polysaccharides associated with LPS [Reinhardt et al., 2016].  However, 
this is the first experimental evidence for this extended binding surface in surfactant protein 
D, beyond Phe335, providing valuable insight into how SP-D is able to recognise longer 
polysaccharide ligands from a variety of pathogens and allergens, using a flexible and 
versatile mechanism across its surface. 
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7.2 Future work 
This study has identified a new binding mechanism for β-D-glucoses and an extended 
binding surface for longer ligands where Glu347 and Arg349 appear to form an important 
secondary binding pocket.  To explore this more fully, mutation studies of both Glu347 and 
Arg349 would provide insight into their role in the binding affinity for longer 
polysaccharide ligands such as mannan and pustulan.  A starting point may be a charge 
switch between the two side chains (i.e. E347R/R349E) which would maintain the hydrogen 
bond network seen in the studies in this thesis, progressing to alanine mutations to explore 
the importance of the secondary binding pocket.  Similarly, the structures reported here 
appear to highlight the importance of Thr336 and Asn337 in recognising tetrasaccharides, 
but this interaction requires further investigation.  Future work should continue to 
characterise the binding surface beyond the central calcium binding pocket, Ca1, as this 
surface may have an additive effect to the selectivity already described for Asp325 and 
Arg343. 
Further work is required into the recognition mechanism for gram-positive bacterial cell 
wall components and their associated soluble markers.  The muramyl disaccharide complex 
demonstrates that hSP-D is able to recognise a small fragment of the polysaccharide core 
of peptidoglycan but provides no information about how, for example, the pentapeptides 
may affect the recognition or whether they may, in fact, interact with a further extended 
binding surface that has not yet been identified.  Larger fragments of intact peptidoglycan 
will make this possible, with an emphasis on including the oligopeptides.  It is unclear how 
successful a soaking protocol would be for these larger fragments as the solvent channels 
and crystal system may prevent the ligand from binding Ca1, in which case a co-
crystallisation protocol may be more suitable, allowing the ligand to bind prior to 
crystallisation.  Surfactant protein D also interacts with lipoteichoic acids on the surface of 
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gram-positive bacteria however this interaction has not been structurally characterised and 
will provide further insight into how gram-positive bacteria are recognised [van de 
Wetering et al., 2001].  It is not immediately clear from the structure of lipoteichoic acid 
what epitope hSP-D recognises as there are only two β(1→6)-linked glucoses in the whole 
chain, but a successful structural study would reveal, at the atomic level, how SP-D is able 
to bind this immunologically important gram-positive cell surface component. 
The work presented here in combination with the work of previous members of the 
research group provides an important foundation in characterising how human surfactant 
protein D recognises the inner core polysaccharide of gram-negative bacterial 
lipopolysaccharide, identifying two recognition mechanisms and an anhydro-Kdo 
[Smallcombe, 2014; Clark et al., 2016; da Silva, 2016; Littlejohn et al., 2018].  In the future, 
however, it is essential to gain a better understanding of how hSP-D recognises 
lipopolysaccharides that represent in vivo LPS more closely in both its intact, membrane-
bound form, and the polysaccharide released from the bacterial surface.  This will require: 
(1) a method for maintaining the KdoI as a six-membered ring following delipidation or 
solubilising LPS; (2) characterisation of how polysaccharide release affects the structural 
components of the polysaccharide.   
A method for delipidating LPS using hydrogen fluoride has been reported that preserves 
the Kdo in its natural, six-membered form which may enable characterisation of the 
interactions suggested by the model of the R5 oligosaccharide [Phillips et al., 1992].  It 
remains unclear if the anhydro-Kdo exists naturally following polysaccharide release from 
LPS.  As previous studies have shown, mass spectrometry is a useful tool in characterising 
the structures in the LPS, however further techniques could be useful, including nuclear 
magnetic resonance (NMR) and X-ray based techniques, to determine if the Kdo is intact in 
the polysaccharide fragments or if it is truly a product only of mild acid hydrolysis.  
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Structural characterisation of the fine detail of the interaction between hSP-D and cell 
surface receptors is an essential step towards completing the picture of hSP-D in the 
immune system, with the potential to provide structural insight into how hSP-D is able to 
regulate the immune system so effectively.  This would be an ambitious project requiring 
production of recombinant hSP-D, both full length trimers and the fragment used in these 
studies, and, more importantly, recombinant forms of putative cell surface receptors.  As 
hSP-D is a C-type lectin, it may be necessary to express the receptors in expression systems 
that permit glycosylation, which SP-D may recognise, presenting its own problems.  
Furthermore, membrane-bound proteins present additional problems to protein 
crystallography in that solubilised protein is required.  However, with the increasing 
accessibility of techniques such as crystallography using lipidic cubic phase, which provides 
a matrix for the insoluble domains of receptors, and increasingly powerful and high 
resolution cryo-electron microscopy (cryo-EM) techniques, the investigation of protein-
protein complexes is rapidly entering the mainstream and may the applied to hSP-D in the 
future. 
The ability of surfactant protein D to recognise, opsonise and clear gram-positive and 
gram-negative bacteria, viruses, fungi and other important pathogenic material makes it a 
tantalising therapeutic target, especially as cases of antibiotic resistance in mainly gram-
negative bacteria continue to increase and traditional treatments become less effective.  
The recombinant fragments of the neck and CRD have already shown promise in animal 
models using minimal invasive administration, however further structural work to 
determine how hSP-D, in particular, recognises both pathogens and host cells is required to 
maximise the safety and efficacy of potential hSP-D based therapeutics.  
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Appendices 
Appendix I:  Refinement statistics for maltotetraose and maltoheptaose complexed with rfhSP-D 
Refinement statistics from the maltotetraose and maltoheptaose bound complexes of 
recombinant fragment human surfactactant protein D.  The data was reprocessed as part of 
the small ligand studies (chapter 4) following the revelation that β-D-glucose can be 
recognised by hSP-D. 
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 Maltotetraose Maltoheptaose 
Data collection   
Wavelength (Å) 1.117 1.488 
Temperature (K) 100 100 
Space group P21 P21 
Cell Dimensions   
     a (Å) 55.53 55.41 
     b (Å) 108.45 108.14 
     c (Å) 55.76 55.67 
      β (°) 90.94 91.24 
Maximal resolution 
(Å) 
1.50 1.65 
Resolution range (Å) 55.75–1.50 (1.54-1.50) 55.43-1.65 (1.74-1.65) 
Observations 1 004 446 (59 772) 190 221 (22 059) 
Unique reflections 104 894 (15 315) 60 189 (6 974) 
Completeness (%) 99.7 95.4 
Rmergea 0.382  
I/σ(I) 2.0 2.4 
   
Refinement   
Protein atomsb 3 475 3 469 
     Residues, chain A 206 - 355 205 - 355 
     Residues, chain B 205 - 355 204 - 355 
     Residues, chain C 206 - 355 206 - 355 
Other atoms   
     Calcium ions 10 10 
     Ligand A = 4, B = 1, C = 1 A = 2, B = 1, C = 1 
     Water 639 525 
Resolution range (Å) 55.75 – 1.50 55.43 – 1.65 
Rworkc 0.1703 0.1664 
Rfreed 0.1903 0.2084 
Average B-values (Å2)   
     Protein main chain 17.89 23.74 
     Ligand 24.93 30.38 
     Water 36.67 34.94 
Ramachandron plot 
valuese (%)   
     Favoured 98.43 98.21 
     Allowed 1.57 1.79 
     Disallowed 0.00 0.00 
aRmerge= ΣhΣj|Ih,j-Ih| / ΣbΣj|Ih,j|, where Ih,j is the jth observation of reflection h and Ih is the 
mean of j for reflection h 
bTotal number of protein atoms used in refinement 
cRwork= Σh||Foh|-|Fch|| / Σh|Foh|, where Foh and Fch are the observed and calculated 
structure factor amplitudes, respectively, for reflection h. 
dRfree= Rwork but for a random 5% subset of reflections 
edefined by MolProbity analysis 
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Abstract  
The crystal structures of a biologically and therapeutically active recombinant 
homotrimeric fragment of native human SP-D (hSP-D) complexed with the inner core 
oligosaccharide of the Salmonella enterica sv Minnesota rough strains R5 and R7 (rough 
mutant chemotypes Rc and Rd1) have been determined. The structures reveal that hSP-D 
specifically and preferentially targets the LPS inner core via the innermost conserved Hep-Kdo 
pair with the flexibility for alternative recognition when this preferred epitope is not available 
for binding. Hep-Kdo binding is achieved through calcium dependent recognition of the 
heptose dihydroxyethyl side chain coupled with specific interactions between the Kdo and the 
binding site flanking residues Arg343 and Asp325 with evidence for an extended binding site 
for LPS inner cores containing multiple Kdo residues. In one subunit of the R5-bound structure 
this preferred mode of binding is precluded by the crystal lattice and oligosaccharide is bound 
through the terminal inner core glucose. The structures presented here thus provide unique 
multiple insights into the recognition and binding of bacterial LPS by hSP-D. Not only is it 
demonstrated that hSP-D targets the highly conserved LPS proximal inner core Hep-Kdo motif, 
but also that hSP-D can recognise either terminal or non-terminal sugars and has the flexibility 
and versatility to adopt alternative strategies for bacterial recognition, utilising alternative LPS 
epitopes when the preferred inner core Hep-Kdo disaccharide is not available for binding.  
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Author Summary 
Host recognition of bacterial surface lipopolysaccharide (LPS) by the innate immune 
protein human surfactant protein D (hSP-D) has previously been shown to target the LPS inner 
core sugar heptose with the binding pocket mechanism including both the heptose and the 
preceding sugar Kdo. This recognition is believed to be compromised by extended LPS 
structures that effectively shield vulnerable sites in the LPS core, allowing pathogens with 
complex LPS extensions to efficiently evade hSP-D mediated innate immune defence. 
The crystal structures of the biologically and therapeutically active recombinant 
fragment of native hSP-D presented here act as an LPS molecular filter, providing binding sites 
that both accept and preclude inner core heptose-Kdo binding. Our study shows for the first 
time that where both an LPS inner core Heptose-Kdo motif and the hSP-D LPS binding site are 
accessible, recognition of bacterial LPS occurs through this motif; where this binding mode is 
not available and a suitable alternative LPS epitope is present, then an alternative mode of 
recognition is adopted. Specifically, we show that hSP-D recognition of Salmonella enterica 
strains R5 and R7 LPS occurs preferentially through the inner core heptose-Kdo, with hSP-D 
having the flexibility and versatility to target the terminal glucose of the R5 mutant LPS when 
the preferred epitope is not accessible for binding.  
 
Introduction 
The innate immune protein human surfactant protein D (hSP-D) is a collagenous C-
type lectin prototypically associated with the lung surfactant but now identified throughout 
the human body [1]. SP-D recognises a wide range of pathogens, through their surface 
carbohydrate arrays, leading to rapid deactivation and clearance through activation of 
phagocytic cells [2-4].  
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Numerous studies of the binding of simple sugars to both hSP-D and rfhSP-D, a 
recombinant homotrimeric native fragment comprised of the neck region plus three CRDs 
which exhibits significant biological and therapeutic activity in vivo and in vitro [5-10] have 
been carried out both in solution and through 3-dimensional structural studies. Binding 
studies which demonstrate affinity for simple sugars such as glucose, mannose, maltose, 
heptose and inositol [11-13] have been confirmed crystallographically (see for example [13-
18]. In all cases recognition is through CRD Ca-dependent binding of the terminal 
monosaccharide through a mannose-type equatorial hydroxyl pair O3' and O4' or a 
stereochemically equivalent pair.  
A number of studies of gram-negative bacteria, including Escherichia coli, Salmonella 
enterica serovar Minnesota and Haemophilus influenzae [19,20] have reported that 
lipopolysaccharide (LPS) on the bacterial surface mediates hSP-D binding with LPS recognition 
initially thought to be via terminal carbohydrate residues through carbohydrate recognition 
domain Ca-dependent binding of a mannose-type equatorial hydroxyl pair on the terminal 
monosaccharide [14-16]. Our recent structural definition of the recognition of H. influenzae 
Eagan strains inner core LPS by a recombinant fragment of native hSP-D (rfhSP-D) [6,7,21] 
revealed that recognition occurs by calcium-dependent binding of the non-terminal heptose in 
the proximal inner core, with the Kdo positioned to interact with the binding site flanking 
residues Asp325 and Arg343 [15,16]. Furthermore, a recent study by Reinhardt and colleagues 
has identified that a number of synthetic oligosaccharide cores can be bound by wildtype hSP-
D with increased affinities for heptose-rich cores and a clear preference for a terminal Hep-Kdo 
motif compared to Hep alone [22]. 
Salmonella enterica is a gram-negative bacterium that causes widespread outbreaks of 
gastroenteritis and bacteraemia in humans, with the most severe S. enterica Typhi infections 
causing enteric fever (reviewed by Coburn et al. [23]). Serovar Minnesota has been identified as 
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the causative agent in a number of gastroenteritis outbreaks and, more recently, urosepsis in a 
Crohn’s patient [24-26]. The LPS oligosaccharide can be divided into the core oligosaccharides, 
containing 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), L-glycero-D-manno-heptose (Hep), 
α-D-glucose (Glc), α-D-galactose (Gal) and N-acetyl-D-glucosamine (GlcNAc), and the 
antigen-specific O-oligosaccharides that extend in repeats away from the bacterial cell surface 
[27]. In Salmonella species the inner and, to a large extent, the outer core oligosaccharides are 
a conserved epitope [28].  
Rough mutants of S. enterica Minnesota lack the O-antigen, leaving the core sugar 
residues exposed to the immune system leading to the possibility of recognition by SP-D in a 
similar manner to that reported for H. influenzae Eagan 4A [21]. While the LPS core is largely 
conserved, mutations in the synthetic enzymes responsible for assembling the LPS can result in 
truncated oligosaccharide cores such as those of strains R5 and R7, equivalent to the Rc and 
Rd1 phenotypes (Fig 1), demonstrated through lectin blotting and agglutination-inhibition 
studies to be recognised by hSP-D [19]. The R5 and R7 rough strain LPS exhibit similar 
structures with the R5 extended by an extra glucose (GlcI) bound to HepII. The R5 strain arises 
from a single mutation in the phosphorylation step of HepI, inhibiting and impacting on the 
phosphorylation of HepII and the addition of GalI and GalII to GlcI. Phosphorylation of HepI 
and HepII initiates the extension of GalI and GalII from GlcI, producing the Rb2 strain [30-33].  
While the H. influenzae Eagan 4A LPS [21] includes a truncated inner core with a single 
Kdo and a single Hep with a single Glc extension, the S. enterica Minnesota strains R5 and 
R7provide the opportunity to investigate, through crystal structure analysis, host recognition of 
more complex natural LPS structures with inner cores containing multiple Kdo and Hep 
alongside a terminal Glc in the R5 strain. Here we show that hSP-D recognition of Salmonella 
enterica sv Minnesota rough strains R5 and R7 (rough mutant chemotypes Rc and Rd1) LPS 
occurs preferentially through the inner core Hep-Kdo, with hSP-D having the flexibility and 
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versatility to target the terminal glucose of R5 when the preferred epitope is not accessible for 
binding.  
 
Results 
The trimeric rfhSP-D structures comprising three carbohydrate recognition domains 
(CRDs) and the α-helical coiled-coil neck region have been refined to 1.65 Å and 1.75 Å 
resolution for the R5-bound and R7-bound structures respectively. In all but one of the CRDs 
the structures reveal oligosaccharide ligand in the Ca1 binding pocket. No ligand is present in 
subunit A of the R7-bound structure while the mode of oligosaccharide recognition in subunit 
A of the R5-bound structure differs from the Hep-Kdo binding seen in subunits B and C of 
both structures.  
The bound oligosaccharide is clearly defined in the electron density of both structures; 
Kdo-HepI-HepII for the R7 and Kdo-HepI-HepII-Glc1 for R5 (Fig 2). The Kdo is in the anhydro 
form (Fig 3) reported by Shrive and co-workers [21] in the rfhSP-D –H. influenzae Eagan 4A 
structure (pdb entry 4E52) but here the 5-membered ring and all substituents are fully defined 
in the electron density (Fig 4) except in subunit A of the R5-bound structure where LPS binding 
is not via HepI and the terminal anhydro Kdo is poorly defined. The Kdo electron density 
clearly shows the 2-oxobutanoic acid sidechain off C4 (Fig 3b) in a beta conformation with 
respect to the glycosidic bond in both structures. KdoII and KdoIII (Fig 1) are not present in the 
electron density. 
In subunits B and C, in both structures, recognition of the oligosaccharide by rfhSP-D 
(Fig 5 and Table 1) is primarily via protein and Ca1 coordination of the 6'OH and 7'OH of the 
dihydroxyethyl side chain of HepI. Further HepI interactions with the binding pocket in these 
four subunits include those routinely associated with carbohydrate recognition by hSP-D [21]. 
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Table 1. Calcium and ligand binding distances (Å) 
 
Atom 1 Atom 2 
R5  R7 
A B C  A B C 
Ca1  Glu 321 OE1 2.63 2.61 2.57  2.65 2.60 2.64 
  Asn 323 OD1 2.46 2.42 2.47  2.49 2.44 2.38 
  Glu 329 OE1 2.42 2.49 2.44  2.51 2.41 2.34 
  Asn 341 OD1 2.50 2.44 2.44  2.37 2.43 2.44 
  Asp 342 OD1 2.47 2.38 2.40  2.35 2.34 2.28 
  Asp 342 O 2.61 2.55 2.62  2.54 2.51 2.51 
  HepI O6' - 2.34 2.34  - 2.36 2.37 
    O7' - 2.38 2.34  - 2.35 2.34 
  GlcI O3' 2.38 - -  - - - 
    O4' 2.36 - -  - - - 
HepI O6' Glu 321 OE2 - 2.67 2.61  - 2.63 2.52 
  Asn 323 ND2 - 3.01 2.92  - 3.03 2.93 
 O7' Glu 329 OE2 - 2.66 2.65  - 2.64 2.57 
  Asn 341 ND2 - 2.98 3.04  - 2.94 3.07 
GlcI O3' Glu 321 OE2 2.67 - -  - - - 
  Asn 323 ND2 2.76 - -  - - - 
 O4' Glu 329 OE2 2.69 - -  - - - 
  Asn 341 ND2 3.00 - -  - - - 
KdoI O1 Arg 343 NH2 - 3.09 2.87  - - - 
KdoI O2 Arg 343 NH1 - 3.09 3.26  - 3.10 3.06 
KdoI O6 Asp  325 OD2 - 2.80 2.56  - 2.76 2.69 
GlcI O6' Arg 343 NH1 3.30 - -  - - - 
GlcI O6' Arg 343 NH2 3.22 - -  - - - 
HepI O4' Arg 343 NH2 3.06 - -  - - - 
 
In contrast to the Ca1-HepI binding in the B and C subunits of both structures, subunit 
A of the R5-bound structure reveals an alternative mode of LPS recognition with calcium-
dependent binding of the terminal glucose GlcI of R5, with the remaining R5 oligosaccharide 
chain HepII-HepI-Kdo extending over Arg343 and the SP-A (surfactant protein A), SP-D 
conserved Arg349 and Glu333 (Fig 6). The relative positions of the LPS for the two alternative 
binding modes are shown in Fig 7a where least-squares fitting of the main chain CRD in the 
two cases reveals the completely different LPS orientations despite the conserved Ca1-OH 
interactions. The position of the Ca1-bound glucose GlcI and its interactions with Ca1 and the 
binding pocket closely mirror those reported in a variety of structures including the rfhSP-D 
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maltose bound structure [14] as shown in Fig7b. The Ca1 coordinates to the terminal glucose 
GlcI through 3'OH (2.38 Å) and 4'OH (2.36 Å). Protein coordination to both calcium (via Glu321, 
Asn323, Glu329, Asn341) and the calcium-bound Glc1 hydroxyls (via Glu321, Asn323, Glu329, 
Asn341, Asp342) follows the established pattern for ligand-bound SP-D structures (Table 1). 
Calcium Ca3, the more weakly coordinated of the three calcium ions Ca1, Ca2, Ca3 [15], is 
absent throughout the R5-bound structure. Ca2 is only weakly defined in subunit B of the R5-
bound structure and is absent in subunit C where the calcium (Ca2 and Ca3) coordinating loop 
between Asp297 and Tyr304 is rearranged and a water molecule replaces Ca2. 
In both structures and for both modes of binding (Ca1 coordination of HepI or GlcI) 
additional direct interactions between the protein and bound oligosaccharide are dominated 
by the binding-pocket flanking residues Arg343 and Asp325 (Table 1). For both ligands where 
HepI is coordinated to Ca1 (subunits B and C, both structures) the Kdo (anhydro) interacts with 
both binding site flanking residues, forming hydrogen bonds with Asp325 through Kdo O6 
(2.56 – 2.80 Å) and with Arg343 through the extended 2-oxobutanoic acid sidechain of the 
anhydro Kdo (Fig 5 and Table 1). In subunit A of the R5-bound structure where GlcI is 
coordinated to Ca1, additional direct interaction between protein and oligosaccharide again 
involves Arg343 (Fig 6) which forms weak hydrogen bonds to both GlcI 6'OH and O4' of HepI 
(Table 1). The direct interactions between protein and oligosaccharide ligand in both structures 
and all subunits where oligosaccharide ligand is present are supplemented by extensive water 
molecule networks linking the ligand to the protein. 
 
Discussion 
The structures of rfhSP-D, a biologically active recombinant native fragment of hSP-D, 
bound to inner core structures of S. enterica Minnesota LPS from deep rough mutant strains 
reveal SP-D targeting of the proximal inner core Hep-Kdo motif through calcium-dependent 
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binding of the (non-terminal) Hep supplemented by interaction of both Hep and Kdo with the 
binding site flanking residues Arg343 and Asp325. The structures also provide a definitive 
demonstration for the first time that hSP-D has the versatility to recognise alternative LPS 
epitopes when the Hep-Kdo inner core unit is inaccessible. This flexibility and versatility of LPS 
recognition is supplemented by evidence of an extended recognition surface that interacts 
with the LPS inner core oligosaccharide. The Kdo structure itself provides the first direct 
confirmation that mild hydrolysis removal of the lipid A from intact LPS exhibiting 4-KdoI 
substituted KdoII is accompanied by the elimination of KdoII from KdoI C4 [35,36] in a manner 
entirely equivalent to the β-elimination of phosphate from KdoI C4 through mild acid 
hydrolysis [21]. This is of some significance in the interpretation of mass spectrometry studies 
of bacterial LPS structure. 
In all subunits where the carbohydrate binding site is openly accessible in the crystal 
(subunits B and C, both structures), HepI is coordinated to calcium Ca1 as reported for the H. 
influenzae Eagan 4A – rfhSP-D structure [21] with KdoI extending between the two binding-
site flanking residues, Asp325 and Arg343, both of which interact directly with the bound 
HepI-Kdo (anhydro) unit (Fig 5). Superposition of the anhydro Kdo furanose rings together 
with HepI from all these subunits reveals an essentially conserved position of both rings 
resulting in very similar Asp325 – anhydro Kdo O6 interactions across the structures (2.56 – 
2.80 Å), but significant variations in the Arg343 – Kdo interactions (2.87 – 3.26 Å) (Table 1). This 
suggests an important flexibility inherent in the Arg343 – Kdo interaction. Combined with the 
well documented ability of Arg343 to respond to different ligands through conformational 
change in the Arg343 side chain [15], this reinforces the importance of the Arg343 -- ligand 
interaction as a flexible determinant of specificity. 
The R5 bound structure (Fig 6) reveals for the first time that hSP-D has the flexibility 
and versatility to recognise and bind alternative LPS epitopes if the HepI-Kdo core motif is not 
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accessible or, in the physiological context, is shielded by extended oligosaccharides in the 
outer core and beyond [21]. In subunit A access to the carbohydrate binding site is restricted 
with the crystal packing precluding binding of either the R5 or R7 oligosaccharide via the 
HepI-Kdo pair. The crystal packing does however allow Ca1 binding of the terminal glucose of 
the longer R5 oligosaccharide, which binds to the SP-D subunit A binding pocket with the 
oligosaccharide ligand (Fig 6) oriented in a direction roughly orthogonal to the ligand when 
HepI is bound to Ca1 (Fig 7) as in subunits B and C of both structures (Fig 5). Interestingly, 
despite the completely different position of HepI with respect to the protein structure, Arg343 
remains fundamental to the recognition of the LPS, stabilising the interaction through an 
Arg343-HepI hydrogen bond (Fig 6 and Table 1) and perhaps contributing to directing the 
glucose into the binding site [15,16]. While this novel structural demonstration that hSP-D can 
adopt alternative binding mechanisms for the same LPS is a fortuitous artefact of 
crystallisation, it clearly shows not only alternative recognition strategies for the same LPS but 
also the ability to recognise more than just the inner core heptose and Kdo residues in natural 
LPS ligands. This potentially provides an explanation for the extraordinary ability of hSP-D to 
recognise such a broad range of gram-negative bacteria by utilising Ca1-dependent binding of 
not just inner core HepI but also of multiple types of saccharide residue in the LPS [13,21]. The 
extent of the LPS, and the variety of different carbohydrate residues displayed on bacterial 
surfaces, provides the opportunity for versatility of recognition by the carbohydrate 
recognition domain.  
The full S. enterica sv. Minnesota R5 and R7 LPS oligosaccharides (Fig 1) are known to 
be recognised by hSP-D [19]. Positioning the full R5 oligosaccharide, including KdoII, KdoIII 
and a full 6-membered KdoI ring, in the R5-bound structure (subunit C) by overlaying HepI 
reveals that KdoI may be oriented such that the dihydroxyethyl side chain (7'OH, 8'OH) off C6 
interacts either with Asp325 or Arg343. In the orientation shown in Fig 8, KdoII sits between 
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KdoI and the conformationally flexible side chain of Arg343 with both KdoII and KdoIII 
proximal to the SP-D conserved Glu347 and the SP-A, SP-D conserved Arg349 and Glu333. 
KdoI O7' interacts with Asp325, KdoII O1' with Arg343, and KdoIII O8' with Glu347. The lipid A 
linked to KdoI O2' extends out from the CRD and the trimer overall. Salmonella enterica 
mutants with more extended cores and which are recognised by SP-D [19] can also be 
accommodated in this orientation. For the Rb3 mutant for example (Fig 1), the sugars linked to 
HepII and Glc1 all extend away from the CRD. This strongly suggests an extended inner core 
binding site with recognition of the Hep-Kdo motif accompanied by additional binding of 
inner cores with multiple Kdo structures such as those of Pseudomonas aeruginosa, 
Escherichia coli and Klebsiella pneumoniae which are known to be recognised by rfhSP-D [37].  
Previous studies of the hSP-D/LPS interaction have shown the importance of Asp325 
and Arg343 as oligosaccharide ligand selection mediators, flanking the binding site and 
directing calcium recognition [13-17], alongside the targeting of the LPS proximal inner core. 
The structures presented here combine and extend these key elements, revealing the preferred 
inner core Hep-Kdo binding mechanism alongside a flexibility to recognise alternative 
epitopes, to provide unique insights into the recognition and binding of a wide variety of gram 
negative bacteria by hSP-D.  
 
Materials and methods 
S. enterica Minnesota R5 and R7 Oligosaccharide Preparation. The oligosaccharide 
(delipidated) portions of Salmonella enterica sv. Minnesota R5 (Enzo Lifesciences-ALX-581-
017-L002) and R7 (Enzo Lifesciences-ALX-581-018-L002) mutants were prepared under mild 
hydrolysis conditions with 2% acetic acid, in accordance with the method previously published 
by Masoud et al. [38] and our previously published procedures [21]. For the R5 LPS the 
molecular weight was calculated as ≈ 3036 D a by the addition of all glycoconjugates and Lipid 
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A. The lipid A portion accounted for ≈ 1800 D a [39], making up 60% of the LPS. 2 mg of R5 LPS 
were initially hydrolysed, yielding ≈0.7 m g of the oligosaccharide representing 88%  hydrolysis 
efficiency. The R5 oligosaccharide was dissolved in deionised water to give a KdoI-HepI-HepII-
GlcI concentration of ≈16 m M  (accounting for the beta elim ination of KdoII-KdoII (see Fig 3)) 
for storage and for use in crystal soaking. The same procedure was followed for the R7 LPS 
providing a stock solution of ≈18m M  for storage and for use in crystal soaking and 
cryoprotection preparation. 
 
Generation and purification of a recombinant fragment of hSP-D. A recombinant 
homotrimeric fragment of human SP-D (rfhSP-D) was expressed and purified as described 
previously [5,6,14]. Each chain contains 177 amino acids (Gly179 to Phe355) comprising a short 
collagen region with eight Gly-X-Y repeats, the α-helical coiled coil neck region and the 
globular CRD. The contaminating level of endotoxin present in the rfhSP-D preparation was 
minimized [6] using a Polymyxin B column (Detoxi-Gel, Pierce, UK) to remove endotoxin 
followed by assaying with the QCL-1000 Limulus amoebocyte lysate system (BioWhittaker, 
Walkersville, MD) according to manufacturer's instructions. The assay was linear over a range 
of 0.1–1.0 EU/ml (10 EU=1 ng of endotoxin).  
 
Crystallisation, ligand soaking and cryoprotection. The endotoxin treated rfhSP-D at 8.8 
mg/ml in PBS was used for crystallisation both directly (for the R7 studies), following addition 
of CaCl2 to give 10mM, and after dialysis (for the R5 studies) into 50 mM Tris, 10 mM CaCl2, 
150 mM NaCl, 0.02% NaN3 at pH7.4. Protein concentrations used were 7.7 – 8.9 mg/ml. Native 
crystals of rfhSP-D were grown in sitting drops using screens around conditions previously 
reported [14]. Those for soaking with the delipidated R5 LPS were grown in precipitant buffer 
0.1 M tris pH 8.0, 16% PEG 6000, and for the delipidated R7 LPS in 0.1 M Tris pH 7.0, 16% PEG 
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10000. Cryoprotectant buffers were prepared as previously described [21] to provide 
increasing concentrations (5-20% for R5; 5-15% for R7) of MPD (2,4-methylpentane diol) in 
precipitant buffer with ligand added to provide final ligand concentrations of ≈8 m M  and ≈13 
mM in the crystallisation drop for R5 and R7 respectively. The crystals were soaked with ligand 
and prepared for cryocooling by successive addition of cryoprotectant containing increasing 
concentrations of MPD (5-15% for R7; 5-20% for R5) in 2 µl aliquots over three minutes 
followed by a final exchange of 6-8 µl of the drop with 6-8 µl of the final MPD cryoprotectant 
solution (15% MPD for R7; 20% MPD for R5). Crystals were flash-frozen at 100 K after a total of 
24 minutes (R5) or 8 minutes (R7) soaking with ligand and cryoprotectant buffer. 
 
Data collection, structure solution and refinement. Data for the rfhSP-D R5 and R7 
complexes were collected at 100 K at Diamond Light Source, Oxfordshire, on beamlines I04-1 
and I03, respectively, using Dectris Pilatus 6M hybrid photon counting detectors. Integrated 
intensities were calculated using the program MOSFLM [40]. The 1.6 Å native structure of 
rfhSP-D (PDB ID 1PW9 [14]) was used as a starting model for modelling both the rfhSP-D/R5 
and rfhSP-D/R7 structures. Electron density maps were calculated using the CCP4 suite of 
programs including AIMLESS, TRUNCATE, SORTMTZ and, where necessary, REINDEX [41]. 
Model building was completed using COOT [42] and refined using maximum likelihood 
refinement in REFMAC5 [43], available as part of the CCP4 package, in alternating rounds. 
Ligand topology and parameter files were generated using ProDRG [44] following fitting into 
the density. Final refinement statistics are presented in Table 2 and the quality of the final 
model was confirmed using the MolProbity web server [45]. The coordinates and structure 
factors for the R5-bound (PDB ID 5OXS) and R7-bound (PDB ID 5OXR) structures have been 
deposited with the Protein Data Bank. All main and side-chain stereochemical parameters are 
within accepted limits or better, with more than 98% of residues in favoured regions of the 
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Ramachandran plot with no outliers. Molecular figures were generated using CCP4mg 
molecular graphics software [46] and the PyMOL Molecular Graphics System Version 1.4 
(Schrödinger, LLC, 2011).  
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Table 2. Data collection and processing 
 
Data collection  Sm R7 oligo  Sm R5 oligo 
Synchrotron station  DLS I03  DLS I04-1 
Wavelength (Å)  0.97625  0.92819 
Space group   P21  P21 
Cell dimensions   a=55.33 Å, b=108.14 Å,   a=55.68 Å, b=108.51 Å, 
 c=55.67 Å, β=91.82⁰  c=56.17 Å, β=92.89⁰ 
  
Resolution range (Å)   55.3 – 1.75  56.10 – 1.65 
  (1.78-1.75)  (1.68-1.65) 
Observations   143,142 (7,653)  230,306 (10,955) 
Unique reflections   61,250 (3,299)  74,199 (3,629) 
Completeness (%)   93.2 (91.2)  93.0 (93.2) 
Rmerge a   0.066 (0.359)  0.054 (0.397) 
Mean (I/σ(I))   7.3 (2.2)  11.4 (2.5) 
   
Refinement   
Protein atoms  3483  3537 
 Residues chain A   205-355  204-355 
 Residues chain B  204-355  203-355 
 Residues chain C  205-355  203-355 
Water molecules  479  477 
Other molecules  
 Subunit  A B C A B C 
 Calcium ions  3 3 3 2 2 1 
 Oligosaccharide  - 1 1 1 1 1 
Rwork b (%)   17.3  16.5 
Rfree c (%)   19.6  18.7 
r.m.s.d. bond length (Å)  0.010  0.010 
r.m.s.d. bond angle (°)  1.40  1.32 
Average B-values (Å2) 
 Protein  23.1  22.6 
 Water  34.2  34.9 
 Other hetero-atoms  31.1  40.2 
PDB ID  5OXR  5OXS 
Ramachandran plot values d (%)   
 Favoured  97.8  97.8 
 Outliers  0.0  0.0 
 
Figures in parentheses refer to the highest resolution bin 
a Rmerge = ΣhΣj |Ih,j - Ih| /ΣhΣj |Ih,j| , where Ih,j is the jth observation of reflection h and Ih is the 
mean of the j measurements of reflection h. 
b Rwork = Σh ||Foh| - |Fch|| /Σh |Foh|  where Foh and Fch are the observed and calculated structure 
factor amplitudes, respectively, for the reflection h.  
c Rfree is equivalent to Rwork for a randomly selected subset (5%) of reflections not used in the 
refinement. 
d Defined according to Molprobity 
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FIGURE LEGENDS 
Fig 1. Core LPS structure of Salmonella enterica rough mutant strains. The LPS phenotypes (Ra, 
Rb1, Rb2, Rb3, Rc, Rd1, Rd2, and Re) and the mutant strains R5 and R7 are shown (modified 
from Mansfield and Forsythe, 2001 [29]). Glc: glucose; GlcNAc: N-acetyl-glucosamine; Gal: 
galactose; Hep: L-D-Heptose; P: phosphate; PEtn: phosphoethanolamine; Kdo: 3-deoxy-D-
manno-oct-2-ulosonic acid. 
 
Fig 2. Structure of the product of mild acid hydrolysis of S. enterica Minnesota rough mutants 
R5 and R7. Glc: glucose; Hep: L-D-Heptose; Kdo: 3-deoxy-D-manno-oct-2-ulosonic acid. 
 
Fig 3. Structure of the 4,7 closure furanoid derivative (anhydro Kdo) of Kdo following LPS 
delipidation by mild acid hydrolysis and β-elimination of the Kdo O4 substituent, reported by 
Shrive and co-workers (PDB ID 4E52, ligand KD5). Anhydro Kdo is proposed to be a racemic 
mixture (Auzanneau et al., 1991 [34]) with the 2-oxobutanoic acid side chain at C4 both alpha 
and beta to the glycosidic bond (at C5). (a) Original Kdo numbering retained. (b) Numbering 
according to pdb entry 4E52 (alpha) and used for the structure here. 
 
Fig 4. Electron density for the Salmonella enterica oligosaccharides bound to rfhSP-D (subunit 
B) with HepI in the Ca1 binding site. The calcium ion is in green and the four calcium and 
ligand coordinating residues Glu321, Asn323, Glu329 and Asn341 are shown in cpk. (a) R7 
oligosaccharide KdoI (anhydro)-HepI-HepII (b) R5 oligosaccharide KdoI (anhydro)-HepI-HepII-
Glc1. Maps are 2mFo-DFc contoured at 1σ. 
 
Fig 5. S. enterica R5 oligosaccharide bound to rfhSP-D (subunit C) with the inner core HepI in 
the Ca1 binding site. KdoI (anhydro) interacts with both Asp325 and Arg343. Similar binding is 
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observed in subunit B and in subunits B and C of the R7-bound structure which lacks the 
terminal glucose GlcI. Calcium coordinating bonds are represented by dots and protein-ligand 
interactions by dashes. The interactions of Glu333 are also indicated. 
 
Fig 6. S. enterica R5 oligosaccharide bound to rfhSP-D (subunit A) with the terminal glucose 
GlcI in the Ca1 binding site. HepI interacts with Arg343. No ligand was observed in subunit A 
of the R7-bound structure due to crystal lattice constraints. Calcium coordinating bonds are 
represented by dots and protein-ligand interactions by dashes. The interactions of Glu333 are 
also indicated.  
 
Fig 7. (a) Superposition of subunit A (GlcI bound) in cyan and subunit B (HepI bound) in yellow 
of the R5 LPS-bound structure following a least-squares fit of the CRD protein main chain 
atoms. (b) Superposition of subunit A (GlcI bound) in cyan of the R5 LPS-bound structure and 
subunit A (Glc1 bound) in coral of the maltose-bound structure [14] following a least-squares 
fit of the CRD protein main chain atoms. 
 
Fig 8. Model of complete S. enterica R5 oligosaccharide bound to rfhSP-D with the inner core 
HepI in the Ca1 binding site. KdoI (intact) is positioned to interact with Asp325, with KdoII and 
KdoIII interacting with Arg343 and Glu347 respectively. (a) subunit C, R5-bound structure (b) 
the rfhSP-D trimer with R5 similarly placed in each subunit and the link to lipid A from KdoI 
O2' indicated by . 
  
  Appendix II 
273 | P a g e  
 
 
 
 
Fig 1. Core LPS structure of Salmonella enterica rough mutant strains. The LPS phenotypes (Ra, 
Rb1, Rb2, Rb3, Rc, Rd1, Rd2, and Re) and the mutant strains R5 and R7 are shown (modified 
from Mansfield and Forsythe, 2001 [29]). Glc: glucose; GlcNAc: N-acetyl-glucosamine; Gal: 
galactose; Hep: L-D-Heptose; P: phosphate; PEtn: phosphoethanolamine; Kdo: 3-deoxy-D-
manno-oct-2-ulosonic acid. 
 
 
 
 
Fig 2. Structure of the product of mild acid hydrolysis of S. enterica Minnesota rough mutants 
R5 and R7. Glc: glucose; Hep: L-D-Heptose; Kdo: 3-deoxy-D-manno-oct-2-ulosonic acid. 
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Figure 3 
Fig 3. Structure of the 4,7 closure furanoid derivative (anhydro Kdo) of Kdo following LPS 
delipidation by mild acid hydrolysis and β-elimination of the Kdo O4 substituent, reported by 
Shrive and co-workers (PDB ID 4E52, ligand KD5). Anhydro Kdo is proposed to be a racemic 
mixture (Auzanneau et al., 1991 [34]) with the 2-oxobutanoic acid side chain at C4 both alpha 
and beta to the glycosidic bond (at C5). (a) Original Kdo numbering retained. (b) Numbering 
according to pdb entry 4E52 (alpha) and used for the structure here. 
Fig 4. Electron density for the Salmonella enterica oligosaccharides (in yellow) bound to rfhSP-
D (subunit B) with HepI in the Ca1 binding site. The calcium ion is in green and the four 
calcium and ligand coordinating residues Glu321, Asn323, Glu329 and Asn341 are shown in 
cpk. (a) R7 oligosaccharide KdoI (anhydro)-HepI-HepII (b) R5 oligosaccharide KdoI (anhydro)-
HepI-HepII-Glc1. Maps are 2mFo-DFc contoured at 1σ. 
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Fig 5. S. enterica R5 oligosaccharide bound to rfhSP-D (subunit C) with the inner core HepI in 
the Ca1 binding site. KdoI (anhydro) interacts with both Asp325 and Arg343. Similar binding is 
observed in subunit B and in subunits B and C of the R7-bound structure which lacks the 
terminal glucose GlcI. Calcium coordinating bonds are represented by dots and protein-ligand 
interactions by dashes. The interactions of Glu333 are also indicated. 
 
 
Fig 6. S. enterica R5 oligosaccharide bound to rfhSP-D (subunit A) with the terminal glucose 
GlcI in the Ca1 binding site. HepI interacts with Arg343. No ligand was observed in subunit A 
of the R7-bound structure due to crystal lattice constraints. Calcium coordinating bonds are 
represented by dots and protein-ligand interactions by dashes. The interactions of Glu333 are 
also indicated.  
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Fig 7. (a) Superposition of subunit A (GlcI bound) in cyan and subunit B (HepI bound) in yellow 
of the R5 LPS-bound structure following a least-squares fit of the CRD protein main chain 
atoms. (b) Superposition of subunit A (GlcI bound) in cyan of the R5 LPS-bound structure and 
subunit A (Glc1 bound) in coral of the maltose-bound structure [14] following a least-squares 
fit of the CRD protein main chain atoms. 
 
Fig 8. Model of complete S. enterica R5 oligosaccharide bound to rfhSP-D with the inner core 
HepI in the Ca1 binding site. KdoI (intact) is positioned to interact with Asp325, with KdoII and 
KdoIII interacting with Arg343 and Glu347 respectively. (a) subunit C, R5-bound structure (b) 
the rfhSP-D trimer with R5 similarly placed in each subunit and the link to lipid A from KdoI 
O2' indicated by . 
 
